  | Vieujean, S., Lindsay, J. O., D'Amico, F., Ahuja, V., Silverberg, M. S., Sood, A., Yamamoto-Furusho, J. K., Nagahori, M., Watanabe, M., Koutroubakis, I. E., Foteinogiannopoulou, K., Avni Biron, I., Walsh, A., Outtier, A., Nordestgaard, R. L. M., Abreu, M. T., Dubinsky, M., Siegel, C., Louis, E., ... Peyrin-Biroulet, L. (2023). Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad180  Peer Reviewed verified by ORBi |
  | Martinez, E., Crevecoeur, S., THIRION, C., GRANDJEAN, J., Fall, P. A., Hayette, M.-P., Moutschen, M., Taminiau, B., Louis, E., & Daube, G. (10 October 2023). Gut Microbiota Associated with Clostridioides difficile Carriage in Three Clinical Groups (Inflammatory Bowel Disease, C. difficile Infection and Healthcare Workers) in Hospital Field. Microorganisms, 11 (10), 2527. doi:10.3390/microorganisms11102527 Peer Reviewed verified by ORBi |
 | Pierre, N., VIEUJEAN, S., Meuwis, M.-A., & Louis, E. (2023). Définir la rémission biologique dans la maladie de Crohn. Medi-Sphere. |
 | Di Giovanni, N., Meuwis, M.-A., Louis, E., & Focant, J.-F. (23 September 2023). Correlations for untargeted GC × GC-HRTOF-MS metabolomics of colorectal cancer. Metabolomics, 19 (10), 85. doi:10.1007/s11306-023-02047-1 Peer Reviewed verified by ORBi |
| Vieujean, S., Kotze, P. G., Netter, P., Germain, A., Louis, E., Danese, S., & Peyrin-Biroulet, L. (2023). Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough? Expert Opinion on Pharmacotherapy, 1 - 13. doi:10.1080/14656566.2023.2232726 Peer Reviewed verified by ORBi |
 | Latour, P., & Louis, E. (2023). La colopathie fonctionnelle : toujours d’actualité ? Place au syndrome de l’intestin irritable. Revue Médicale de Liège. Editorial Reviewed verified by ORBi |
 | Bhatt, K., Orlando, T., Meuwis, M.-A., Louis, E., Stefanuto, P.-H., & Focant, J.-F. (01 June 2023). Comprehensive Insight into Colorectal Cancer Metabolites and Lipids for Human Serum: A Proof-of-Concept Study. International Journal of Molecular Sciences, 24 (11), 9614. doi:10.3390/ijms24119614 Peer Reviewed verified by ORBi |
 | Bacha, R. A., Bouhnik, Y., Serrero, M., Filippi, J., Roblin, X., Bourrier, A., Bouguen, G., Franchimont, D., Savoye, G., Buisson, A., Louis, E., Nancey, S., Abitbol, V., Reimund, J.-M., DeWit, O., Vuitton, L., Mathieu, N., Peyrin-Biroulet, L., Gilletta, C., ... Picon, L. (Other coll.). (2023). Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID. Digestive and Liver Disease. doi:10.1016/j.dld.2023.05.008 Peer reviewed |
  | Loftus, E. V. J., Panés, J., Lacerda, A. P., Peyrin-Biroulet, L., D'Haens, G., Panaccione, R., Reinisch, W., Louis, E., Chen, M., Nakase, H., Begun, J., Boland, B. S., Phillips, C., Mohamed, M.-E. F., Liu, J., Geng, Z., Feng, T., Dubcenco, E., & Colombel, J.-F. (25 May 2023). Upadacitinib Induction and Maintenance Therapy for Crohn's Disease. New England Journal of Medicine, 388 (21), 1966-1980. doi:10.1056/NEJMoa2212728 Peer Reviewed verified by ORBi |
| Pierre, N., Vieujean, S., Peyrin-Biroulet, L., Meuwis, M.-A., & Louis, E. (2023). Defining biological remission in Crohn's disease: interest, challenges and future directions. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad086 Peer Reviewed verified by ORBi |
 | Vieujean, S., Lindsay, J., Rubin, D., D’Amico, F., Ahuja, V., Silverberg, M., Sood, A., Yamamoto-Furusho, J., Nagahori, M., Watanabe, M., Koutroubakis, I., Foteinogiannopoulou, K., Walsh, A., Outtier, A., Abreu, M., Dubinsky, M., Siegel, C., Louis, E., Dotan, I., ... Peyrin-Biroulet, L. (06 May 2023). Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD [Poster presentation]. Digestive Disease Week. Peer reviewed |
 | Guiot, J., Henket, M., Remacle, C., Cambier, M., Struman, I., Winandy, M.-L., Moermans, C., Louis, E., Malaise, M., Ribbens, C., Louis, R., & Njock, M.-S. (15 April 2023). Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respiratory Research, 24 (1), 112. doi:10.1186/s12931-023-02413-6 Peer Reviewed verified by ORBi |
 | Loly, J.-P., Vieujean, S., Reenaers, C., Van Kemseke, C., Seidel, L., Louis, E., & Somja, J. (2023). In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or Vedolizumab. Inflammatory Bowel Diseases. doi:10.1093/ibd/izad066 Peer Reviewed verified by ORBi |
 | Horrigan, J. M., Louis, E., Spinelli, A., Travis, S., Moum, B., Salwen-Deremer, J., Halfvarson, J., Panaccione, R., Dubinsky, M. C., Munkholm, P., & Siegel, C. A. (April 2023). The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease. Crohn's & colitis 360, 5 (2), 006. doi:10.1093/crocol/otad006 Peer reviewed |
 | Amiot, A., Chaibi, S., Bouhnik, Y., Serrero, M., Filippi, J., Roblin, X., Bourrier, A., Bouguen, G., Franchimont, D., Savoye, G., Buisson, A., Louis, E., Nancey, S., Abitbol, V., Reimund, J.-M., Dewit, O., Vuitton, L., Mathieu, N., Peyrin-Biroulet, L., ... GETAID-patient experience study, G. (2023). Prevalence and determinants of fatigue in patients with IBD: a cross-sectional survey from the GETAID. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad060 Peer Reviewed verified by ORBi |
| Vieujean, S., Louis, E., Danese, S., & Peyrin-Biroulet, L. (2023). A critical review of ustekinumab for the treatment of active ulcerative colitis in adults. Expert Review of Gastroenterology and Hepatology, 1 - 18. doi:10.1080/17474124.2023.2194632 Peer Reviewed verified by ORBi |
 | Vieujean, S., Lindsay, J., Rubin, D., D’Amico, F., Ahuja, V., Silverberg, M., Sood, A., Yamamoto-Furusho, J. K., Nagahori, M., Watanabe, M., Koutroubakis, I. E., Foteinogiannopoulou, K., Walsh, A., Outtier, A., Abreu, M. T., Dubinsky, M., Siegel, C., Louis, E., Dotan, I., ... Peyrin-Biroulet, L. (March 2023). Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. Peer reviewed |
 | Vieujean, S., GILLARD, R., Calvaer, F., Chayeb, M., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Louis, E., & Meunier, P. (March 2023). Assessment of therapeutic response in Crohn’s disease by dynamic contrast enhanced MRI [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
| Bequet, E., Salée, C., BLETARD, N., Vieujean, S., Massot, C., Fonzé, F., Sarter, H., Ley, D., Colinet, S., Delvenne, P., Seghaye, M.-C., Louis, E., & Meuwis, M.-A. (March 2023). Characterization of Protein Disulfide Isomerases in adult and pediatric Crohn’s Disease and association with inflammation and fibrosis [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023, Copenhagen, Denmark. Peer reviewed |
Stefanuto, P.-H., Bhatt, K., Meuwis, M.-A., Louis, E., & Focant, J.-F. (March 2023). Développement d’une approche multimodale combinant metabolomique et lipidomique compatible avec la GC×GC-MS [Paper presentation]. SEP23, Paris, France. Editorial reviewed |
 | Vieujean, S., Lindsay, J., Rubin, D., D'Amico, F., Ahuja, V., Silverberg, M., Sood, A., Yamamoto-Furusho, J. K., Nagahori, M., Watanabe, M., Koutroubakis, I. E., Foteinogiannopoulou, K., Walsh, A., Outtier, A., Abreu, M. T., Dubinsky, M., Siegel, C., Louis, E., Dotan, I., ... Peyrin-Biroulet, L. (March 2023). Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
 | Vieujean, S., GILLARD, R., Calvaer, F., Chayeb, M., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Louis, E., & Meunier, P. (March 2023). Assessment of therapeutic response in Crohn’s disease by dynamic contrast enhanced MRI [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
| Bequet, E., Salée, C., BLETARD, N., Vieujean, S., Massot, C., Fonzé, F., Sarter, H., Ley, D., Colinet, S., Delvenne, P., Seghaye, M.-C., Louis, E., & Meuwis, M.-A. (March 2023). Characterization of Protein Disulfide Isomerases in adult and pediatric Crohn’s Disease and association with inflammation and fibrosis [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
| Gofflot, A., MONIN, L., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Forthomme, B., Croisier, J.-L., Louis, E., & Vieujean, S. (March 2023). Impact of different types of physical activity in inflammatory bowel disease [Paper presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
 | Louis, E., Resche-Rigon, M., Laharie, D., Satsangi, J., Ding, N., Siegmund, B., D'Haens, G., Picon, L., Bossuyt, P., Vuitton, L., Irving, P., Viennot, S., Lamb, C. A., Pollok, R., Baert, F., Nachury, M., Fumery, M., Gilletta, C., Almer, S., ... Roblin, X. (Other coll.). (March 2023). Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. Lancet. Gastroenterology and Hepatology, 8 (3), 215-227. doi:10.1016/S2468-1253(22)00385-5 Peer Reviewed verified by ORBi |
| Gofflot, A., MONIN, L., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Forthomme, B., Croisier, J.-L., Louis, E., & Vieujean, S. (March 2023). Impact of different types of physical activity in inflammatory bowel disease [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. Peer reviewed |
 | Lovinfosse, P., Vieujean, S., Louis, E., & Hustinx, R. (2023). Commentary to "[68 Ga]Ga-FAPI-04 PET/CT on assessing Crohn's disease intestinal lesions" by Chen and colleagues. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06135-1 Peer Reviewed verified by ORBi |
 | Bouhnik, Y., Pineton de Chambrun, G., Lambert, J., Nachury, M., Seksik, P., Altwegg, R., Vuitton, L., Stefanescu, C., Nancey, S., Aubourg, A., Serrero, M., Filippi, J., Desseaux, K., Viennot, S., Abitbol, V., Boualit, M., Bourreille, A., Giletta, C., Buisson, A., ... Painchart, C. (Other coll.). (2023). Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2023.01.013 Peer Reviewed verified by ORBi |
 | Pierre, N., Huynh-Thu, V. A., Baiwir, D., Mazzucchelli, G., Fleron, M., Trzpiot, L., Eppe, G., Laharie, D., Satsangi, J., Colombel, J. F., Hertervig, E., Meuwis, M.-A., & Louis, E. (30 January 2023). Distinct biological profiles associated with the risk of short-term relapse and mid/long-term relapse in Crohn’s disease patients stopping infliximab. Journal of Crohn's and Colitis, 17 (Supplement_1), 3-i6. doi:10.1093/ecco-jcc/jjac190.0002 Peer Reviewed verified by ORBi |
 | Noor, N. M., Sousa, P., Bettenworth, D., Gomollon, F., Lobaton, T., Bossuyt, P., Casanova, M. J., Ding, N. S., Dragoni, G., Furfaro, F., van Rheenen, P. F., Chaparro, M., Gisbert, J. P., Louis, E., & Papamichael, K. (2023). ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad001 Peer Reviewed verified by ORBi |
 | Louis, E., Siegel, C. A., James, B., Heidenreich, S., Krucien, N., & Ghosh, S. (2023). Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study]. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjac130 Peer Reviewed verified by ORBi |
 | Vieujean, S., & Louis, E. (2023). Precision Medicine and Drug Optimization in Adults Inflammatory Bowel Disease Patients. Therapeutic Advances in Gastroenterology. doi:10.1177/17562848231173331 Peer Reviewed verified by ORBi |
Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., Di giovanni, N., GILTAY, L., Henket, M., GUISSARD, F., Schleich, F., Guiot, J., André, B., Malaise, M., Potjewijd, J., Meuwis, M.-A., Louis, E., Louis, R., & Focant, J.-F. (2023). A Journey over Current Usage of GC×GC -TOFMS in Metabolomic [Paper presentation]. GCxGC & GCTOF metabonomics Webinar. |
 | Cheon, J. H., Paridaens, K., Awadhi, S. A., Begun, J., Fullarton, J. R., Louis, E., Magro, F., Marquez, J. R., Moschen, A. R., Narula, N., Rydzewska, G., Dignass, A. U., & Travis, S. P. (January 2023). The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis. Intestinal Research, 21 (1), 161-167. doi:10.5217/ir.2022.00006 Peer Reviewed verified by ORBi |
 | Reenaers, C., GILLARD, R., Coimbra, C., GILLARD, R., Meunier, P., LECHANTEUR, C., BAUDOUX, E., BOUTAFFALA, L., Beguin, Y., & Louis, E. (2023). Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn’s disease: results from a prospective monocentric study. Journal of Crohn's and Colitis, 17, 728-737. doi:10.1093/ecco-jcc/jjac192 Peer Reviewed verified by ORBi |
 | Pierre, N., Huynh-Thu, V. A., Baiwir, D., Mazzucchelli, G., Fleron, M., Trzpiot, L., Eppe, G., David, L., Jack, S., Jean-Frédéric, C., Erik, H., Meuwis, M.-A., & Louis, E. (2023). Distinct biological profiles associated with the risk of short-term relapse and mid/long-term relapse in Crohn’s disease patients stopping infliximab [Paper presentation]. Belgian Week of Gastroenterology 2023. Peer reviewed |
 | Bequet, E., Salée, C., BLETARD, N., Vieujean, S., Massot, C., Fonzé, F., Sarter, H., Ley, D., Collinet, S., Seghaye, M.-C., Delvenne, P., Louis, E., & Meuwis, M.-A. (2023). Etude de la distribution de disulphides isomérases dans l’épithélium iléal et colique de maladies de Crohn sténosantes adultes et pédiatriques [Paper presentation]. Journées Francophones d'Hépato-gastroentérologie et d'Oncologie Digestive. Peer reviewed |
 | DANDOY, P., Louis, E., Gast, P., Poncin, M., Seidel, L., & Loly, J.-P. (2022). Factors associated with the efficacy and safety of endoscopic dilatation of symptomatic strictures in Crohn's disease: a retrospective cohort study. Scandinavian Journal of Gastroenterology, 1 - 9. doi:10.1080/00365521.2022.2156808 Peer Reviewed verified by ORBi |
 | Gonza Quito, I. E., Goya-Jorge, E., Douny, C., Scippo, M.-L., Louis, E., & Delcenserie, V. (15 December 2022). Effect of food additives on gut microbiota of healthy donors and IBD patients [Paper presentation]. FARAH Day, Liège, Belgium. Editorial reviewed |
 | Chevet, E., Bassal, F., Beq, S., Bonhomme, B., Boisteau, E., Calloch, J., Cazals-Hatem, D., Delom, F., Fessart, D., Evrard, S., Hrstka, R., hupp, T., Lièvre, A., Louis, E., Mariau, J., Meuwis, M.-A., Ogier-Denis, E., Paradis, V., Pernot, S., ... Vieujean, S. (2022). AGR2 protein expression in colorectal tumour epithelial compartment [letter to the editor]. Gut, 2022-328739. doi:10.1136/gutjnl-2022-328739 Peer Reviewed verified by ORBi |
 | Valdes-Socin, H. G., Calvete, O., Benitez, J., Louis, E., & Pétrossians, P. (05 December 2022). Familial autoimmune thyrogastric syndrome: clinical, genetic and in vitro studies. Acta Clinica Belgica, 77 (sup2), 1-74. doi:10.1080/17843286.2022.2149807 Peer Reviewed verified by ORBi |
 | Truyens, M., Lobatón, T., Ferrante, M., Bossuyt, P., Vermeire, S., Pouillon, L., Dewint, P., Cremer, A., Peeters, H., Lambrecht, G., Louis, E., Rahier, J.-F., Dewit, O., Muls, V., Holvoet, T., Vandermeulen, L., Peeters, A., Gonzales, G. B., Bos, S., ... De Vos, M. (November 2022). Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial. Gastroenterology, 163 (5), 1294-1305.e3. doi:10.1053/j.gastro.2022.07.052 Peer Reviewed verified by ORBi |
 | Peyrin-Biroulet, L., Ghosh, S., Lee, S. D., Lee, W.-J., Griffith, J., Wallace, K., Berg, S., Liao, X., Panes, J., Loftus, E. V. J., & Louis, E. (2022). Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials. Alimentary Pharmacology and Therapeutics. doi:10.1111/apt.17242 Peer Reviewed verified by ORBi |
 | D'Haens, G., Panés, J., Louis, E., Lacerda, A., Zhou, Q., Liu, J., & Loftus, E. V. J. (October 2022). Upadacitinib Was Efficacious and Well-tolerated Over 30 Months in Patients With Crohn's Disease in the CELEST Extension Study. Clinical Gastroenterology and Hepatology, 20 (10), 2337-2346.e3. doi:10.1016/j.cgh.2021.12.030 Peer Reviewed verified by ORBi |
 | CORE-IBD Collaborators, Ma, C., Hanzel, J., Panaccione, R., Sandborn, W. J., D'Haens, G. R., Ahuja, V., Atreya, R., Bernstein, C. N., Bossuyt, P., Bressler, B., Bryant, R. V., Cohen, B., Colombel, J.-F., Danese, S., Dignass, A., Dubinsky, M. C., Fleshner, P. R., Gearry, R. B., ... Jairath, V. (October 2022). CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. Gastroenterology, 163 (4), 950 - 964. doi:10.1053/j.gastro.2022.06.068 Peer Reviewed verified by ORBi |
 | Castiglione, V., Berodes, M., LUKAS, P., Louis, E., Cavalier, E., & Lutteri, L. (27 September 2022). New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method. Diagnostics, 12 (10), 2338. doi:10.3390/diagnostics12102338 Peer reviewed |
 | Laharie, D., D'Haens, G., Nachury, M., Lambrecht, G., Bossuyt, P., Bouhnik, Y., Louis, E., Janneke van der Woude, C., Buisson, A., Van Hootegem, P., Allez, M., Filippi, J., Brixi, H., Gilletta, C., Picon, L., Baert, F., Vermeire, S., Duveau, N., & Peyrin-Biroulet, L. (September 2022). Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial. Clinical Gastroenterology and Hepatology, 20 (9), 2074-2082. doi:10.1016/j.cgh.2021.11.030 Peer Reviewed verified by ORBi |
 | International IBD Genetics Consortium, Rahmouni, S., Georges, M., & LOUIS, E. (September 2022). Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility. Nature Genetics, 54 (9), 1275-1283. doi:10.1101/2021.06.15.21258641 Peer Reviewed verified by ORBi |
 | Perée, H., Petrov, V., Tokunaga, Y., Jacques, S., Coppieters, W., Louis, E., Georges, M., & Rahmouni, S. (29 August 2022). Towards identifying novel eQTLs driving inherited predisposition to IBD in 22 distinct circulating immune cell populations [Poster presentation]. Internation SYSCID symposium, Kiel, Germany. |
 | Sazonovs, A., Stevens, C. R., Venkataraman, G. R., Yuan, K., Avila, B., Abreu, M. T., Ahmad, T., Allez, M., Ananthakrishnan, A. N., Atzmon, G., Baras, A., Barrett, J. C., Barzilai, N., Beaugerie, L., Beecham, A., Bernstein, C. N., Bitton, A., Bokemeyer, B., Chan, A., ... Daly, M. J. (2022). Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility. Nature Genetics. doi:10.1038/s41588-022-01156-2 Peer Reviewed verified by ORBi |
 | Pierre, N., Huynh-Thu, V. A., Marichal, T., Allez, M., Bouhnik, Y., Laharie, D., Bourreille, A., Colombel, J.-F., Meuwis, M.-A., Louis, E., & GETAID (Groupe d’Etude Thérapeutique des Affections Inflammatoires du tube Digestif). (2022). Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity. Gut, 2022-327321. doi:10.1136/gutjnl-2022-327321 Peer Reviewed verified by ORBi |
 | Peyrin-Biroulet, L., Arkkila, P., Armuzzi, A., Danese, S., Guardiola, J., Jahnsen, J., Lees, C., Louis, E., Lukáš, M., Reinisch, W., Roblin, X., Jang, M., Byun, H. G., Kim, D.-H., Lee, S. J., & Atreya, R. (08 June 2022). Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterology, 22 (1), 291. doi:10.1186/s12876-022-02347-1 Peer Reviewed verified by ORBi |
 | D'Haens, G. R., Sandborn, W. J., Loftus, E. V. J., Hanauer, S. B., Schreiber, S., Peyrin-Biroulet, L., Panaccione, R., Panés, J., Baert, F., Colombel, J.-F., Ferrante, M., Louis, E., Armuzzi, A., Zhou, Q., Goteti, V. S., Mostafa, N. M., Doan, T. T., Petersson, J., Finney-Hayward, T., ... Danese, S. (June 2022). Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results. Gastroenterology, 162 (7), 1876-1890. doi:10.1053/j.gastro.2022.01.044 Peer Reviewed verified by ORBi |
 | Panés, J., Colombel, J.-F., D'Haens, G. R., Schreiber, S., Panaccione, R., Peyrin-Biroulet, L., Loftus, E. V. J., Danese, S., Tanida, S., Okuyama, Y., Louis, E., Armuzzi, A., Ferrante, M., Vogelsang, H., Hibi, T., Watanabe, M., Lefebvre, J., Finney-Hayward, T., Sanchez Gonzalez, Y., ... Sandborn, W. J. (June 2022). Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results. Gastroenterology, 162 (7), 1891-1910. doi:10.1053/j.gastro.2022.02.033 Peer Reviewed verified by ORBi |
 | VIEUJEAN, S., Caron, B., Jairath, V., Benetos, A., Danese, S., LOUIS, E., & Peyrin-Biroulet, L. (22 May 2022). Is it time to include older adults in inflammatory bowel disease trials? A call for action. The Lancet Healthy Longevity, 3 (5), 356 - e366. doi:10.1016/S2666-7568(22)00060-5 Peer reviewed |
 | Gonza Quito, I. E., Goya-Jorge, E., Douny, C., Mohring, V., Scippo, M.-L., Louis, E., & Delcenserie, V. (05 May 2022). Impact of food additives on human gut microbiota and intestinal inflammation [Poster presentation]. International Conference on Food Digestion, Cork, Ireland. Editorial reviewed |
 | Pierre, N., Baiwir, D., Mazzucchelli, G., Fleron, M., PAULISSEN, G., Huynh-Thu, V. A., De Pauw, E., Eppe, G., LOUIS, E., & MEUWIS, M.-A. (04 May 2022). Improving precision of selected reaction monitoring with a two steps internal standard normalisation [Paper presentation]. 5th Symposium of the Belgian Proteomics Association. Peer reviewed |
 | Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., DiGiovanni, N., GILTAY, L., HENKET, M., GUISSARD, F., SCHLEICH, F., GUIOT, J., ANDRE, B., MALAISE, M., Potjewijd, J., MEUWIS, M.-A., LOUIS, E., & Focant, J.-F. (May 2022). Recent advances in medical applications of GC×GC [Paper presentation]. HTC-17, Ghent, Belgium. Peer reviewed |
 | Perée, H., Petrov, V., Tokunaga, Y., Jacques, S., Coppieters, W., LOUIS, E., Georges, M., & Rahmouni, S. (May 2022). Towards identifying novel eQTLs driving inherited predisposition to IBD in 22 distinct circulating immune cell populations [Poster presentation]. 34th meeting on The Biology of Genomes. |
 | Reenaers, C., & Louis, E. (May 2022). Nouveautés dans la prise en charge des maladies inflammatoires chroniques intestinales. Revue Médicale de Liège, 77 (5-6), 323-329. Editorial Reviewed verified by ORBi |
 | Petrov, V., Sharapov, S., Shagam, L., Nostaeva, A., Pezer, M., Li, D., Hanić, M., McGovern, D., LOUIS, E., Rahmouni, S., Lauc, G., Georges, M., & Aulchenko, Y. S. (29 April 2022). Association between human gut microbiome and N-glycan composition of total plasma proteome. Frontiers in Microbiology, 13:811922. Peer Reviewed verified by ORBi |
Tokunaga, Y., Wéry, M., Mayer, A., Karim, L., Azarzar, S., Demeulenaere, L., Petrov, V., Deckers, M., Detry, E., Coppieters, W., LOUIS, E., Georges, M., & Rahmouni, S. (09 April 2022). Single cell RNA sequencing to uncover intestinal cell-type specific cis-eQTL driving inherited predisposition to IBD [Paper presentation]. Keystone symposia Single Cell Biology, Florence, Italy. |
 | Hardy, P.-Y., Fikri, J., LIBBRECHT, D., LOUIS, E., & JORIS, J. (2022). Pain characteristics in patients with inflammatory bowel disease: A monocentric cross-sectional study. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjac051 Peer Reviewed verified by ORBi |
 | Dignass, A. U., Paridaens, K., Al Awadhi, S., Begun, J., Cheon, J. H., Fullarton, J. R., Louis, E., Magro, F., Marquez, J. R., Moschen, A. R., Narula, N., Rydzewska, G., & Travis, S. P. L. (April 2022). Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis. Scandinavian Journal of Gastroenterology, 57 (4), 424-431. doi:10.1080/00365521.2021.2015801 Peer Reviewed verified by ORBi |
 | GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211. Editorial Reviewed verified by ORBi |
 | Reenaers, C., Vieujean, S., COIMBRA MARQUES, C., GILLARD, R., Meunier, P., BOUTAFFALA, L., & Louis, E. (March 2022). Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn's disease: results from a prospective monocentric study [Paper presentation]. 34th Belgian Week of Gastroenterology 2022. Peer reviewed |
 | Loly, J.-P., Vieujean, S., Reenaers, C., Van Kemseke, C., Seidel, L., Somja, J., & Louis, E. (March 2022). Remission state in inflammatory bowel disease patients on anti-TNF or vedolizumab: a confocal endomicroscopy study [Paper presentation]. 34th Belgian Week of Gastroenterology 2022. Peer reviewed |
 | Reenaers, C., Vieujean, S., COIMBRA MARQUES, C., BOUTAFFALA, L., GILLARD, R., Meunier, P., & Louis, E. (March 2022). Efficacité et sécurité du traitement par cellules souches mésenchymateuses hématopoïétiques dans les lésions ano-périnéales de maladie de Crohn : résultats d’une étude prospective monocentrique [Paper presentation]. Journées Francophones D’hépato-Gastroenterologie Et D’oncologie Digestive. Peer reviewed |
 | Louis, E., Paridaens, K., Al Awadhi, S., Begun, J., Cheon, J. H., Dignass, A. U., Magro, F., Márquez, J. R., Moschen, A. R., Narula, N., Rydzewska, G., Freddi, M. J., & Travis, S. P. (February 2022). Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis. BMJ Open Gastroenterology, 9 (1). doi:10.1136/bmjgast-2021-000853 Peer Reviewed verified by ORBi |
 | Peyrin-Biroulet, L., Hart, A., Bossuyt, P., Long, M., Allez, M., Juillerat, P., Armuzzi, A., Loftus, E. V. J., Ostad-Saffari, E., Scalori, A., Oh, Y. S., Tole, S., Chai, A., Pulley, J., Lacey, S., Sandborn, W. J., HICKORY Study, G., Louis, E. (Other coll.), Aguilar, H. (Other coll.), ... Zeuzem, S. (Other coll.). (February 2022). Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. Lancet. Gastroenterology and Hepatology, 7 (2), 128-140. doi:10.1016/S2468-1253(21)00298-3 Peer Reviewed verified by ORBi |
 | Danese, S., Colombel, J.-F., Lukas, M., Gisbert, J. P., D'Haens, G., Hayee, B. H., Panaccione, R., Kim, H.-S., Reinisch, W., Tyrrell, H., Oh, Y. S., Tole, S., Chai, A., Chamberlain-James, K., Tang, M. T., Schreiber, S., GARDENIA Study, G., Louis, E. (Other coll.), Aboo, N. (Other coll.), ... Ziady, C. (Other coll.). (February 2022). Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. Lancet. Gastroenterology and Hepatology, 7 (2), 118-127. doi:10.1016/S2468-1253(21)00294-6 Peer Reviewed verified by ORBi |
 | Reenaers, C., & Louis, E. (2022). Progressing Towards the Implementation of a Treat-To-Target Strategy in Perianal Crohn's Disease. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjab166 Peer reviewed |
| MOREAU, A.-C., SEIDEL, L., VIEUJEAN, S., REENAERS, C., & LOUIS, E. (January 2022). Impact clinique de la vidéocapsule endoscopique du grêle dans les saignements digestifs inexpliqués. Etude rétrospective monocentrique. Revue Médicale de Liège, 77 (1), 25-31. Editorial Reviewed verified by ORBi |
 | Pierre, N., Baiwir, D., Mazzucchelli, G., Fleron, M., Paulissen, G., Huynh-Thu, V. A., De Pauw, E., Eppe, G., Louis, E., & Meuwis, M.-A. (2022). Improving precision of selected reaction monitoring with a two steps internal standard normalisation [Poster presentation]. Next-Generation Protein Analysis and Detection (4th edition), Ghent, Belgium. Editorial reviewed |
 | VIEUJEAN, S., DELANAYE, P., SEIDEL, L., CAVALIER, E., Pierre, N., & LOUIS, E. (2022). Matrix Gla Protein, a potential marker of tissue remodelling and physiological ageing of the gut in Crohn's disease [Paper presentation]. Belgian Week of Gastroenterology 2022. Peer reviewed |
 | VIEUJEAN, S., DELANAYE, P., SEIDEL, L., CAVALIER, E., Pierre, N., & LOUIS, E. (01 January 2022). P168 Matrix Gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in Crohn’s Disease [Poster presentation]. European Crohn's and Colitis Organisation 2022. doi:10.1093/ecco-jcc/jjab232.296 Peer reviewed |
| Valdes-Socin, H., calvete, O., Benitez, J., Louis, E., & Pétrossians, P. (2022). Le syndrome thyro-gastrique auto-immun familial : études cliniques et génétiques. Annales d'Endocrinologie. doi:10.1016/j.ando.2022.07.088 Peer Reviewed verified by ORBi |
 | Louis, E. (January 2022). Stopping Anti-TNF in Crohn's Disease Remitters: Pros and Cons: The Pros. Inflammatory Intestinal Diseases, 7 (1), 64-68. doi:10.1159/000520942 |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154 Peer Reviewed verified by ORBi |
 | D'Haens, G. R., Reinisch, W., Lee, S. D., Tarabar, D., Louis, E., Kłopocka, M., Klaus, J., Schreiber, S., Il Park, D., Hébuterne, X., Nagy, P., Cataldi, F., Martin, S. W., Nayak, S., Banerjee, A., Gorelick, K. J., & Sandborn, W. J. (2022). Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study. Inflammatory Bowel Diseases. doi:10.1093/ibd/izab215 Peer Reviewed verified by ORBi |
 | Reenaers Dr, C., Vieujean, S., Coimbra, C., GILLARD, R., Meunier, P., BOUTAFFALA, L., & Louis, E. (01 January 2022). DOP31 Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn’s Disease: Results from a prospective monocentric study [Paper presentation]. 17th Congress of European Crohn's and Colitis Organisation. doi:10.1093/ecco-jcc/jjab232.070 Peer reviewed |
 | AMICONE, C., Marques, C. C., Reenaers, C., Van Kemseke, C., Seidel, L., & Louis, E. (2022). Early Post-Operative Endoscopy Is Associated with Lower Surgical Recurrence of Crohn's Disease: A Retrospective Study of Three Successive Cohorts. Gastroenterology Research and Practice, 2022, 6341069. doi:10.1155/2022/6341069 Peer Reviewed verified by ORBi |
 | Reenaers, C., De Roover, A., KOHNEN, L., Nachury, M., Simon, M., Pourcher, G., Trang-Poisson, C., Rajca, S., Msika, S., Viennot, S., Alttwegg, R., Serrero, M., Seksik, P., Peyrin-Biroulet, L., Picon, L., Bourbao Tournois, C., Gontier, R., Gilletta, C., Stefanescu, C., ... Coffin, B. (2022). Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID. Inflammatory Bowel Diseases. doi:10.1093/ibd/izab249 Peer Reviewed verified by ORBi |
 | LOLY, J.-P., VIEUJEAN, S., REENAERS, C., VAN KEMSEKE, C., SEIDEL, L., SOMJA, J., & LOUIS, E. (01 January 2022). P234 Remission state in Inflammatory Bowel Disease patients on anti TNF or vedolizumab: a confocal endomicroscopy study. Journal of Crohn's and Colitis, 16 (Supplement_1), 283-i283. doi:10.1093/ecco-jcc/jjab232.361 Peer Reviewed verified by ORBi |
Focant, J.-F., Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., Di Giovanni, N., GILTAY, L., Henket, M., GUISSARD, F., Schleich, F., Guiot, J., André, B., Malaise, M., Potjewijd, J., Meuwis, M.-A., Louis, E., & Louis, R. (2022). Exploring Volatolomes with GC×GC-TOFMS [Paper presentation]. Analytics Nantes 2022, Nantes, France. Peer reviewed |
 | Gonza Quito, I. E., Douny, C., Mohring, V., Scippo, M.-L., Louis, E., & Delcenserie, V. (07 October 2021). Impact of food additives on intestinal microbiota and inflammation [Poster presentation]. Conference of Food Microbiology, Brussels, Belgium. Editorial reviewed |
 | VIEUJEAN, S., Hu, S., Bequet, E., SALEE, C., MASSOT, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., COIMBRA MARQUES, C., DELVENNE, P., Rieder, F., LOUIS, E., & MEUWIS, M.-A. (October 2021). Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homolog in Crohn’s Disease Fibrosis. Journal of Crohn's and Colitis, 15 (10), 1737-1750. doi:10.1093/ecco-jcc/jjab061 Peer Reviewed verified by ORBi |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (October 2021). Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study [Poster presentation]. United European Gastroenterology. Peer reviewed |
| HARDY, P.-Y., Fikri, J., LIBBRECHT, D., LOUIS, E., & JORIS, J. (23 September 2021). Caractérisation des douleurs abdominales chroniques chez les patients souffrant d'une maladie inflammatoire chronique des intestins : investigation d'une potentielle composante neuropathique [Poster presentation]. Congrès national de la Société Française d'Anéesthésie-Réanimation, Paris, France. |
| VIEUJEAN, S., LATOUR, P., COIMBRA MARQUES, C., DELVENNE, P., LOUIS, E., & VAN KEMSEKE, C. (2021). Unusual intra-rectal “laterally spreading tumour” in immunosuppressed patient with ulcerative colitis. Acta Gastro-Enterologica Belgica. doi:10.51821/84.3.018 Peer Reviewed verified by ORBi |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., Pariente, B., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BEGUIN, Y., & LOUIS, E. (July 2021). Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study [Poster presentation]. 16th Congress of European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases 2021 Virtual. Peer reviewed |
 | VIEUJEAN, S., Hu, S., Bequet, E., SALEE, C., MASSOT, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., COIMBRA MARQUES, C., Delvenne, P., LOUIS, E., & MEUWIS, M.-A. (July 2021). Potential Role of Epithelial Protein Disulphide Isomerases in Crohn’s Disease Fibrosis [Poster presentation]. 16th Congress of European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases 2021 Virtual. Peer reviewed |
 | Basbous, C., Hayette, M.-P., LEONARD, P., Louis, E., LOLY, J.-P., & Detry, O. (July 2021). Cholangite obstructive chez un patient atteint d’une hydatidose. Revue Médicale de Liège, 76 (7-8), 575-578. Peer reviewed |
| Latour, S., Shagam, L., Mariman, R., Momozawa, Y., Louis, E., Rahmouni, S., & Georges, M. (June 2021). Identification of novel loci associated with human microbiota composition [Poster presentation]. International Human Microbiome Consortium Congress 2021. |
| Vieujean, S., Hu, S., Bequet, E., SALEE, C., MASSOT, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., COIMBRA MARQUES, C., DELVENNE, P., LOUIS, E., & MEUWIS, M.-A. (03 March 2021). Potential Role of Epithelial Protein Disulphide Isomerases in Crohn’s Disease Fibrosis [Paper presentation]. Belgian Week of Gastroenterology_33rd edition. Peer reviewed |
 | Merli, A.-M., Vieujean, S., MASSOT, C., BLETARD, N., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., Servais, L., Wéra, O., Oury, C., de Leval, L., Sempoux, C., Manzini, R., Bluemel, S., Scharl, M., Rogler, G., De Pauw, E., COIMBRA MARQUES, C., Colard, A., ... Meuwis, M.-A. (01 February 2021). Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis. Journal of Crohn's & colitis, 15 (2), 287-297. doi:10.1093/ecco-jcc/jjaa168 Peer reviewed |
 | Ghosh, S., Sanchez Gonzalez, Y., Zhou, W., Clark, R., Xie, W., Louis, E., Loftus, E. V. J., Panes, J., & Danese, S. (2021). Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjab099 Peer reviewed |
 | Pouillon, L., Remen, T., AMICONE, C., Louis, E., Maes, S., REENAERS, C., Germain, A., Baumann, C., Bossuyt, P., & Peyrin-Biroulet, L. (2021). Risk of Late Postoperative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2020.05.027 Peer Reviewed verified by ORBi |
 | Nachury, M., Bouhnik, Y., Serrero, M., Filippi, J., Roblin, X., Kirchgesner, J., Bouguen, G., Franchimont, D., Savoye, G., Buisson, A., Louis, E., Nancey, S., Abitbol, V., Reimund, J.-M., DeWit, O., Vuitton, L., Matthieu, N., Peyrin-Biroulet, L., Gilletta, C., ... Amiot, A. (2021). Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group. Digestive and Liver Disease. doi:10.1016/j.dld.2020.10.020 Peer reviewed |
 | Monin, L., Dubois, S., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., VAN DAELE, D., VIEUJEAN, S., SEIDEL, L., & Louis, E. (2021). Ustekinumab in bio-naïve and bio-failure Crohn's disease patients: Results from a « real-life » monocentric cohort. Digestive and Liver Disease. doi:10.1016/j.dld.2020.10.040 Peer reviewed |
 | Pierre, N., Salée, C., Vieujean, S., Bequet, E., Merli, A.-M., Siegmund, B., Meuwis, M.-A., & Louis, E. (2021). Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology. Alimentary Pharmacology and Therapeutics, 54 (6), 779-791. doi:10.1111/apt.16536 Peer reviewed |
 | Siegel, C. A., Thompson, K. D., Walls, D., Gollins, J., Buisson, A., Olympie, A., Beaugerie, L., Colombel, J.-F., & Louis, E. (2021). Perspectives From Patients and Gastroenterologists on De-escalating Therapy for Crohn's Disease. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2019.11.062 Peer Reviewed verified by ORBi |
 | Pierre, N., Huynh-Thu, V. A., Matthieu, A., Yoram, B., David, L., Arnaud, B., Jean-Frédéric, C., Meuwis, M.-A., & Louis, E. (2021). Blood proteins linked to immune tolerance, inflammation and cellular junctions reveal a succession of pathophysiological events preceding the relapse in Crohn’s disease patients stopping infliximab [Paper presentation]. 33rd Belgian Week of Gastroenterology 2021, Belgium. Peer reviewed |
 | D'Amico, F., Rubin, D. T., Kotze, P. G., Magro, F., Siegmund, B., Kobayashi, T., Olivera, P. A., Bossuyt, P., Pouillon, L., Louis, E., Domènech, E., Ghosh, S., Danese, S., & Peyrin-Biroulet, L. (2021). International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United European Gastroenterology Journal, 9 (4), 451-460. doi:10.1002/ueg2.12069 Peer Reviewed verified by ORBi |
 | Thibault, G., Paintaud, G., Sung, H. C., Lajoie, L., Louis, E., The Getaid, Desvignes, C., Watier, H., Gouilleux-Gruart, V., & Ternant, D. (2021). Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients. International Journal of Molecular Sciences, 22 (11). doi:10.3390/ijms22116051 Peer Reviewed verified by ORBi |
 | Siegel, C. A., Melmed, G. Y., McGovern, D. P., Rai, V., Krammer, F., Rubin, D. T., Abreu, M. T., Dubinsky, M. C., & Louis, E. (Other coll.). (2021). SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Gut, 70 (4), 635-640. doi:10.1136/gutjnl-2020-324000 Peer Reviewed verified by ORBi |
 | Scherer, M., Gasparoni, G., Rahmouni, S., Shashkova, T., Arnoux, M., Louis, E., Nostaeva, A., Avalos, D., Dermitzakis, E. T., Aulchenko, Y. S., Lengauer, T., Lyons, P. A., Georges, M., & Walter, J. R. (2021). Identification of tissue-specific and common methylation quantitative trait loci in healthy individuals using MAGAR. Epigenetics and Chromatin, 14 (1), 44. doi:10.1186/s13072-021-00415-6 Peer Reviewed verified by ORBi |
 | Pauwels, R. W. M., van der Woude, C. J., Nieboer, D., Steyerberg, E. W., Casanova, M. J., Gisbert, J. P., Kennedy, N. A., Lees, C. W., Louis, E., Molnár, T., Szántó, K., Leo, E., Bots, S., Downey, R., Lukas, M., Lin, W. C., Amiot, A., Lu, C., Roblin, X., ... de Vries, A. C. (2021). Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2021.03.037 Peer Reviewed verified by ORBi |
 | Liefferinckx, C., Bottieau, J., Toubeau, J.-F., Thomas, D., Rahier, J.-F., Louis, E., Baert, F., Dewint, P., Pouillon, L., Lambrecht, G., Vallée, F., Vermeire, S., Bossuyt, P., & Franchimont, D. (2021). Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. doi:10.1093/ibd/izab042 Peer Reviewed verified by ORBi |
 | Olivera, P. A., Zuily, S., Kotze, P. G., Regnault, V., Al Awadhi, S., Bossuyt, P., Gearry, R. B., Ghosh, S., Kobayashi, T., Lacolley, P., Louis, E., Magro, F., Ng, S. C., Papa, A., Raine, T., Teixeira, F. V., Rubin, D. T., Danese, S., & Peyrin-Biroulet, L. (2021). International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nature Reviews Gastroenterology and Hepatology, 18 (12), 857-873. doi:10.1038/s41575-021-00492-8 |
 | Gomollón, F., & Louis, E. (2021). Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020? Frontiers in Medicine, 8, 673991. doi:10.3389/fmed.2021.673991 Peer Reviewed verified by ORBi |
 | Dubinsky, M. C., Icahn School of Medicine at Mount Sinai, N. Y., Collins, R., Abreu, M. T., Division of Gastroenterology and Hepatology, D. O. M., Jairath, V., Lewis, J. D., Lindsay, J., Merad, M., Ng, S., Panaccione, R., Panes, J., Sands, B., Siegal, C. A., Singh, S. K., Vermeire, S., Ahuja, V., Allez, M., Ananthakrishnan, A., ... Louis, E. (Other coll.). (2021). Challenges and Opportunities in IBD Clinical Trial Design. Gastroenterology, 161 (2), 400-404. doi:10.1053/j.gastro.2021.03.065 Peer Reviewed verified by ORBi |
 | Pierre, N., Huynh-Thu, V. A., Allez, M., Bouhnik, Y., Laharie, D., Bourreille, A., Colombel, J. F., Meuwis, M.-A., & Louis, E. (2021). Blood proteins related to immunoregulation or cellular junctions reveal distinct biological profiles associated with the risk of short-term versus mid/long-term relapse in Crohn’s Disease patients stopping infliximab. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjab075.011 Peer Reviewed verified by ORBi |
 | Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x Peer Reviewed verified by ORBi |
 | Peyrin-Biroulet, L., Louis, E., Loftus, E. V., Lacerda, A., Zhou, Q., Sanchez Gonzalez, Y., & Ghosh, S. (2021). Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn’s Disease. Advances in Therapy. doi:10.1007/s12325-021-01660-7 Peer Reviewed verified by ORBi |
 | Ferrante, M., Feagan, B. G., Panés, J., Baert, F., Louis, E., Dewit, O., Kaser, A., Duan, W. R., Pang, Y., Lee, W.-J., Gustafson, D., Liao, X., Wallace, K., Kalabic, J., & D'Haens, G. R. (2021). Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study. Journal of Crohn's & colitis. doi:10.1093/ecco-jcc/jjab093 Peer reviewed |
 | Tannoury, J., Nachury, M., Martins, C., Serrero, M., Filippi, J., Roblin, X., Bourrier, A., Bouguen, G., Franchimont, D., Savoye, G., Buisson, A., Louis, E., Nancey, S., Abitbol, V., Reimund, J.-M., DeWitt, O., Vuitton, L., Mathieu, N., Peyrin-Biroulet, L., ... Amiot, A. (2021). Determinants of IBD-related disability: a cross-sectional survey from the GETAID. Alimentary pharmacology & therapeutics, 53 (10), 1098-1107. doi:10.1111/apt.16353 Peer reviewed |
 | Parzibut, G., Henket, M., Moermans, C., Struman, I., Louis, E., Malaise, M., Louis, R., Misset, B., NJOCK, M.-S.* , & Guiot, J.*. (2021). A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome. Frontiers in Molecular Biosciences, 8, 640042. doi:10.3389/fmolb.2021.640042 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Guillo, L., Peyrin-Biroulet, L., & Louis, E. (2021). Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story? Journal of Crohn's & colitis, 15 (7), 1087-1088. doi:10.1093/ecco-jcc/jjab006 Peer reviewed |
 | LABILLE, V., Louis, E., & LOLY, C. (2021). Stratégie «Watch and Wait» dans la prise en charge des adénocarcinomes du rectum. Revue Médicale de Liège, 76 (5-6), 515-518. |
 | Bouhuys, M., Lexmond, W. S., Dijkstra, G., Lobatón, T., Louis, E., van Biervliet, S., Groen, H., Guardiola, J., & Rheenen, P. V. (2021). Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial. BMJ Open, 11 (11), 054154. doi:10.1136/bmjopen-2021-054154 Peer Reviewed verified by ORBi |
 | Pierre, N., Baiwir, D., Huynh-Thu, V. A., Mazzucchelli, G., Smargiasso, N., De Pauw, E., Bouhnik, Y., Laharie, D., Colombel, J.-F., Meuwis, M.-A., & Louis, E. (2021). Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study. Gut. doi:10.1136/gutjnl-2020-322100 Peer Reviewed verified by ORBi |
 | Buisson, A., Filippi, J., Amiot, A., Cadiot, G., Allez, M., Marteau, P., Bouhnik, Y., Pineton de Chambrun, G., Pelletier, A. L., Nancey, S., Moussata, D., Attar, A., Blain, A., Vuitton, L., Vernier-Massouille, G., Seksik, P., Nachury, M., Dupas, J. L., Laharie, D., ... Mary, J. Y. (2021). Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID. Journal of Crohn's & colitis, 15 (6), 1000-1008. doi:10.1093/ecco-jcc/jjaa250 Peer reviewed |
 | Tadbiri, S., Nachury, M., Bouhnik, Y., Serrero, M., Hébuterne, X., Roblin, X., Kirchgesner, J., Bouguen, G., Franchimont, D., Savoye, G., Buisson, A., Louis, E., Nancey, S., Abitbol, V., Reimund, J.-M., DeWit, O., Vuitton, L., Matthieu, N., Peyrin-Biroulet, L., ... Amiot, A. (2021). The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjaa244 Peer reviewed |
Parzibut, G., GUIOT, J., Misset, B., MALAISE, M., LOUIS, R., LOUIS, E., HENKET, M., MOERMANS, C., & NJOCK, M.-S. (September 2020). Alteration of Plasma Exosome Content in Acute Respiratory Distress Syndrome: a miRNA signature associated to lung fibrosing process [Poster presentation]. ERS International Congress 2020. doi:10.1183/13993003.congress-2020.3828 |
| VIEUJEAN, S., COIBION, C., SEIDEL, L., LOUIS, E., & MEUNIER, P. (2020). Magnetic resonance enterography perfusion parameters reveal complex changes in affected and unaffected segments in Crohn's disease. Scandinavian Journal of Gastroenterology. doi:10.1080/00365521.2020.1802773 Peer Reviewed verified by ORBi |
 | GUIOT, J., Cambier, M., Boeckx, A., HENKET, M., Nivelles, O., GESTER, F., LOUIS, E., MALAISE, M., Dequiedt, F., LOUIS, R., Struman, I.* , & NJOCK, M.-S.*. (05 August 2020). Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p. Thorax, 75 (10), 870-881. doi:10.1136/thoraxjnl-2019-214077 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Di Giovanni, N., MEUWIS, M.-A., LOUIS, E., & Focant, J.-F. (August 2020). Specificity of metabolic colorectal cancer biomarkers in serum through effect size. Metabolomics, 16 (8). doi:10.1007/s11306-020-01707-w Peer reviewed |
 | Poulet, C., NJOCK, M.-S., MOERMANS, C., LOUIS, E., LOUIS, R., MALAISE, M., & GUIOT, J. (01 May 2020). Exosomal Long Non-Coding RNAs in Lung Diseases. International Journal of Molecular Sciences, 21 (10), 3580. doi:10.3390/ijms21103580 Peer Reviewed verified by ORBi |
Vieujean, S., Hu, S., Bequet, E., Salee, C., Massot, C., BLETARD, N., Pierre, N., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., Delvenne, P., Louis, E., & Meuwis, M.-A. (05 March 2020). Increased Endoplasmic Reticulum stress specific chaperones characterise CD fibrosis epithelium tissues and participates to in vitro induction of intestinal fibroblasts differentiation [Poster presentation]. Belgian Week of Gastroenterology, Antwerpen, Belgium. Peer reviewed |
Merli, A.-M., Vieujean, S., MASSOT, C., BLETARD, N., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., Servais, L., WERA, O., Oury, C., de Leval, L., Sempoux, C., Manzini, R., Scharl, M., Rogler, G., De Pauw, E., COIMBRA MARQUES, C., COLARD, A., Vijverman, A., ... LOUIS, E. (04 March 2020). SLC12A2 as a potential histological marker of ulcerative colitis associated colorectal dysplasia [Paper presentation]. Belgian Week of Gastroenterologyw, Antwerp, Belgium. Peer reviewed |
Vieujean, S., Hu, S., Bequet, E., Salee, C., Massot, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., Delvenne, P., LOUIS, E., & Meuwis, M.-A. (14 February 2020). Increased Endoplasmic Reticulum stress specific chaperones characterise CD fibrosis epithelium tissues and participate to in vitro induction of intestinal fibroblasts differentiation [Poster presentation]. European Crohn's and Colitis Organisation (ECCO), Vienna, Austria. Peer reviewed |
Di Giovanni, N., Meuwis, M.-A., Louis, E., & Focant, J.-F. (29 January 2020). Effect Size in Metabolomics. Studying colorectal cancer beyond biomarkers [Paper presentation]. HTC-16, Gand, Belgium. |
Di Giovanni, N., Meuwis, M.-A., Louis, E., & Focant, J.-F. (22 January 2020). Colorectal Cancer : Biomarkers and Effect Size [Poster presentation]. Europeam RFMF Metabomeeting, Toulouse, France. |
 | Klarić, L., Tsepilov, Y. A., Stanton, C. M., Mangino, M., Sikka, T. T., Esko, T., Pakhomov, E., Salo, P., Deelen, J., McGurnaghan, S. J., Keser, T., Vučković, F., Ugrina, I., Krištić, J., Gudelj, I., Štambuk, J., Plomp, R., Pučić-Baković, M., Pavić, T., ... Hayward, C. (2020). Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases. Science Advances, 6 (8), 0301. doi:10.1126/sciadv.aax0301 Peer Reviewed verified by ORBi |
 | Louis, E., Ramos-Goñi, J. M., Cuervo, J., Kopylov, U., Acosta, M. B.-D., McCartney, S., Rosenfeld, G., Bettenworth, D., Hart, A., Novak, K., Donnet, X., Easton, D., Saldaña, R., Protze, K., Tzur, E., Alperovich, G., & Casellas, F. (2020). A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective. Patient. doi:10.1007/s40271-019-00407-5 Peer reviewed |
 | Chapman, T. P., Frias Gomes, C., Louis, E., Colombel, J.-F., & Satsangi, J. (2020). Review article: withdrawal of 5-aminosalicylates in inflammatory bowel disease. Alimentary pharmacology & therapeutics, 52 (1), 73-84. doi:10.1111/apt.15771 Peer reviewed |
 | Frontali, A., Cohen, L., Bridoux, V., Myrelid, P., Sica, G., Poggioli, G., Espin, E., Beyer-Berjot, L., Laharie, D., Spinelli, A., Zerbib, P., Sampietro, G., Frasson, M., Louis, E., Danese, S., Fumery, M., Denost, Q., Altwegg, R., Nancey, S., ... Panis, Y. (2020). Segmental colectomy for ulcerative colitis: is there a place in selected patients without active colitis ? An international multicentric retrospective study in 72 patients. Journal of Crohn's & colitis. doi:10.1093/ecco-jcc/jjaa107 Peer reviewed |
 | Kouam, C., WARLING, O., VAN KEMSEKE, C., LOLY, J.-P., Louis, E., & Delwaide, J. (2020). Risques néoplasiques majorés dans la rectocolite ulcéro-hémorragique associée à la cholangite sclérosante primitive. Revue Médicale de Liège, 75 (11), 724-730. Peer reviewed |
 | ZEEVAERT, J.-B., Wain, E., Louis, E., Dorthu, L., MEURISSE, N., & Moerman, F. (2020). Abcès hépatique : rapport de cas et revue de la littérature. Revue Médicale de Liège, 75 (11), 731-737. Peer reviewed |
 | Brand, E. C., Elias, S. G., Minderhoud, I. M., van der Veen, J. J., Baert, F. J., Laharie, D., Bossuyt, P., Bouhnik, Y., Buisson, A., Lambrecht, G., Louis, E., Pariente, B., Pierik, M. J., van der Woude, C. J., D'Haens, G. R. A. M., Vermeire, S., & Oldenburg, B. (2020). Systematic review and external validation of prediction models based on symptoms and biomarkers for identifying endoscopic activity in Crohn's disease. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2019.12.014 |
 | Sinatra, T., Grzesinski, Q., DULGHERU, R. E., Louis, E., Lancellotti, P., Maquet, P., & Radermecker, M. (2020). Grande clinique intégrée. La maladie cardiaque carcinoïde. Revue Médicale de Liège, 75 (7-8), 478-483. Peer reviewed |
 | Chapman, T. P., Gomes, C. F., Louis, E., Colombel, J.-F., & Satsangi, J. (2020). De-escalation of immunomodulator and biological therapy in inflammatory bowel disease. Lancet. Gastroenterology and Hepatology, 5 (1), 63-79. doi:10.1016/S2468-1253(19)30186-4 |
 | de Bruyn, J. R., Bossuyt, P., Ferrante, M., West, R. L., Dijkstra, G., Witteman, B. J., Wildenberg, M., Hoentjen, F., Franchimont, D., Clasquin, E., van der Bilt, J. D., Tollens, T., Bemelman, W. A., D'Hoore, A., Duijvestein, M., D'Haens, G. R., & Louis, E. (Other coll.). (2020). High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2020.05.037 Peer Reviewed verified by ORBi |
 | Rubin, D. T., Abreu, M. T., Rai, V., Siegel, C. A., & Louis, E. (Other coll.). (2020). Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. Gastroenterology, 159 (1), 6-13.e6. doi:10.1053/j.gastro.2020.04.002 Peer Reviewed verified by ORBi |
 | Bouhnik, Y., Louis, E., & Peyrin-Biroulet, L. (2020). Looking for Innovative Digital Solutions to Optimize Patient Recruitment in Inflammatory Bowel Disease Trials. Gastroenterology, 158 (8), 2306-2307. doi:10.1053/j.gastro.2019.11.313 Peer Reviewed verified by ORBi |
 | Preda, C., Manuc, T., Chifulescu, A. E., Istratescu, D., Louis, E., Baicus, C., Sandra, I., Diculescu, M., Reenaers, C., VAN KEMSEKE, C., Nitescu, M., Tieranu, C., Popescu, M. C., Tugui, L., Andrei, A., Ciora, C.-A., Gheorghe, L.-S., & Manuc, M. (2020). Diet as an environmental trigger in inflammatory bowel disease: A retrospective comparative study in two European cohorts. Revista Espanola de Enfermedades Digestivas, 112 (6), 440-447. doi:10.17235/reed.2020.6552/2019 |
 | DELHOUGNE, N., Allepaerts, S., GAST, P., & Louis, E. (2020). Approche critique du traitement prolonge par inhibiteurs de la pompe a protons chez les personnes agees. Revue Médicale de Liège, 75 (1), 10-16. |
 | Moens, A., van der Woude, C. J., Julsgaard, M., Humblet, E., Sheridan, J., Baumgart, D. C., Gilletta De Saint-Joseph, C., Nancey, S., Rahier, J.-F., Bossuyt, P., Cremer, A., Dewit, S., Eriksson, C., Hoentjen, F., Krause, T., Louis, E., Macken, E., Milenkovic, Z., Nijs, J., ... Ferrante, M. (2020). Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. Alimentary pharmacology & therapeutics, 51 (1), 129-138. doi:10.1111/apt.15539 Peer reviewed |
 | Chapman, T. P., Frias Gomes, C., Louis, E., Colombel, J.-F., & Satsangi, J. (2020). Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply. Alimentary pharmacology & therapeutics, 52 (10), 1621. doi:10.1111/apt.16113 Peer reviewed |
 | Massart, I. S., PAULISSEN, G., Loumaye, A., Lause, P., Pötgens, S. A., Thibaut, M. M., Balan, E., Deldicque, L., Atfi, A., Louis, E., Gruson, D., Bindels, L. B., Meuwis, M.-A., & Thissen, J.-P. (2020). Marked Increased Production of Acute Phase Reactants by Skeletal Muscle during Cancer Cachexia. Cancers, 12 (11). doi:10.3390/cancers12113221 Peer Reviewed verified by ORBi |
 | Bossuyt, P., Dreesen, E., Rimola, J., Devuysere, S., De Bruecker, Y., Vanslembrouck, R., Laurent, V., Zappa, M., Savoye-Collet, C., Pariente, B., Filippi, J., Baert, F., D'Haens, G., Laharie, D., Peyrin-Biroulet, L., Vermeire, S., & Louis, E. (Other coll.). (2020). Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2020.04.052 Peer Reviewed verified by ORBi |
 | Di Giovanni, N., MEUWIS, M.-A., Louis, E., & Focant, J.-F. (2020). Untargeted Serum Metabolic Profiling by Comprehensive Two-Dimensional Gas Chromatography-High-Resolution Time-of-Flight Mass Spectrometry. Journal of Proteome Research, 19, 1013-1028. doi:10.1021/acs.jproteome.9b00535 Peer Reviewed verified by ORBi |
Di Giovanni, N., Meuwis, M.-A., Louis, E., & Focant, J.-F. (08 July 2019). Control and Interpretation of Untargeted Metabolomics Data [Paper presentation]. Journée du département de chimie, Liège, Belgium. |
Di Giovanni, N., Meuwis, M.-A., Louis, E., & Focant, J.-F. (23 June 2019). Colorectal Cancer : Biomarkers and Effect Size [Poster presentation]. 15th Annual Conference of the Metabolomics Society, La Haye, Netherlands. |
Di Giovanni, N., MEUWIS, M.-A., Louis, E., & Focant, J.-F. (12 June 2019). Colorectal cancer research with GC×GC-(HR)TOFMS [Paper presentation]. Séminaire de thèse. |
Di Giovanni, N., Meuwis, M.-A., Louis, E., & Focant, J.-F. (21 May 2019). Colorectal Cancer : Biomarkers and Effect Size [Poster presentation]. 12émes journées scientifiques du RFMF, Clermont-Ferrand, France. |
 | DE SENY, D., DEROYER, C., Charlier, E., CIREGIA, F., COBRAIVILLE, G., MEUWIS, M.-A., LOUIS, E., Fillet, M., & MALAISE, M. (May 2019). Increased serological levels of vitronectin(amino acid 381-397) and C3f peptides in osteoarthritis, lupus and scleroderma. Interaction with TGF-β [Poster presentation]. OARSI, Toronto, Canada. |
VIEUJEAN, S., BURY, T., GASPARD, L., GIOT, J.-B., MAWEJA, S., LOUIS, E., & VAN KEMSEKE, C. (February 2019). Ganglionic tuberculosis in a Crohn’s disease patient treated by infliximab despite anti-tuberculosis chemoprophylaxis [Paper presentation]. Belgian Week of Gastroenterology 31st Edition - BWGE 2019. Peer reviewed |
| Hu, S., Cheng, M., Fan, R., Wang, Z., Wang, L., Zhang, T., Zhang, M., Louis, E., & Zhong, J. (2019). Beneficial effects of dual TORC1/2 inhibition on chronic experimental colitis. International Immunopharmacology, 70, 88-100. doi:10.1016/j.intimp.2019.02.022 Peer Reviewed verified by ORBi |
 | Preda, C. M., Manuc, T., Istratescu, D., Louis, E., Baicus, C., Sandra, I., Diculescu, M., REENAERS, C., VAN KEMSEKE, C., Nitescu, M., Tieranu, C., Sandu, C. G., Oprea-Calin, G., Tugui, L., Viziru, S., Ciora, C.-A., Gheorghe, L.-S., & Manuc, M. (2019). Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative Study. Mædica, 14 (3), 233-239. doi:10.26574/maedica.2019.14.3.233 |
 | Sharapov, S. Z., Tsepilov, Y. A., Klaric, L., Mangino, M., Thareja, G., Shadrina, A. S., Simurina, M., Dagostino, C., Dmitrieva, J. B., Vilaj, M., Vuckovic, F., Pavic, T., Stambuk, J., Trbojevic-Akmacic, I., Kristic, J., Simunovic, J., Momcilovic, A., Campbell, Doherty, M., ... Aulchenko, Y. S. (2019). Defining the genetic control of human blood plasma N-glycome using genome-wide association study. Human Molecular Genetics, 28 (12), 2062-2077. doi:10.1093/hmg/ddz054 Peer Reviewed verified by ORBi |
 | Gonzalez, J. A., Vanzieleghem, T., Dumazy, A., MEURIS, C., MUTSERS, J., Christiaens, G., LECLERCQ, P., LOLY, J.-P., Louis, E., & GAST, P. (2019). On-site comparison of an enzymatic detergent and a non-enzymatic detergent-disinfectant for routine manual cleaning of flexible endoscopes. Endoscopy International Open, 7 (4), 412-E420. doi:10.1055/a-0838-4995 Peer Reviewed verified by ORBi |
 | WARLING, O., Oger, A., LAMPROYE, A., BERNARD, V., MARTING, A., DETRY, O., Louis, E., & Delwaide, J. (2019). L'hepatite alcoolique aigue. Revue Médicale de Liège, 74 (5-6), 326-331. Peer reviewed |
 | Cremer, A., Demetter, P., De Vos, M., Rahier, J.-F., Baert, F., Moreels, T., Macken, E., Louis, E., Ferdinande, L., Fervaille, C., Dedeurwaerdere, F., BLETARD, N., Driessen, A., De Hertogh, G., Vermeire, S., & Franchimont, D. (2019). Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2019.05.062 |
 | LOLY, J.-P., MEURISSE, N., GAST, P., Honoré, P., Louis, E., & Meurisse, M. (2019). Alcool et complications pancréatiques. Revue Médicale de Liège, 74 (5-6), 342-348. |
 | Sands, B. E., Sandborn, W. J., Panaccione, R., O'Brien, C. D., Zhang, H., Johanns, J., Adedokun, O. J., Li, K., Peyrin-Biroulet, L., Van Assche, G., Danese, S., Targan, S., Abreu, M. T., Hisamatsu, T., Szapary, P., Marano, C., & Louis, E. (Other coll.). (2019). Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. The New England journal of medicine, 381 (13), 1201-1214. doi:10.1056/NEJMoa1900750 Peer reviewed |
 | Pariente, B., & Louis, E. (2019). Letter to the editor - Reply [letter to the editor]. Clinical Gastroenterology and Hepatology, 17 (12), 2623. doi:10.1016/j.cgh.2019.05.020 |
 | Danese, S., Hart, A., Dignass, A., Fiorino, G., Louis, E., Bonovas, S., D'Haens, G., Dotan, I., Rogler, G., Paridaens, K., & Peyrin-Biroulet, L. (2019). A multicentre prospective cohort study assessing the effectiveness of budesonide MMX(R) (Cortiment(R)(MMX(R))) for active, mild-to-moderate ulcerative colitis. United European Gastroenterology Journal, 7 (9), 1171-1182. doi:10.1177/2050640619864848 Peer Reviewed verified by ORBi |
 | Varkas, G., RIBBENS, C., Louis, E., Van den Bosch, F., Lories, R., Vermeire, S., Elewaut, D., & De Vos, M. (2019). Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies. Alimentary pharmacology & therapeutics, 50 (11-12), 1204-1213. doi:10.1111/apt.15519 Peer reviewed |
 | VALDES SOCIN, H. G., LECLERCQ, P., POLUS, M., Rohmer, V., Beckers, A., & Louis, E. (2019). La gastrite chronique auto-immune : une prise en charge multidisciplinaire. Revue Médicale de Liège, 74 (11), 598-605. |
 | Pierre, N., Salee, C., MASSOT, C., BLETARD, N., Mazzucchelli, G., Smargiasso, N., Morsa, D., Baiwir, D., De Pauw, E., REENAERS, C., VAN KEMSEKE, C., LOLY, J.-P., Delvenne, P., Meuwis, M.-A., & Louis, E. (2019). Proteomics highlights common and distinct pathophysiological processes associated with ileal and colonic ulcers in Crohn's disease. Journal of Crohn's & colitis. doi:10.1093/ecco-jcc/jjz130 Peer reviewed |
 | Louis, E. (2019). Do we still need predictors of disease severity when applying a treat-to-target approach in Inflammatory Bowel Disease? Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjy182 Peer Reviewed verified by ORBi |
 | Pariente, B., Hu, S., Bettenworth, D., Speca, S., Desreumaux, P., Meuwis, M.-A., Danese, S., Rieder, F., & Louis, E. (2019). Treatments for Crohn's Disease-Associated Bowel Damage: A Systematic Review. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2018.06.043 Peer Reviewed verified by ORBi |
 | D'Haens, G., Kelly, O., Battat, R., Silverberg, M. S., Laharie, D., Louis, E., Savarino, E., Bodini, G., Yarur, A., Boland, B. S., Afif, W., Li, X.-J., Hale, M., Ho, J., Kondragunta, V., Huang, B., Kuy, C., Okada, L., Hester, K. D., ... Dulai, P. S. (2019). Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins. Gastroenterology. doi:10.1053/j.gastro.2019.10.034 Peer Reviewed verified by ORBi |
 | Liefferinckx, C., Verstockt, B., Gils, A., Noman, M., VAN KEMSEKE, C., Macken, E., De Vos, M., Van Moerkercke, W., Rahier, J.-F., Bossuyt, P., Dutre, J., Humblet, E., Staessen, D., Peeters, H., Van Hootegem, P., Louis, E., Franchimont, D., Baert, F., & Vermeire, S. (2019). Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study. Journal of Crohn's & colitis, 13 (11), 1401-1409. doi:10.1093/ecco-jcc/jjz080 |
 | GUIOT, J., Struman, I., Louis, E., Louis, R., Malaise, M., & Njock, M.-S. (2019). Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets. Journal of Clinical Medicine, 8 (9). doi:10.3390/jcm8091345 Peer Reviewed verified by ORBi |
 | De Chambrun, G. P., Rouillon, C., Peyrin-Biroulet, L., Bouhnik, Y., Louis, E., Laharie, D., & Beaugerie, L. (2019). État des lieux sur les MICI en France: Enquête nationale du GETAID. Hépato-Gastro et Oncologie Digestive, 26 (2), 167-176. doi:10.1684/hpg.2019.1751 |
 | Louis, E. (2019). Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease. Frontiers in Medicine, 6, 302. doi:10.3389/fmed.2019.00302 Peer Reviewed verified by ORBi |
 | Dreesen, E., Baert, F., Laharie, D., Bossuyt, P., Bouhnik, Y., Buisson, A., Lambrecht, G., Louis, E., Oldenburg, B., Pariente, B., Pierik, M., van der Woude, C. J., D'Haens, G., Vermeire, S., & Gils, A. (2019). Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2019.05.029 |
 | Pineton de Chambrun, G., Amiot, A., Bouguen, G., Viennot, S., Altwegg, R., Louis, E., Collins, M., Fumery, M., Poullenot, F., Armengol, L., Buisson, A., Abitbol, V., Laharie, D., Seksik, P., Nancey, S., Blanc, P., Bouhnik, Y., Pariente, B., & Peyrin-Biroulet, L. (2019). Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2019.05.060 |
 | El Abbas, S., Radermecker, C., Bai, Q., BEGUIN, C., Schyns, J., Meunier, M., Pirottin, D., Desmet, C., Meuwis, M.-A., Art, T., Louis, E., Tam, S.-Y., Tsai, M., Bureau, F., Galli, S. J., & Marichal, T. (2019). Epithelial RABGEF1 deficiency promotes intestinal inflammation by dysregulating intrinsic MYD88-dependent innate signaling. Mucosal Immunology. doi:10.1038/s41385-019-0211-z Peer Reviewed verified by ORBi |
 | Bolin, K., Hertervig, E., & Louis, E. (2019). The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's Disease. Journal of Crohn's & colitis, 13 (10), 1323-1333. doi:10.1093/ecco-jcc/jjz063 |
| Di Giovanni, N., Cojocariu, C., Silcock, P., MEUWIS, M.-A., LOUIS, E., & Focant, J.-F. (18 December 2018). GC×GC-(HR)TOFMS in colorectal cancer metabolomics [Paper presentation]. Metabomeeting 2018, Nottingham, United Kingdom. |
 | DE SENY, D., COBRAIVILLE, G., DEROYER, C., MEUWIS, M.-A., LOUIS, E., Fillet, M., & MALAISE, M. (10 December 2018). Elévation des taux sériques des peptides C3f et vitronectine (acide aminés 381-397) dans l’arthrose, le lupus et la sclérodermie. Interaction avec le TGF-β [Poster presentation]. 31ème Congrès Français de Rhumatologie, Paris, France. |
 | GREGOIRE, C., BRIQUET, A., PIRENNE, C., LECHANTEUR, C., LOUIS, E.* , & BEGUIN, Y.*. (November 2018). Allogeneic mesenchymal stromal cells for refractory luminal Crohn's disease: A phase I-II study. Digestive and Liver Disease, 50 (11), 1251-1255. doi:10.1016/j.dld.2018.08.015 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Di Giovanni, N., MEUWIS, M.-A., Louis, E., & Focant, J.-F. (19 September 2018). Colorectal cancer study with GC×GC-(HR)TOFMS [Paper presentation]. Benelux Metabolomics Days, Rotterdam, Netherlands. |
| Pauwen, N. Y., Louis, E., Siegel, C., Colombel, J.-F., & Macq, J. (2018). Integrated Care for Crohn's Disease: a plea for the development of clinical decision support systems. Journal of Crohn's and Colitis, 1-6. doi:10.1093/ecco-jcc/jjy128 Peer Reviewed verified by ORBi |
Di Giovanni, N., MEUWIS, M.-A., Louis, E., & Focant, J.-F. (05 July 2018). GC-MS Orbitrap and GC×GC-(HR)TOFMS in Colorectal Cancer Metabolomics [Paper presentation]. 9ème Journée du Département de chimie. |
 | Focant, J.-F., Zanella, D., Di Giovanni, N., Meuwis, M.-A., Louis, E., Schleich, F., Louis, R., & Stefanuto, P.-H. (June 2018). GC×GC-(HR)-TOFMS for Metabolomics and Volatilomics [Paper presentation]. High-throughput MS-based proteomics and metabolomics: from cells to clinic, Novara, Italy. |
 | Focant, J.-F., Stefanuto, P.-H., Zanella, D., Meuwis, M.-A., Louis, E., Schleich, F., & LOUIS, R. (May 2018). CONTRIBUTION OF GC×GC-(HR) TOFMS TO MEDICAL APPLICATIONS [Poster presentation]. 42nd International Symposium on Capillary Chromatography & 15th GC×GC Symposium, Riva Del Garda, Italy. |
 | Di Giovanni, N., Meuwis, M.-A., Louis, E., & Focant, J.-F. (May 2018). A new comprehensive GC×GC-HRTOFMS approach in metabolomics [Paper presentation]. 11èmes journées scientifiques du RFMF, Liege, Belgium. |
 | Di Giovanni, N., Cojocariu, C., Silcock, P., Meuwis, M.-A., LOUIS, E., & Focant, J.-F. (March 2018). GC-MS Orbitrap and GC×GC-(HR)TOFMS in Colorectal Cancer Metabolomics [Poster presentation]. BSMS meeting 2018, Liege, Belgium. |
 | VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Étude dans la vie réelle de l’association d’un traitement immunosuppresseur avec l’Infliximab et l’Adalimumab dans la colite ulcéreuse [Poster presentation]. Journées Francophones d'Hépato-gastroentérologie et d'Oncologie Digestive. |
 | Pierre, N., REENAERS, C., VAN KEMSEKE, C., LOLY, J.-P., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Morsa, D., De Pauw, E., MEUWIS, M.-A., & Louis, E. (2018). Proteomic analysis highlights divergences and convergences between ileal and colonic pathological processes involved in Crohn’s ulcers. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjx180.184 Peer Reviewed verified by ORBi |
 | VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Immunosuppressive co-treatment with Infliximab and adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time [Poster presentation]. 30th edition of Belgian Week of Gastroenterology. Peer reviewed |
 | Pierre, N., REENAERS, C., VAN KEMSEKE, C., LOLY, J.-P., Mazzucchelli, G., Smargiasso, N., Baiwir, D., De Pauw, E., MEUWIS, M.-A., & LOUIS, E. (February 2018). Proteomic analysis highlights divergences and convergences between ileal and colonic pathological processes involved in Crohn’s ulcers [Poster presentation]. 30th edition of the Belgian Week of Gastroenterology, Anvers, Belgium. |
 | VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Immunosuppressive co-treatment with Infliximab and Adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time in ulcerative colitis [Poster presentation]. 13th Congress of ECCO, Vienna, Austria. Peer reviewed |
| VIEUJEAN, S., LATOUR, P., COIMBRA MARQUES, C., LOUIS, E., & VAN KEMSEKE, C. (February 2018). Curious intra-rectal “laterally spreading tumor” in immunosuppressed patient with ulcerative colitis [Paper presentation]. Belgian Week of Gastroenterology 30th Edition - BWGE 2018. Peer reviewed |
 | Merli, A.-M., MASSOT, C., BLETARD, N., QUESADA-CALVO, F., Baiwir, D., Mazzucchelli, G., Smargiasso, N., Servais, L., Oury, C., De Pauw-Gillet, M.-C., De Pauw, E., COIMBRA MARQUES, C., Colard, A., Vijverman, A., DELVENNE, P., MEUWIS, M.-A., & LOUIS, E. (February 2018). Potential diagnostic biomarkers of Ulcerative colitis-associated colorectal dysplasia [Paper presentation]. 13th congress of European Crohn's and Colitis Organisation, Vienne, Austria. |
 | Merli, A.-M., MASSOT, C., BLETARD, N., QUESADA-CALVO, F., Baiwir, D., Mazzucchelli, G., Smargiasso, N., Servais, L., Oury, C., De Pauw-Gillet, M.-C., De Pauw, E., COIMBRA MARQUES, C., Colard, A., Vijverman, A., DELVENNE, P., MEUWIS, M.-A., & LOUIS, E. (27 January 2018). Potential diagnostic biomarkers of Ulcerative Colitis-associated colorectal dysplasia [Poster presentation]. Belgian Association for Cancer Research Annual Meeting 2018, Liège, Belgium. |
 | REENAERS, C., Mary, J.-Y., Nachury, M., Bouhnik, Y., Laharie, D., Allez, M., Fumery, M., Amiot, A., Savoye, G., Altwegg, R., Devos, M., Malamut, G., Bourreille, A., Flourie, B., Marteau, P., Vuitton, L., Coffin, B., Viennot, S., Lambert, J., ... Louis, E. (2018). Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2017.09.061 Peer Reviewed verified by ORBi |
 | DE FLINES, J., Louis, E., & Paquot, N. (2018). Vignette diagnostique de l'etudiant. Exploration d'un syndrome de malabsorption digestive. Revue Médicale de Liège, 73 (10), 526-532. |
 | Louis, E., Reinisch, W., Schwartz, D. A., Lofberg, R., Robinson, A. M., Berg, S., Wang, A. W., Maa, J.-F., Huang, B., & Pappalardo, B. (2018). Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies. Advances in Therapy, 35 (4), 563-576. doi:10.1007/s12325-018-0678-0 |
| Franchimont, D., Ferrante, M., Louis, E., De Vos, M., Dewit, O., Van Hootegem, P., Moreels, T., Liefferinckx, C., Bossuyt, P., Baert, F., Rahier, J.-F., & Vermeire, S. (2018). Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD). Acta Gastro-Enterologica Belgica, 81 (1), 49-53. |
| Peeters, H., Louis, E., Baert, F., Dewit, O., Coche, J. C., Ferrante, M., Lambrecht, G., Colard, A., Van Gossum, A., Bossuyt, P., Moreels, T., Vander Cruyssen, B., Gils, A., & De Vos, M. (2018). Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab. Acta Gastro-Enterologica Belgica, 81 (1), 15-21. |
| Louis, E. (2018). Stopping Biologics in IBD-What Is the Evidence? Inflammatory Bowel Diseases, 24 (4), 725-731. doi:10.1093/ibd/izx098 Peer Reviewed verified by ORBi |
| D'Haens, G., Vermeire, S., Lambrecht, G., Baert, F., Bossuyt, P., Pariente, B., Buisson, A., Bouhnik, Y., Filippi, J., Vander Woude, J., Van Hootegem, P., Moreau, J., Louis, E., Franchimont, D., De Vos, M., Mana, F., Peyrin-Biroulet, L., Brixi, H., Allez, M., ... Laharie, D. (2018). Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease. Gastroenterology, 154 (5), 1343-1351.e1. doi:10.1053/j.gastro.2018.01.004 Peer Reviewed verified by ORBi |
 | Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366 Peer reviewed |
 | Feagan, B. G., Panes, J., Ferrante, M., Kaser, A., D'Haens, G. R., Sandborn, W. J., Louis, E., Neurath, M. F., Franchimont, D., Dewit, O., Seidler, U., Kim, K.-J., Selinger, C., Padula, S. J., Herichova, I., Robinson, A. M., Wallace, K., Zhao, J., Minocha, M., ... Bocher, W. O. (2018). Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study. Lancet. Gastroenterology and Hepatology, 3 (10), 671-680. doi:10.1016/S2468-1253(18)30233-4 Peer Reviewed verified by ORBi |
 | Vermeire, S., D'heygere, F., Nakad, A., Franchimont, D., Fontaine, F., Louis, E., Van Hootegem, P., Dewit, O., Lambrecht, G., Strubbe, B., & Baert, F. (2018). Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study. Patient Preference and Adherence, 12, 1193-1202. doi:10.2147/PPA.S154181 |
 | Merli, A.-M., MASSOT, C., BLETARD, N., QUESADA-CALVO, F., Baiwir, D., Mazzucchelli, G., Smargiasso, N., Servais, L., Oury, C., De Pauw-Gillet, M.-C., De Pauw, E., COIMBRA MARQUES, C., Colard, A., Vijverman, A., DELVENNE, P., MEUWIS, M.-A., & LOUIS, E. (2018). Potential diagnostic biomarkers of Ulcerative colitis-associated colorectal dysplasia. Acta Gastro-Enterologica Belgica. Peer Reviewed verified by ORBi |
 | Paulissen, G., de Walque, R., Bindels, L., Delzenne, N., Thissen, J.-P., Meuwis, M.-A., & Louis, E. (2018). Identification of new pathways driving muscle atrophy and biomarkers reflecting muscle atrophy in cancer cachexia. Acta Gastro-Enterologica Belgica. Peer Reviewed verified by ORBi |
 | Amininejad, L.* , Charloteaux, B.* , Theatre, E., Liefferinckx, C., Dmitrieva, J., Hayard, P., Muls, V., Maisin, J.-M., Schapira, M., Ghislain, J.-M., Closset, P., Talib, M., Abramowicz, M., Momozawa, Y., Deffontaine, V., Crins, F., Mni, M., Karim, L., Cambisano, N., ... Franchimont, D.*. (2018). Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's Disease. Gastroenterology, 154 (8), 2165-2177. doi:10.1053/j.gastro.2018.02.028 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
| Forster, C., VANHAUDENHUYSE, A., GAST, P., Louis, E., HICK, G., Brichant, J.-F., & Joris, J. (2018). Intravenous infusion of lidocaine significantly reduces propofol dose for colonoscopy: a randomised placebo-controlled study. British Journal of Anaesthesia, 121 (5), 1059-1064. doi:10.1016/j.bja.2018.06.019 Peer Reviewed verified by ORBi |
 | Sandborn, W. J., Lee, S. D., Tarabar, D., Louis, E., Klopocka, M., Klaus, J., Reinisch, W., Hebuterne, X., Park, D.-I., Schreiber, S., Nayak, S., Ahmad, A., Banerjee, A., Brown, L. S., Cataldi, F., Gorelick, K. J., Cheng, J. B., Hassan-Zahraee, M., Clare, R., & D'Haens, G. R. (2018). Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study. Gut. doi:10.1136/gutjnl-2016-313457 Peer Reviewed verified by ORBi |
 | Doherty, G., Katsanos, K. H., Burisch, J., Allez, M., Papamichael, K., Stallmach, A., Mao, R., Berset, I. P., Gisbert, J. P., Sebastian, S., Kierkus, J., Lopetuso, L., Szymanska, E., & Louis, E. (2018). European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ('Exit Strategies') in Inflammatory Bowel Disease. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjx101 Peer Reviewed verified by ORBi |
 | Momozawa, Y., Dmitrieva, J. B., Theatre, E., Deffontaine, V., Rahmouni, S., Charloteaux, B., Crins, F., Elansary, M., Gori, A.-S., LECUT, C., Mariman, R., Mni, M., Oury, C., Altukhov, I., Alexeev, D., Aulchenko, Y., Amininejad, L., van der Meulen-de Jong, A. E., van der Woude, C. J., ... Georges, M. (2018). IBD risk loci are enriched in multigenic regulatory modules encompassing causative genes. Nature Communications. doi:10.1038/s41467-018-04365-8 Peer Reviewed verified by ORBi |
 | Deflandre, L.-A., LOLY, J.-P., LECLERCQ, P., LOLY, C., Louis, E., & GAST, P. (2018). Adenocarcinome obstructif localement avance de la tete du pancreas : importance du drainage biliaire precoce. Revue Médicale Suisse, 14 (615), 1443-1447. Peer Reviewed verified by ORBi |
| De Vos, M., Dhooghe, B., Vermeire, S., Louis, E., Mana, F., Elewaut, A., Bossuyt, P., Baert, F., REENAERS, C., Van Gossum, M., Macken, E., Ferrante, M., Hindryckx, P., Dewit, O., Holvoet, T., & Franchimont, D. (2018). Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists. United European Gastroenterology Journal, 6 (3), 439-445. doi:10.1177/2050640617722310 Peer Reviewed verified by ORBi |
| Bossuyt, P., Baert, F., D'Heygere, F., Nakad, A., REENAERS, C., Fontaine, F., Franchimont, D., Dewit, O., Van Hootegem, P., Vanden Branden, S., Lambrecht, G., Ferrante, M., & Louis, E. (Other coll.). (2018). Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort. Inflammatory Bowel Diseases. doi:10.1093/ibd/izy219 Peer Reviewed verified by ORBi |
| Bossuyt, P., Louis, E., Mary, J.-Y., Vermeire, S., & Bouhnik, Y. (2018). Defining Endoscopic Remission in Ileocolonic Crohn's Disease: Let's Start from Scratch. Journal of Crohn's and Colitis, 12 (10), 1245-1248. doi:10.1093/ecco-jcc/jjy097 Peer Reviewed verified by ORBi |
| Van de Vondel, S., Baert, F., Reenaers, C., Vanden Branden, S., Amininejad, L., Dewint, P., Van Moerkercke, W., Rahier, J.-F., Hindryckx, P., Bossuyt, P., Ferrante, M., & Louis, E. (Other coll.). (2018). Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study. Inflammatory Bowel Diseases, 24 (5), 1099-1105. doi:10.1093/ibd/izx103 Peer Reviewed verified by ORBi |
 | DELHOUGNE, N., COLARD, A., & Louis, E. (2018). Maladies inflammatoires chroniques de l'intestin et phenomenes thromboemboliques veineux. Revue Médicale de Liège, 73 (9), 462-467. Peer reviewed |
 | Bouhnik, Y., Carbonnel, F., Laharie, D., Stefanescu, C., Hebuterne, X., Abitbol, V., Nachury, M., Brixi, H., Bourreille, A., Picon, L., Bourrier, A., Allez, M., Peyrin-Biroulet, L., Moreau, J., Savoye, G., Fumery, M., Nancey, S., Roblin, X., Altwegg, R., ... Mary, J.-Y. (2018). Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut. doi:10.1136/gutjnl-2016-312581 Peer Reviewed verified by ORBi |
 | Laharie, D., Bourreille, A., Branche, J., Allez, M., Bouhnik, Y., Filippi, J., Zerbib, F., Savoye, G., Vuitton, L., Moureau, J., Amiot, A., Cosnes, J., Ricart, E., Dewit, O., Lopez-Sanroman, A., Fumery, M., Carbonnel, F., Bommelaer, G., Coffin, B., ... Louis, E. (2018). Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab. Gut. doi:10.1136/gutjnl-2016-313060 Peer Reviewed verified by ORBi |
 | Gagnière, C., Bourrier, A., Seksik, P., Gornet, J.-M., DeWit, O., Nancey, S., Altwegg, R., Abitbol, V., Laharie, D., REENAERS, C., Buisson, A., Pariente, B., Viennot, S., Vuitton, L., Stefanescu, C., Marteau, P., Bouguen, G., Cosnes, J., Amiot, A., ... Louis, E. (Other coll.). (2018). Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Alimentary Pharmacology and Therapeutics, 48 (7), 713-722. doi:10.1111/apt.14926 |
 | Di Giovanni, N., Cojocariu, C., Silcock, P., MEUWIS, M.-A., Louis, E., & Focant, J.-F. (December 2017). GC-MS Orbitrap and GC×GC-(HR)TOFMS in colorectal cancer metabolomics [Poster presentation]. MetaboMeeting 2017, Birmingham, United Kingdom. |
 | Di Giovanni, N., Cojocariu, C., Silcock, P., MEUWIS, M.-A., Louis, E., & Focant, J.-F. (December 2017). Untargeted Metabolomics of Colorectal Cancer Using GC-Orbitrap [Paper presentation]. Orbitrap user meeting, Paris, France. |
 | VIEUJEAN, S., LOUIS, E., & REENAERS, C. (October 2017). Immunosuppressive co-treatment with Infliximab and Adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time in ulcerative colitis [Poster presentation]. 25th UEG week, Barcelona, Spain. Peer reviewed |
Di Giovanni, N., MEUWIS, M.-A., Louis, E., & Focant, J.-F. (06 July 2017). New strategies for untargeted metabolomics [Paper presentation]. Journée du département de chimie. |
 | Di Giovanni, N., Cojocariu, C., Silcock, P., Souza, A., MEUWIS, M.-A., LOUIS, E., & Focant, J.-F. (June 2017). Untargeted serum metabolite profiling of colorectal cancer using GC-Orbitrap technology [Poster presentation]. 13th Annual Conference of the Metabolomics Society, Brisbane, Australia. |
 | QUESADA-CALVO, F., MASSOT, C., Bertrand, V., Longuespée, R., BLETARD, N., SOMJA, J., Mazzucchelli, G., Smargiasso, N., Baiwir, D., De Pauw-Gillet, M.-C., Delvenne, P., MALAISE, M., COIMBRA MARQUES, C., POLUS, M., De Pauw, E., MEUWIS, M.-A., & Louis, E. (24 March 2017). OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages. Clinical Proteomics, 24 (9). doi:10.1186/s12014-017-9143-3 Peer Reviewed verified by ORBi |
QUESADA-CALVO, F., Merli, A.-M., MASSOT, C., BLETARD, N., SOMJA, J., Smargiasso, N., Baiwir, D., Mazzucchelli, G., De Pauw-Gillet, M.-C., COIMBRA MARQUES, C., POLUS, M., MALAISE, M., De Pauw, E., DELVENNE, P., MEUWIS, M.-A., & LOUIS, E. (10 February 2017). Proteomic differential distribution of 53BP1 in serrated and conventional adenomas validated by histological characterisation [Poster presentation]. Belgian week of Gastroenterology, Anvers, Belgium. |
Merli, A.-M., QUESADA-CALVO, F., MASSOT, C., BLETARD, N., Smargiasso, N., Baiwir, D., Mazzucchelli, G., De Pauw-Gillet, M.-C., MALAISE, M., De Pauw, E., DELVENNE, P., Meuwis, M.-A., & Louis, E. (09 February 2017). Identification of proteins discriminating inflammation induced dysplasia from simple inflammation in ulcerative colitis by laser capture microdissection and label free proteomics – a pilot study [Paper presentation]. XXIXth edition of the Belgian Week of Gastroenterology, Anvers, Belgium. |
 | Merli, A.-M., QUESADA-CALVO, F., MASSOT, C., BLETARD, N., Smargiasso, N., Baiwir, D., Mazzucchelli, G., De Pauw-Gillet, M.-C., MALAISE, M., De Pauw, E., DELVENNE, P., Meuwis, M.-A., & Louis, E. (01 February 2017). Identification of proteins discriminating inflammation induced dysplasia from simple inflammation in ulcerative colitis by laser capture microdissection and label free proteomics – a pilot study [Poster presentation]. GIGA DAY 2017, Liège, Belgium. |
 | Louis, E., VAN KEMSEKE, C., & REENAERS, C. (2017). Objective assessment of clinical disease activity. In D. C. Baumgart (Ed.), Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach (pp. 259-266). Springer, Cham - D.C. Baumgart (ed.). doi:10.1007/978-3-319-33703-6_23 |
 | GREGOIRE, C., Louis, E., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., GIET, O., Beguin, Y., & BARON, F. (2017). The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 730-753). Hoboken, United States: John Wiley & Sons, Inc. Peer reviewed |
 | Michetti, P., Weinman, J., Mrowietz, U., Smolen, J., Peyrin-Biroulet, L., Louis, E., Schremmer, D., Tundia, N., Nurwakagari, P., & Selenko-Gebauer, N. (2017). Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study. Advances in Therapy, 34 (1), 91-108. doi:10.1007/s12325-016-0441-3 Peer Reviewed verified by ORBi |
 | Katsanos, K. H., Domenech, E., Rahier, J.-F., Kopylov, U., Fiorino, G., Rogler, G., Louis, E., & Ben-Horin, S. (2017). Making a Case for Case Reports: The ECCO-CONFER Viewpoint on Investigating Rare Events in a Medical World Reigned by Group-comparative Statistics. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjw131 Peer Reviewed verified by ORBi |
 | Feagan, B. G., Sandborn, W. J., D'Haens, G., Panes, J., Kaser, A., Ferrante, M., Louis, E., Franchimont, D., Dewit, O., Seidler, U., Kim, K.-J., Neurath, M. F., Schreiber, S., Scholl, P., Pamulapati, C., Lalovic, B., Visvanathan, S., Padula, S. J., Herichova, I., ... Bocher, W. O. (2017). Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study. Lancet, 389 (10080), 1699-1709. doi:10.1016/S0140-6736(17)30570-6 |
 | Ghosh, S., Louis, E., Beaugerie, L., Bossuyt, P., Bouguen, G., Bourreille, A., Ferrante, M., Franchimont, D., Frost, K., Hebuterne, X., Marshall, J. K., O'Shea, C., Rosenfeld, G., Williams, C., & Peyrin-Biroulet, L. (2017). Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases, 23 (3), 333-340. doi:10.1097/MIB.0000000000001033 Peer Reviewed verified by ORBi |
 | Martelli, L., Colard, A., Fontaine, F., Deflandre, J., Bastens, B., & Louis, E. (2017). Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea. Scandinavian Journal of Gastroenterology, 52 (5), 564-569. doi:10.1080/00365521.2017.1284893 Peer Reviewed verified by ORBi |
 | Bello, C., Roseth, A., Guardiola, J., REENAERS, C., Ruiz-Cerulla, A., VAN KEMSEKE, C., Arajol, C., Reinhard, C., SEIDEL, L., & Louis, E. (2017). Usability of a home-based test for the measurement of fecal calprotectin in asymptomatic IBD patients. Digestive and Liver Disease, 49 (9), 991-996. doi:10.1016/j.dld.2017.05.009 Peer Reviewed verified by ORBi |
 | VAN DAELE, D., Honoré, P., COLLIGNON, J., POLUS, M., LOLY, C., MUTIJIMA NZARAMBA, E., De Roover, A., Coucke, P., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localises de l'oesophage. Etat actuel des donnees et strategie therapeutique. 1ere partie : le point sur les approches chirurgicales et non chirurgicales. Revue Médicale de Liège, 72 (2), 58-63. Peer reviewed |
 | GREGOIRE, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., BARON, F., LOUIS, E., & BEGUIN, Y. (2017). Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 45, 205-221. doi:10.1111/apt.13864 Peer Reviewed verified by ORBi |
 | Gower-Rousseau, C., Sarter, H., Savoye, G., Tavernier, N., Fumery, M., Sandborn, W. J., Feagan, B. G., Duhamel, A., Guillon-Dellac, N., Colombel, J.-F., Peyrin-Biroulet, L., Reinisch, W., Tilg, H., Kamm, M., D'Haens, G., Louis, E., Van Assche, G., Feagan, B., Irvine, E. J., ... Sands, B. E. (2017). Validation of the inflammatory bowel disease disability index in a population-based cohort. Gut, 66 (4), 588-596. doi:10.1136/gutjnl-2015-310151 Peer Reviewed verified by ORBi |
Di Giovanni, N., MEUWIS, M.-A., Louis, E., & Focant, J.-F. (January 2017). Metabolomic Investigation of inflammatory bowel disease phenotypes using GCxGC-HRTOFMS [Paper presentation]. 8th Multidimensional Chromatography Workshop, Toronto, Canada. |
 | Fodil, N., Moradin, N., Leung, V., Olivier, J.-F., Radovanovic, I., Jeyakumar, T., Flores Molina, M., McFarquhar, A., Cayrol, R., Bozec, D., Shoukry, N. H., Kubo, M., Dimitrieva, J., Louis, E., Theatre, E., Dahan, S., Momozawa, Y., Georges, M., Yeretssian, G., & Gros, P. (2017). CCDC88B is required for pathogenesis of inflammatory bowel disease. Nature Communications, 8 (1), 932. doi:10.1038/s41467-017-01381-y Peer Reviewed verified by ORBi |
 | DESIR, C., COIMBRA MARQUES, C., Decker, M., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., Louis, E., & Meunier, P. (2017). Comment j'explore ... la maladie de Crohn par imagerie. Revue Médicale de Liège, 72 (1), 51-56. Peer reviewed |
 | LOLY, J.-P., SOMJA, J., REENAERS, C., VAN KEMSEKE, C., GAST, P., & Louis, E. (2017). Endomicroscopie confocale dans la prise en charge des maladies inflammatoires chroniques de l'intestin. Revue Médicale Suisse, 13 (571), 1431-1434. Peer Reviewed verified by ORBi |
 | VAN DAELE, D., Honoré, P., COLLIGNON, J., POLUS, M., LOLY, C., MUTIJIMA NZARAMBA, E., De Roover, A., Coucke, P., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localises de l'oesophage. Etat actuel des donnees et strategie therapeutique. 2eme partie : l'interet des approches multimodales avec ou sans chirurgie. Revue Médicale de Liège, 72 (4), 168-174. Peer reviewed |
 | Wauters, L., Smets, F., De Greef, E., Bontems, P., Hoffman, I., Hauser, B., Alliet, P., Arts, W., Peeters, H., Van Biervliet, S., Paquot, I., Van de Vijver, E., De Vos, M., Bossuyt, P., Rahier, J.-F., Dewit, O., Moreels, T., Franchimont, D., Muls, V., ... Veereman, G. (2017). Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO). Inflammatory Bowel Diseases, 23 (9), 1584-1591. doi:10.1097/MIB.0000000000001193 Peer Reviewed verified by ORBi |
 | Huang, H.* , Fang, M.* , Jostins, L.* , Umicevic - Mirkov, M., Boucher, G., Anderson, C. A., Andersen, V., Cleynen, I., Cortes, A., Crins, F., D'Amato, M., Deffontaine, V., Dmitrieva, J. B., DOCAMPO MARTINEZ, E., Elansary, M., Farh, K. K.-H., Franke, A., Gori, A.-S., Goyette, P., ... Barrett, J. C.*. (2017). Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature, 547 (7662), 173-178. doi:10.1038/nature22969 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Di Giovanni, N., MEUWIS, M.-A., LOUIS, E., & Focant, J.-F. (August 2016). Metabolomic Investigation of inflammatory bowel disease phenotypes using GC×GC-HRTOFMS [Paper presentation]. 21st International Mass Spectrometry Conference (IMSC 2016), Toronto, Canada. |
Di Giovanni, N., Meuwis, M.-A., LOUIS, E., & Focant, J.-F. (07 July 2016). Robust biomarkers for inflammatory bowel disease phenotypes using GC×GC-HRTOFMS [Paper presentation]. 7ème Journée du Département de Chimie, Liège, Belgium. |
 | Di Giovanni, N., Meuwis, M.-A., LOUIS, E., & Focant, J.-F. (28 June 2016). In the quest of robust biomarkers for inflammatory bowel disease phenotypes using GC×GC-HRTOFMS [Paper presentation]. 12th Annual Conference of the Metabolomics Society. |
 | Di Giovanni, N., MEUWIS, M.-A., LOUIS, E., & Focant, J.-F. (30 May 2016). Discrimination between inflammatory bowel disease (IBD) phenotypes by GC×GC-HRTOFMS [Paper presentation]. 40th International Symposium on Capillary Chromatography & 13th GC×GC Symposium, Riva Del Garda, Italy. |
 | Pesesse, R., Stefanuto, P.-H., Bertrand, V., De Pauw-Gillet, M.-C., MEUWIS, M.-A., LOUIS, E., LOUIS, R., & Focant, J.-F. (30 May 2016). GC×GC-(HR)TOFMS in Cancer Research [Paper presentation]. 40th International Symposium on Capillary Chromatography & 13th GC×GC Symposium, Riva Del Garda, Italy. |
 | Pesesse, R., Stefanuto, P.-H., SCHLEICH, F., MEUWIS, M.-A., LOUIS, E., LOUIS, R., & Focant, J.-F. (30 May 2016). Investigation of the possible effect of sampling on human exhaled breath sample integrity [Poster presentation]. 40th International Symposium on Capillary Chromatography & 13th GC×GC Symposium, Riva Del Garda, Italy. |
QUESADA-CALVO, F., Meuwis, M.-A., Bertrand, V., Longuespée, R., BLETARD, N., SOMJA, J., Mazzucchelli, G., Smargiasso, N., Baiwir, D., De Pauw-Gillet, M.-C., Delvenne, P., Malaise, M., COIMBRA MARQUES, C., POLUS, M., De Pauw, E., & Louis, E. (19 February 2016). Proteins in early CRC stages - from proteomic discovery to immunohistochemistry tissue distribution characterisation [Poster presentation]. Belgian Week of Gastroenterology, Bruxelles, Belgium. |
 | Pesesse, R., Stefanuto, P.-H., SCHLEICH, F., MEUWIS, M.-A., Louis, E., Louis, R., & Focant, J.-F. (28 January 2016). Characterization of human exhaled breath for non-invasive detection of diseases by GC×GC-TOFMS [Paper presentation]. 14th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology, Ghent, Belgium. |
 | Marteau, P., Laharie, D., Colombel, J.-F., Martin, L., Coevoet, H., Allez, M., Cadiot, G., Bourreille, A., Carbonnel, F., Bouhnik, Y., Coffin, B., Duclos, B., Dupas, J. L., Moreau, J., Louis, E., & Mary, J.-Y. (2016). Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn's Disease. Journal of Crohn's and Colitis, 10 (9), 1001-5. doi:10.1093/ecco-jcc/jjw082 Peer Reviewed verified by ORBi |
 | VALDES SOCIN, H. G., SID, S., LUTTERI, L., POLUS, M., Louis, E., Beguin, Y., & Beckers, A. (2016). Le syndrome thyro-gastrique auto-immun : actualités cliniques et thérapeutiques. Vaisseaux, Coeur, Poumons, 21 (4), 40-45. Peer reviewed |
 | Bourseau, S., Meunier, P., COIMBRA MARQUES, C., & Louis, E. (2016). LA MALADIE DE CROHN STENOSANTE: Presentation clinique, diagnostic et modalites de traitement. Revue Médicale de Liège, 71 (4), 178-83. Peer reviewed |
 | Regueiro, M., Feagan, B. G., Zou, B., Johanns, J., Blank, M. A., Chevrier, M., Plevy, S., Popp, J., Cornillie, F. J., Lukas, M., Danese, S., Gionchetti, P., Hanauer, S. B., Reinisch, W., Sandborn, W. J., Sorrentino, D., Rutgeerts, P., & Louis, E. (2016). Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. Gastroenterology, 150 (7), 1568-78. doi:10.1053/j.gastro.2016.02.072 Peer Reviewed verified by ORBi |
 | Satsangi, J., Kitten, O., CHAVEZ, V., Kalla, R., Prel, N., Meuwis, M.-A., Scott, S., Bonetti, I., Ventham, N. T., & Louis, E. (2016). How to Apply for and Secure EU Funding for Collaborative IBD Research Projects. Journal of Crohn's and Colitis, 10 (3), 363-70. doi:10.1093/ecco-jcc/jjv237 Peer Reviewed verified by ORBi |
 | Boschetti, G., Nancey, S., Daniel, F., Pariente, B., Lerebours, E., Duclos, B., Bourreille, A., Cadiot, G., Fumery, M., Moreau, J., Marteau, P., Bouhnik, Y., Louis, E., & Flourie, B. (2016). Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years. Inflammatory Bowel Diseases, 22 (12), 2924-2932. doi:10.1097/MIB.0000000000000967 Peer Reviewed verified by ORBi |
 | De Greef, E., Hoffman, I., Smets, F., Van Biervliet, S., Bontems, P., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., De Vos, M., Baert, F., Bossuyt, P., Rahier, J.-F., Franchimont, D., Vermeire, S., Fontaine, F., Louis, E., Coche, J. C., & Veereman, G. (2016). Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up. Journal of Pediatric Gastroenterology and Nutrition, 63 (2), 253-8. doi:10.1097/MPG.0000000000001132 Peer Reviewed verified by ORBi |
 | Carbonnel, F., Colombel, J. F., Filippi, J., Katsanos, K. H., Peyrin-Biroulet, L., Allez, M., Nachury, M., Novacek, G., Danese, S., Abitbol, V., Bossa, F., Moreau, J., Bommelaer, G., Bourreille, A., Fumery, M., Roblin, X., Reinisch, W., Bouhnik, Y., Brixi, H., ... Laharie, D. (2016). Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis. Gastroenterology, 150 (2), 380-8.e4. doi:10.1053/j.gastro.2015.10.050 Peer Reviewed verified by ORBi |
 | REENAERS, C., Pirard, C., VAN KEMSEKE, C., LATOUR, P., Belaiche, J., & Louis, E. (2016). Long-term evolution and predictive factors of mild inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 51 (6), 712-9. doi:10.3109/00365521.2015.1128965 Peer Reviewed verified by ORBi |
 | MALAISE, O., RELIC, B., Charlier, E., Zeddou, M., NEUVILLE, S., Deroyer, C., Gillet, P., Louis, E., Malaise, M., & DE SENY, D. (2016). Glucocorticoid-induced leucine zipper (GILZ) is involved in glucocorticoid-induced and mineralocorticoid-induced leptin production by osteoarthritis synovial fibroblasts. Arthritis Research and Therapy, 18 (1), 219. doi:10.1186/s13075-016-1119-6 Peer Reviewed verified by ORBi |
 | GAST, P., LOLY, J.-P., LECLERCQ, P., & Louis, E. (2016). Complications oesogastriques de la thermoablation dans le cadre de la fibrillation auriculaire. Revue Médicale Suisse, 12 (527), 1362-1366. Peer Reviewed verified by ORBi |
 | Cleynen, I., Boucher, G., Jostins, L., Schumm, L. P., Zeissig, S., Ahmad, T., Andersen, V., Andrews, J. M., Annese, V., Brand, S. L., Brant, S. R., Cho, J. H., Daly, M. J., Dubinsky, M., Duerr, R. H., Ferguson, L. R., Franke, A., Gearry, R., Goyette, P., ... Louis, E. (Other coll.). (2016). Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet. doi:10.1016/s0140-6736(15)00465-1 Peer Reviewed verified by ORBi |
 | Danese, S., Hart, A., Dignass, A., Louis, E., D'Haens, G., Dotan, I., Rogler, G., D'Agay, L., Iannacone, C., & Peyrin-Biroulet, L. (2016). Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study. BMJ Open Gastroenterology, 3 (1), 000092. doi:10.1136/bmjgast-2016-000092 Peer Reviewed verified by ORBi |
 | Dumont, R., LOLY, J.-P., DELWAIDE, J., & LOUIS, E. (2016). La maladie de Rendu-Osler: une cause rare d'encéphalopathie ammoniacale. Revue Médicale de Liège, 71 (2), 83-89. Peer reviewed |
 | Peyrin-Biroulet, L., Salleron, J., Filippi, J., REENAERS, C., Antunes, O., Filipe, V., Louis, E., Hebuterne, X., & Roblin, X. (2016). Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience. Journal of Crohn's and Colitis, 10 (5), 516-24. doi:10.1093/ecco-jcc/jjw008 Peer Reviewed verified by ORBi |
| Sid, S., LUTTERI, L., BEGUIN, Y., Louis, E., Beckers, A., & VALDES SOCIN, H. G. (2015). Familial thyrogastric autoimmune syndrome : a study of 22 kindreds. In Abstract book - 20th Annual Congress of the Belgian Society of Internal Medicine. |
 | Baiwir, D., Mazzucchelli, G., Smargiasso, N., QUESADA CALVO, F., De Pauw, E., MALAISE, M., Louis, E., & MEUWIS, M.-A. (December 2015). Comparison of serum fractionation methods by data independent label-free proteomics. EuPA Open Proteomics, 9, 14-22. doi:10.1016/j.euprot.2015.07.009 Peer Reviewed verified by ORBi |
QUESADA-CALVO, F., Meuwis, M.-A., Bertrand, V., Longuespée, R., BLETARD, N., Somja, J., Mazzucchelli, G., Smargiasso, N., Baiwir, D., De Pauw-Gillet, M.-C., Delvenne, P., Malaise, M., POLUS, M., De Pauw, E., & Louis, E. (27 October 2015). LABEL FREE PROTEOMICS IDENTIFIES OLFACTOMEDIN-4 AS A MARKER OF EPITHELIAL TRANSITION OF EARLY CRC STAGES [Paper presentation]. UEG Week Barcelona 2015, Barcelona, Spain. |
 | Senéjoux, A., Siproudhis, L., Abramowitz, L., Munoz-Bongrand, N., Desseaux, K., Bouguen, G., Bourreille, A., Dewit, O., Stefanescu, C., Vernier, G., Louis, E., Grimaud, J. C., Godart, B., Savoye, G., Hebuterne, X., Bauer, P., Nachury, M., Laharie, D., Chevret, S., ... GETAID. (2015). Fistula plug in fistulising ano-perineal Crohn's disease: a randomised controlled trial. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjv162 |
| VALDES SOCIN, H. G., MESUREUR, T., POLUS, M., DELWAIDE, J., Louis, E., LUTTERI, L., & Beckers, A. (2015). Syndrome thyrogastrique autoimmun (STGA) : la gastrite auto-immune isolée (GAI) et celle associée à Helicobacter (Hp) ont des caractéristiques anatomocliniques différentes. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie. |
 | Louis, E. (2015). When it is not inflammatory bowel disease: differential diagnosis. Current Opinion in Gastroenterology, 283-189. doi:10.1097/MOG.0000000000000183 |
Di Giovanni, N., Meuwis, M.-A., Louis, E., & Focant, J.-F. (02 July 2015). High-quality analytical method in metabolomics [Poster presentation]. Journée du département de Chimie, Liège, Belgium. |
 | Louis, E., Dotan, I., Ghosh, S., Mlynarsky, L., REENAERS, C., & Schreiber, S. (2015). Optimising the Inflammatory Bowel Disease Unit to Improve Quality Of Care: Expert Recommandations. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjv085 |
Docampo Martínez, E., Fang, M., Dmitrieva, J. B., Theatre, E., Elansary, M., Mariman, R., Gori, A.-S., Mini, M., Crins, F., Coppieters, W., LOUIS, E., & Georges, M. (05 May 2015). Prioritizing likely causative genes in GWAS identified risk loci for immune-mediated inflammatory disorders using cell-type specific eQTL information [Poster presentation]. cold spring harbor laboratory THE BIOLOGY OF GENOMES. |
QUESADA CALVO, F., MEUWIS, M.-A., Bertrand, V., Longuespée, R., SOMJA, J., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Delvenne, P., MALAISE, M., POLUS, M., De Pauw-Gillet, M.-C., De Pauw, E., & Louis, E. (2015). Comparison of early stages of colorectal cancer by label free proteomics. In Acta Gastroenterologica. Peer reviewed |
MEUWIS, M.-A., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., Smargiasso, N., De Pauw, E., MALAISE, M., GETAID, & LOUIS, E. (2015). Potential Proteomic Biomarkers Associated with Mucosal Healing and Relapse Prediction after IFX Withdrawals in Crohn’s Disease. In Acta gastroenterologica. Peer reviewed |
 | Goyette, P., Boucher, G., Mallon, D., Ellinghaus, E., Jostins, L., Huang, H., Ripke, S., Gusareva, E., Annese, V., Hauser, S. L., Oksenberg, J. R., Thomsen, I., Leslie, S., Theatre, E., Georges, M., Louis, E., Daly, M. J., Van Steen, K., Duerr, R. H., ... Rioux, J. D. (05 January 2015). High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nature Genetics, 47 (2), 172-9. doi:10.1038/ng.3176 Peer Reviewed verified by ORBi |
 | Cleynen, I., Konings, P., Robberecht, C., Laukens, D., Amininejad, L., Théâtre, E., Machiels, K., Arijs, I., Rutgeerts, P., Louis, E., Franchimont, D., De Vos, M., Van Steen, K., Georges, M., Moreau, Y., Vermeesch, J., & Vermeire, S. (2015). Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease. Inflammatory Bowel Diseases. doi:10.1097/MIB.0000000000000623 Peer Reviewed verified by ORBi |
 | Louis, E., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., BELAICHE, J., MEUNIER, P., & COIMBRA MARQUES, C. (2015). De l'"Evidence-based Medecine" à la médecine personnalisée dans la maladie de Crohn. Revue Médicale de Liège, 70 (5-6), 316-320. |
 | Van Biervliet, S., Smets, F., Hofmann, I., Degreef, E., Hauser, B., Bontems, P., Vande Velde, S., Arts, W., Paquot, I., Alliet, P., Bossuyt, P., Louis, E., Baert, F., Bauraind, O., Rahier, J.-F., & Veereman, G. (2015). The course of anaemia in children and adolescents with Crohn's disease included in a prospective registry. International Journal of Colorectal Disease, 30 (1), 51-6. doi:10.1007/s00384-014-2042-4 Peer Reviewed verified by ORBi |
 | REENAERS, C., & Louis, E. (2015). Complications de la rectocolite hémorragique et impact des traitements actuels sur l'histoire naturelle de ces complications. Hépato-Gastro, 22, 38-44. doi:10.1684/hpg.2015.1190 |
 | Schreiber, S., Panés, J., Louis, E., Holley, D., Buch, M., & Paridaens, K. (2015). Perception gaps between patients with ulcerative colitis and healthcare professionals: An online survey. South African Gastroenterology Review, 13 (1), 7-15. |
 | Torres, J., Boyapati, R. K., Kennedy, N. A., Louis, E., Colombel, J.-F., & Satsangi, J. (2015). Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease. Gastroenterology, 149 (7), 1716-1730. doi:10.1053/j.gastro.2015.08.055 Peer Reviewed verified by ORBi |
 | Pariente, B., Mary, J.-Y., Danese, S., Chowers, Y., De Cruz, P., D'Haens, G., Loftus, E. V. J., Louis, E., Panes, J., Scholmerich, J., Schreiber, S., Vecchi, M., Branche, J., Bruining, D., Fiorino, G., Herzog, M., Kamm, M. A., Klein, A., Lewin, M., ... Cosnes, J. (2015). Development of the lemann index to assess digestive tract damage in patients with Crohn's disease. Gastroenterology, 148 (1), 52-63. doi:10.1053/j.gastro.2014.09.015 Peer Reviewed verified by ORBi |
 | VAN DAELE, D., Puleo, F., Dumont, R., POLUS, M., Loly, C., Martinive, P., Meunier, P., Collignon, J., Hendlisz, A., Marechal, R., Louis, E., & Van Laethem, J.-L. (2015). Evolution dans la prise en charge de l'adenocarcinome du pancreas localise estime resecable. Revue Médicale Suisse, 11 (483), 1543-8. Peer Reviewed verified by ORBi |
 | MALAISE, O., RELIC, B., QUESADA CALVO, F., Charlier, E., Zeddou, M., NEUVILLE, S., Gillet, P., Louis, E., DE SENY, D., & MALAISE, M. (2015). Selective glucocorticoid receptor modulator compound A, in contrast to prednisolone, does not induce leptin or the leptin receptor in human osteoarthritis synovial fibroblasts. Rheumatology. doi:10.1093/rheumatology/keu428 Peer Reviewed verified by ORBi |
 | Vermeire, S., Louis, E., Dewit, O., Franchimont, D., Moreels, T., Ferrante, M., RAHIER, J.-F., Van Hootegem, P., De Vos, M., Mana, F., & Baert, F. (2015). Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD). Acta Gastro-Enterologica Belgica, 78, 26-29. Peer Reviewed verified by ORBi |
 | Van Kemseke, C., Louis, E., & REENAERS, C. (2015). LE MEDICAMENT DU MOIS. Vedolizumab (Entyvio(R)), nouveau traitement des maladies inflammatoires intestinales. Revue Médicale de Liège, 70 (11), 575-82. Peer reviewed |
 | Louis, E. (2015). Fecal calprotectin: towards a standarized use for inflammatory bowel disease management in routine practice. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jju012 |
 | VAN DAELE, D., Martinive, P., LOLY, C., POLUS, M., COLLIGNON, J., GAST, P., Louis, E., & Van Laethem, J.-L. (2015). COMMENT JE TRAITE ... Point de vue critique sur l'approche actuelle du cancer du pancreas localisé. Revue Médicale de Liège, 70 (11), 540-5. Peer reviewed |
 | MEUNIER, P., COUSIN, F., VAN KEMSEKE, C., REENAERS, C., LATOUR, P., BELAICHE, J., SEIDEL, L., & LOUIS, E. (2015). Persisting signs of disease activity at magnetic resonance enterocolonography predict clinical relapse and disease progression in quiescent Crohn's disease. Acta Gastro-Enterologica Belgica, 73 (3), 274-81. Peer Reviewed verified by ORBi |
 | Reinisch, W.* , Louis, E.* , & Danese, S.*. (2015). The scientific and regulatory rationale for indication extrapolation: A case study based on the infliximab biosimilar CT-P13. Expert Review of Gastroenterology and Hepatology, 9, 17-S26. doi:10.1586/17474124.2015.1091306 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Ternant, D., Berkane, Z., Picon, L., Gouilleux-Gruart, V., Colombel, J.-F., Allez, M., Louis, E., & Paintaud, G. (2015). Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's Disease. Clinical Pharmacokinetics, 551-562. doi:10.1007/s40262-014-0225-3 Peer Reviewed verified by ORBi |
Louis, E. (2015). When and how to stop anti-TNF treatment in inflammatory bowel disease: Predictors of relapse after stopping treatment. In Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease (pp. 224-228). S. Karger AG. doi:10.1159/000381610 |
 | MEUWIS, M.-A., Baiwir, D., Mazzucchelli, G., Smargiasso, N., Quesada-Calvo, F., MALAISE, M., De Pauw, E., The GETAID, & LOUIS, E. (06 October 2014). Potential Proteomic Biomarkers Associated To Mucosal Healing In Crohn’s Disease [Poster presentation]. HUPO2014, Madrid, Spain. |
 | Warling, O., BOVY, C., COIMBRA MARQUES, C., Noterdaeme, T., DELWAIDE, J., & LOUIS, E. (28 April 2014). Overlap syndrome consisting of PSC-AIH with concomitant presence of a membranous glomerulonephritis and ulcerative colitis. World Journal of Gastroenterology, 20 (16), 4811-4816. doi:10.3748/wjg.v20.i16.4811 Peer Reviewed verified by ORBi |
Docampo Martínez, E., Theatre, E., Dmitrieva, J. B., Elansary, M., Mariman, R., Mni, M., Crins, F., Gori, A.-S., Fang, M., LOUIS, E., & Georges, M. (24 April 2014). Identifying Inflammatory Bowel Disease causative genes through trans-eQTLs mapping within GWAS loci [Poster presentation]. BeMGI. |
Gori, A.-S., LECUT, C., Theatre, E., Momozawa, Y., Docampo Martínez, E., Mariman, R., Dmitrieva, J. B., Elansary, M., Charloteaux, B., Defontaine, V., Mni, M., Crins, F., LOUIS, E., Georges, M., & Oury, C. (24 April 2014). Combined use of GWAS and eQTL information to identify genes controlling platelet biology [Poster presentation]. BeMGI. doi:10.13140/RG.2.1.4044.9763 |
 | Tack, J., LOUIS, E., Persy, V., & Urbain, D. (March 2014). Utilisation optimale des inhibiteurs de la pompe à protons dans le cadre des soins primaires. Revue Médicale de Liège, 69 (3), 139-145. Peer reviewed |
 | VALDES SOCIN, H. G., LUTTERI, L., Cavalier, E., POLUS, M., Geenen, V., Louis, E., & Beckers, A. (2014). El sindrome tirogastrico autoinmune : sus efectos sobre los micronutrientes y la tumorigenesis gastrica. Revista Argentina de Endocrinologia y Metabolismo, 51, 37-43. Peer Reviewed verified by ORBi |
 | SABOURY, B., SALAVATI, A., BROTHERS, A., BASU, S., KWEE, T., LAM, M., HUSTINX, R., LOUIS, E., TORIGIAN, D., & ALAVI, A. (2014). FDG PET/CT in Crohn's disease : correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity. European Journal of Nuclear Medicine and Molecular Imaging, 41, 605-614. doi:10.1007/s00259-013-2625-2 Peer Reviewed verified by ORBi |
 | Poncin, M., REENAERS, C., VAN KEMSEKE, C., Belaiche, J., Seidel, L., MEUNIER, P., & Louis, E. (2014). Depth of remission in Crohn's disease patients seen in a referral centre : associated factors and impact on disease outcome. Acta Gastro-Enterologica Belgica, 77 (1), 41-6. Peer Reviewed verified by ORBi |
 | QUESADA CALVO, F., Bertrand, V., Longuespée, R., Delga, A., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Delvenne, P., MALAISE, M., De Pauw-Gillet, M.-C., De Pauw, E., Louis, E., & Meuwis, M.-A. (2014). Comparison of two FFPE preparation methods using label-free shotgun proteomics: Application to tissues of diverticulitis patients. Journal of Proteomics, 112C, 250-261. doi:10.1016/j.jprot.2014.08.013 Peer Reviewed verified by ORBi |
 | Smargiasso, N., Mazzucchelli, G., Baiwir, D., LOUIS, E., Quesada-Calvo, F., MEUWIS, M.-A., & De Pauw, E. (2014). Data dependent versus Data independent acquisition applied to samples with different protein dynamic range [Poster presentation]. 13th Human Proteome Organization World Congress. |
 | Benitez, J.-M., & Louis, E. (2014). Can we predict the high-risk patient? Digestive Diseases, 32 (4), 328-36. doi:10.1159/000358132 Peer Reviewed verified by ORBi |
 | Louis, E., Irving, P., & Beaugerie, L. (2014). Use of azathioprine in IBD: modern aspects of an old drug. Gut, 63 (11), 1695-9. doi:10.1136/gutjnl-2013-306711 Peer Reviewed verified by ORBi |
 | Louis, E. (2014). Diagnostic differentiel d'une diarrhee chronique. Revue Médicale de Liège, 69 (1), 51-6. Peer reviewed |
 | Rajca, S., Grondin, V., Louis, E., Vernier-Massouille, G., Grimaud, J.-C., Bouhnik, Y., Laharie, D., Dupas, J.-L., Pillant, H., Picon, L., Veyrac, M., Flamant, M., Savoye, G., Jian, R., Devos, M., Paintaud, G., Piver, E., Allez, M., Mary, J. Y., ... Seksik, P. (2014). Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflammatory Bowel Diseases, 20 (6), 978-86. doi:10.1097/MIB.0000000000000036 Peer Reviewed verified by ORBi |
| VALDES SOCIN, H. G., LOLY, J.-P., BETEA, D., LOUIS, E., Beckers, A., & POLUS, M. (October 2013). Hypercalcémie réfractaire et sécrétion ectopique de calcitonine dans un cancer neuroendocrine du pancréas : Effets hypocalcémiants du Cinacalcet. Annales d'Endocrinologie, 74, 294. Peer Reviewed verified by ORBi |
 | LEDOUBLE, V., BECK, E., PETERS, P., LAMPROYE, A., & Louis, E. (2013). Thrombose portale étendue chez un patient sous anti-vitamine K. Revue Médicale de Liège, (68(7-8)), 382-6. Peer reviewed |
 | Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., Fox, I., Milch, C., Sankoh, S., Wyant, T., Xu, J., Parikh, A., & Louis, E. (2013). Vedolizumab as induction and maintenance therapy for ulcerative colitis. New England Journal of Medicine, 369 (8), 699-710. doi:10.1056/NEJMoa1215734 Peer Reviewed verified by ORBi |
 | Panaccione, R., Colombel, J.-F., Louis, E., Peyrin-Biroulet, L., & Sandborn, W. J. (2013). Evolving definitions of remission in Crohn's disease. Inflammatory Bowel Diseases, 19 (8), 1645-53. doi:10.1097/MIB.0b013e318283a4b3 Peer Reviewed verified by ORBi |
Mazzucchelli, G., Smargiasso, N., Baiwir, D., Louis, E., De Pauw, E., & MEUWIS, M.-A. (2013). Comparison of five serum depletion or fractionation methods applied for clinical biomarkers discovery studies [Poster presentation]. 61st ASMS Conference on Mass Spectrometry and Allied Topics. |
 | VALDES SOCIN, H. G., LUTTERI, L., CAVALIER, E., POLUS, M., LOUIS, E., & BECKERS, A. (2013). le syndrome auto-immun thyrogastrique: ses effets sur les micronutriments et la tumorigénèse gastrique. Revue Médicale de Liège. Peer reviewed |
 | Beyaert, R., Beaugerie, L., Van Assche, G., Brochez, L., Renauld, J.-C., Viguier, M., Cocquyt, V., JERUSALEM, G., Machiels, J.-P., Prenen, H., Masson, P., Louis, E., & De Keyser, F. (2013). Cancer risk in immune-mediated inflammatory diseases (IMID). Molecular Cancer, 12 (1), 98. doi:10.1186/1476-4598-12-98 Peer Reviewed verified by ORBi |
 | De Vos, M., Louis, E., Jahnsen, J., Vandervoort, J. G. P., Noman, M., Dewit, O., D'haens, G. R., Franchimont, D., Baert, F. J., Torp, R. A., Henriksen, M., Potvin, P. M. R., Van Hootegem, P. P., Hindryckx, P. M., Moreels, T. G., Collard, A., Karlsen, L. N., Kittang, E., Lambrecht, G., ... Vermeire, S. A. R. A. (2013). Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy. Inflammatory Bowel Diseases, 19 (10), 2111-7. doi:10.1097/MIB.0b013e31829b2a37 Peer Reviewed verified by ORBi |
 | Van Assche, G., Herrmann, K. A., Louis, E., Everett, S. M., Colombel, J.-F., Rahier, J.-F., Vanbeckevoort, D., Meunier, P., Tolan, D., Ernst, O., Rutgeerts, P., Vermeire, S., Aerden, I., Oortwijn, A., & Ochsenkuhn, T. (2013). Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease. Journal of Crohn's and Colitis, 7 (12), 950-7. doi:10.1016/j.crohns.2013.01.011 Peer Reviewed verified by ORBi |
 | LOUIS, E., Lofberg, R., Reinisch, W., Camez, A., Yang, M., Pollack, P. F., Chen, N., Chao, J., & Mulani, P. M. (2013). Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial. Journal of Crohn's and Colitis, 7. doi:10.1016/j.crohns.2012.02.017 Peer Reviewed verified by ORBi |
 | Benitez, J. M., & LOUIS, E. (2013). Commentary: predicting complicated Crohn's disease and surgery--phenotypes, genetics, serology and psychological characteristics of a population-based cohort. Alimentary Pharmacology and Therapeutics, 38 (5), 555-6. doi:10.1111/apt.12416 Peer Reviewed verified by ORBi |
 | REENAERS, C., Louis, E., Belaiche, J., Seidel, L., Keshav, S., & Travis, S. (2013). Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply. Alimentary Pharmacology and Therapeutics, 37 (7), 752-3. doi:10.1111/apt.12245 Peer Reviewed verified by ORBi |
 | Benitez, J.-M., Meuwis, M.-A., REENAERS, C., VAN KEMSEKE, C., Meunier, P., & Louis, E. (2013). Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring. Gut, 62 (12), 1806-16. doi:10.1136/gutjnl-2012-303957 Peer Reviewed verified by ORBi |
 | Baert, F., Glorieus, E., REENAERS, C., D'Haens, G., Peeters, H., Franchimont, D., Dewit, O., Caenepeel, P., LOUIS, E., & Van Assche, G. (2013). Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients. Journal of Crohn's and Colitis, 7 (2). doi:10.1016/j.crohns.2012.03.018 Peer Reviewed verified by ORBi |
 | De Greef, E., Mahachie John, J., Hoffman, I., Smets, F., Van Biervliet, S., Scaillon, M., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., Peeters, H., Baert, F., D'Haens, G., Rahier, J.-F., Etienne, I., Bauraind, O., Van Gossum, A., Vermeire, S., ... Veereman, G. (2013). Profile of pediatric Crohn's disease in Belgium. Journal of Crohn's and Colitis, 7 (11), 588-98. doi:10.1016/j.crohns.2013.04.016 Peer Reviewed verified by ORBi |
 | Papay, P., Ignjatovic, A., Karmiris, K., Amarante, H., Milheller, P., Feagan, B., D'Haens, G., Marteau, P., Reinisch, W., Sturm, A., Steinwurz, F., Egan, L., Panes, J., Louis, E., Colombel, J.-F., & Panaccione, R. (2013). Optimising monitoring in the management of Crohn's disease: a physician's perspective. Journal of Crohn's and Colitis, 7 (8), 653-69. doi:10.1016/j.crohns.2013.02.005 Peer Reviewed verified by ORBi |
 | Chiu, Y.-L., Rubin, D. T., Vermeire, S., Louis, E., Robinson, A. M., Lomax, K. G., Pollack, P. F., & Paulson, S. K. (2013). Serum adalimumab concentration and clinical remission in patients with Crohn's disease. Inflammatory Bowel Diseases, 19 (6), 1112-22. doi:10.1097/MIB.0b013e3182813242 Peer Reviewed verified by ORBi |
 | Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., Fox, I., Rosario, M., Sankoh, S., Xu, J., Stephens, K., Milch, C., Parikh, A., & Louis, E. (2013). Vedolizumab as induction and maintenance therapy for Crohn's disease. New England Journal of Medicine, 369 (8), 711-21. doi:10.1056/NEJMoa1215739 Peer Reviewed verified by ORBi |
 | Schreiber, S., Panes, J., LOUIS, E., Holley, D., Buch, M., & Paridaens, K. (2013). National differences in ulcerative colitis experience and management among patients from five European countries and Canada: An online survey. Journal of Crohn's and Colitis, 7. doi:10.1016/j.crohns.2012.07.027 Peer Reviewed verified by ORBi |
 | Louis, E. (2013). Strategic use of immunosuppressants and anti-TNF in inflammatory bowel disease. Digestive Diseases, 31 (2), 207-12. doi:10.1159/000353370 Peer Reviewed verified by ORBi |
 | Tack, J., Louis, E., Persy, V., & Urbain, D. (2013). Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care. Acta Gastro-Enterologica Belgica, 76 (4), 393-402. Peer Reviewed verified by ORBi |
 | LOUIS, E. (2013). Is it ever appropriate to stop anti-tumor necrosis factor in a stable patient? In D. T. Rubin, S. Friedman, ... F. A. Farraye, Curbside Consultation in IBD: 49 Clinical Questions, Second Edition (seconde édition, pp. 107-109). Slack incorporated. |
 | Meuwis, M.-A., Vernier-Massouille, G., Grimaud, J. C., Bouhnik, Y., Laharie, D., Piver, E., Seidel, L., Colombel, J. F., & Louis, E. (2013). Serum calprotectin as a biomarker for Crohn's disease. Journal of Crohn's and Colitis, 7 (12), 678-83. doi:10.1016/j.crohns.2013.06.008 Peer Reviewed verified by ORBi |
 | COUSIN, F., Louis, E., & Meunier, P. (2013). Maladie de Crohn et entero-IRM evaluation de l'activite de la maladie et du dommage tissulaire. Revue Médicale Suisse, 9 (395), 1502-6. Peer Reviewed verified by ORBi |
 | Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Schumm, L. P., Sharma, Y., Anderson, C. A., Essers, J., Mitrovic, M., Ning, K., Cleynen, I., Theatre, E., Spain, S. L., Raychaudhuri, S., Goyette, P., Wei, Z., ... Cho, J. H. (October 2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature, 491 (7422), 119-24. doi:10.1038/nature11582 Peer Reviewed verified by ORBi |
| De Greef, E., Mahachie John, J., Hoffman, I., Smets, F., Van Biervliet, S., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., Peeters, H., Baert, F., D'haens, G., Rahier, J.-F., Etienne, I., Bauraind, O., Van Gossum, A., Vermeire, S., Fontaine, F., ... Veereman, G. (2012). Factors determining therapeutic strategy at diagnosis and evolution of disease severity in a cohort of Belgian pediatric Crohn's disease patients (BELCRO). Gastroenterology. Peer Reviewed verified by ORBi |
 | Louis, E., REENAERS, C., Meuwis, M.-A., VAN KEMSEKE, C., LATOUR, P., CHAPELIER, N., WERTZ, S., COIMBRA MARQUES, C., MEUNIER, P., & Belaiche, J. (March 2012). Quinze ans d'anti-TNF dans la maladie de Crohn: comment tirer le meilleur de cette revolution therapeutique? Revue Médicale de Liège, 67 Spec No, 8-13. Peer reviewed |
 | Louis, E., Mary, J. Y., Vernier-Massouille, G., Grimaud, J. C., Bouhnik, Y., Laharie, D., Dupas, J. L., Pillant, H., Picon, L., Veyrac, M., Flamant, M., Savoye, G., Jian, R., DEVOS, M., Porcher, R., Paintaud, G., Piver, E., Colombel, J. F., & Lemann, M. (2012). Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped. Gastroenterology, 142 (1), 63-70.e5; quiz e31. doi:10.1053/j.gastro.2011.09.034 Peer Reviewed verified by ORBi |
 | Schreiber, S., Panes, J., LOUIS, E., Holley, D., Buch, M., & Paridaens, K. (2012). Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey. BMC Gastroenterology, 12 (1), 108. doi:10.1186/1471-230X-12-108 Peer Reviewed verified by ORBi |
 | Desselle, F., VERSET, G., POLUS, M., Louis, E., & VAN DAELE, D. (2012). Le syndrome de Lynch et l'instabilité des microsatellites : revue de littérature. Revue Médicale de Liège, 67 (12), 638-642. Peer reviewed |
| LOUIS, E., & Panes, J. (2012). Adalimumab in ulcerative colitis: can pharmacodynamics be improved based on pharmacokinetics? Gastroenterology, 142 (1), 176-8. doi:10.1053/j.gastro.2011.11.011 Peer Reviewed verified by ORBi |
 | LOUIS, E., Baumgart, D. C., Ghosh, S., Gomollon, F., Hanauer, S., Hart, A., & Irving, P. (2012). What changes in inflammatory bowel disease management can be implemented today? Journal of Crohn's and Colitis, 6 Suppl 2, 260-7. doi:10.1016/S1873-9946(12)60506-6 Peer Reviewed verified by ORBi |
 | Louis, E., GAST, P., VAN KEMSEKE, C., & REENAERS, C. (2012). Commentary: endoscopic dilatation for stricturing Crohn's disease. Alimentary Pharmacology and Therapeutics, 36 (5), 494-6. doi:10.1111/j.1365-2036.2012.05209.x Peer Reviewed verified by ORBi |
 | LOUIS, E. (2012). Epidemiology of the transition from early to late Crohn's disease. Digestive Diseases, 30 (4), 376-9. doi:10.1159/000338129 Peer Reviewed verified by ORBi |
 | De Greef, E., Hoffman, I., D'Haens, G., Van Biervliet, S., Smets, F., Scaillon, M., Dewit, O., Peeters, H., Paquot, I., Alliet, P., Arts, W., Hauser, B., Vermeire, S., Van Gossum, A., Rahier, J.-F., Etienne, I., Louis, E., Coche, J. C., Mahachie John, J., ... Veereman, G. (2012). Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease. Acta Gastro-Enterologica Belgica, 75 (4), 425-31. Peer Reviewed verified by ORBi |
 | REENAERS, C., Belaiche, J., & Louis, E. (2012). Impact of medical therapies on inflammatory bowel disease complication rate. World Journal of Gastroenterology, 18 (29), 3823-7. doi:10.3748/wjg.v18.i29.3823 Peer Reviewed verified by ORBi |
 | Colombel, J.-F., Louis, E., Peyrin-Biroulet, L., Sandborn, W. J., & Panaccione, R. (2012). Deep remission: A new concept? Digestive Diseases. doi:10.1159/000342732 Peer Reviewed verified by ORBi |
 | Rivas, M. A., Beaudoin, M., Gardet, A., Stevens, C., Sharma, Y., Zhang, C. K., Boucher, G., Ripke, S., Ellinghaus, D., Burtt, N., Fennell, T., Kirby, A., Latiano, A., Goyette, P., Green, T., Halfvarson, J., Haritunians, T., Korn, J. M., Kuruvilla, F., ... LOUIS, E. (Other coll.). (2012). Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nature Genetics, 43 (11), 1066-73. doi:10.1038/ng.952 Peer Reviewed verified by ORBi |
 | De Vos, M., Dewit, O., D'Haens, G., Baert, F., Fontaine, F., Vermeire, S., Franchimont, D., Moreels, T., Staessen, D., Terriere, L., Vander Cruyssen, B., & LOUIS, E. (2012). Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis. Journal of Crohn's and Colitis, 6 (5), 557-62. doi:10.1016/j.crohns.2011.11.002 Peer Reviewed verified by ORBi |
| De Greef, E., Hoffman, I., D'haens, G., Van Biervliet, S., Smets, F., Scaillon, M., De Wit, O., Peeters, H., Paquot, I., Alliet, P., Arts, W., Hauser, B., Vermeire, S., Van Gossum, A., Rahier, J.-F., Etienne, I., Louis, E., Coche, J. C., Mahachie John, J., ... Veereman, G. (2012). Safety And Cost Of Infliximab For The Treatment Of Belgian Pediatric Patients With Crohn’s Disease. Journal of Crohn's and Colitis. Peer Reviewed verified by ORBi |
 | VALDES SOCIN, H. G., TOME, M., LUTTERI, L., Reenaers, C., POLUS, M., Geenen, V., LOUIS, E., & Beckers, A. (2012). Auto-immune gastritis characteristics in a large series of patients with auto-immune thyroiditis. In XXIVth Belgian Week of Gastroenterology 2012 - Abstract book. |
 | Peyrin-Biroulet, L., Billioud, V., D'Haens, G., Panaccione, R., Feagan, B., Panes, J., Danese, S., Schreiber, S., Ogata, H., Hibi, T., Higgins, P. D. R., Beaugerie, L., Chowers, Y., LOUIS, E., Steinwurz, F., Reinisch, W., Rutgeerts, P., Colombel, J.-F., Travis, S., & Sandborn, W. J. (2012). Development of the paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process. American Journal of Gastroenterology, 107 (12), 1770-6. doi:10.1038/ajg.2012.117 Peer Reviewed verified by ORBi |
 | Vermeire, S., Carbonnel, F., Coulie, P., Geenen, V., Hazes, J. M. W., Masson, P., de Keyser, F., & LOUIS, E. (2012). Management of inflammatory bowel disease in pregnancy. Journal of Crohn's and Colitis, 6 (8), 811-23. doi:10.1016/j.crohns.2012.04.009 Peer Reviewed verified by ORBi |
 | Lecat, A., Di Valentin, E., Somja, J., Jourdan, S., Fillet, M., Kufer, T., Habraken, Y., Sadzot-Delvaux, C., Louis, E., Delvenne, P., Piette, J., & Legrand-Poels, S. (2012). The c-jun N-terminal Kinase (JNK)-binding Protein (JNKBP1) Acts as a Negative Regulator of NOD2 Protein Signaling by Inhibiting Its Oligomerization Process. Journal of Biological Chemistry, 287 (35), 29213-26. doi:10.1074/jbc.M112.355545 Peer Reviewed verified by ORBi |
 | REENAERS, C., LOUIS, E., Belaiche, J., Seidel, L., Keshav, S., & Travis, S. (2012). Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? Alimentary Pharmacology and Therapeutics, 36 (11-12), 1040-8. doi:10.1111/apt.12076 Peer Reviewed verified by ORBi |
 | LOUIS, R., SCHLEICH, F., Corhay, J.-L., & Louis, E. (2012). L'asthme: une maladie complexe mettant en jeu facteurs environnementaux et terrain genetique. Revue Médicale de Liège, 67 (5-6), 286-91. Peer reviewed |
 | Louis, E., VAN KEMSEKE, C., LATOUR, P., Belaiche, J., & REENAERS, C. (2012). Genetique et environnement dans les maladies inflammatoires chroniques de l'intestin. Revue Médicale de Liège, 67 (5-6), 298-304. Peer reviewed |
| De Greef, E., Mahachie John, J., Hoffman, I., Smets, F., Van Biervliet, S., Scaillon, M., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., Baert, F., D'haens, G., Rahier, J.-F., Etienne, I., Bauraind, O., Van Gossum, A., Vermeire, S., Fontaine, F., ... Veereman, G. (2012). Factors determining therapeutic strategy at diagnosis and evolution of disease severity in a cohort of Belgian pediatric Crohn’s disease patients (BELCRO). Acta Gastro-Enterologica Belgica. Peer Reviewed verified by ORBi |
 | Hazes, J. M. W., Coulie, P. G., Geenen, V., Vermeire, S., Carbonnel, F., LOUIS, E., Masson, P., & De Keyser, F. (2011). Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. Rheumatology. doi:10.1093/rheumatology/ker302 Peer Reviewed verified by ORBi |
 | Anderson, C. A., Boucher, G., Lees, C. W., Franke, A., D'Amato, M., Taylor, K. D., Lee, J. C., Goyette, P., Imielinski, M., Latiano, A., Lagace, C., Scott, R., Amininejad, L., Bumpstead, S., Baidoo, L., Baldassano, R. N., Barclay, M., Bayless, T. M., Brand, S., ... Rioux, J. D. (February 2011). Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature Genetics, 43 (3), 246-52. doi:10.1038/ng.764 Peer Reviewed verified by ORBi |
 | Daperno, M., Castiglione, F., de Ridder, L., Dotan, I., Farkkila, M., Florholmen, J., Fraser, G., Fries, W., Hebuterne, X., Lakatos, P. L., Panes, J., Rimola, J., & Louis, E. (2011). Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease. Journal of Crohn's and Colitis, 5 (5), 484-98. doi:10.1016/j.crohns.2011.07.003 Peer Reviewed verified by ORBi |
| TOME GARCIA, M., VALDES SOCIN, H. G., LUTTERI, L., BETEA, D., VROONEN, L., PETROSSIANS, P., Geenen, V., Louis, E., & Beckers, A. (2011). The Thyro-gastric syndrome : its prevalence, clinical, pathological and predictive factors in a prospective series of 360 patients with Hashimoto's Thyroiditis. In Abstract book - 21st Meeting of the Belgian Endocrine Society. |
 | Pariente, B., Cosnes, J., Danese, S., Sandborn, W. J., Lewin, M., Fletcher, J. G., Chowers, Y., D'Haens, G., Feagan, B. G., Hibi, T., Hommes, D. W., Irvine, E. J., Kamm, M. A., Loftus, E. V. J., Louis, E., Michetti, P., Munkholm, P., Oresland, T., Panes, J., ... Lemann, M. (2011). Development of the Crohn's disease digestive damage score, the Lemann score. Inflammatory Bowel Diseases, 17 (6), 1415-22. doi:10.1002/ibd.21506 Peer Reviewed verified by ORBi |
 | Galmiche, J.-P., Hatlebakk, J., Attwood, S., Ell, C., Fiocca, R., Eklund, S., Langstrom, G., Lind, T., Lundell, L., & Louis, E. (2011). Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA: Journal of the American Medical Association, 305 (19), 1969-77. doi:10.1001/jama.2011.626 Peer Reviewed verified by ORBi |
 | Kopylov, U., Mantzaris, G. J., Katsanos, K. H., Reenaers, C., Ellul, P., Rahier, J.-F., Israeli, E., Lakatos, P. L., Fiorino, G., Cesarini, M., Tsianos, E. V., Louis, E., & Ben-Horin, S. (2011). The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. Alimentary Pharmacology and Therapeutics, 33 (3), 349-57. doi:10.1111/j.1365-2036.2010.04523.x Peer Reviewed verified by ORBi |
| De Greef, E., Hoffman, I., Smets, F., Van Biervliet, S., Scaillon, M., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., Peeters, H., Baert, F., D'Haens, G., Rahier, J., Etienne, I., Bauraind, O., Van Gossum, A., Vermeire, S., Fontaine, F., ... Veereman, G. (2011). Profile of Belgian Pediatric Crohn's Disease Patients: Presentation and diagnostic features. Acta Gastro-Enterologica Belgica, 74, 05. Peer Reviewed verified by ORBi |
| De Greef, E., Hoffman, I., Smets, F., Van Biervliet, S., Scaillon, M., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., Peeters, H., Baert, F., D'Haens, G., Rahier, J., Etienne, I., Baureind, O., Van Gossum, A., Vermeire, S., Fontaine, F., ... Veereman, G. (2011). Profile of Belgian Pediatric Crohn's Disease Patients: Presentation and diagnostic features. Journal of Crohn's and Colitis, 5 (1), 155. Peer Reviewed verified by ORBi |
 | Rahier, J.-F., Papay, P., Salleron, J., Sebastian, S., Marzo, M., Peyrin-Biroulet, L., Garcia-Sanchez, V., Fries, W., van Asseldonk, D. P., Farkas, K., de Boer, N. K., Sipponen, T., Ellul, P., Louis, E., Peake, S. T. C., Kopylov, U., Maul, J., Makhoul, B., Fiorino, G., ... Chaparro, M. (2011). H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy. Gut, 60 (4), 456-62. doi:10.1136/gut.2010.233981 Peer Reviewed verified by ORBi |
 | Löfberg, R., Louis, E., Reinisch, W., Robinson, A. M., Kron, M., Camez, A., & Pollack, P. F. (2011). Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE. Inflammatory Bowel Diseases. doi:10.1002/ibd.21663 Peer Reviewed verified by ORBi |
 | Phan-Ba, R., LAMBINET, N., Louis, E., Delvenne, P., TSHIBANDA, L., BOVERIE, J., Moonen, G., & Belachew, S. (2011). Natalizumab to kill two birds with one stone: A case of celiac disease and multiple sclerosis. Inflammatory Bowel Diseases, 17 (6), 62-63. doi:10.1002/ibd.21716 Peer Reviewed verified by ORBi |
 | Louis, E., VAN KEMSEKE, C., & Reenaers, C. (2011). Necessity of phenotypic classification of inflammatory bowel disease. Best Practice and Research. Clinical Gastroenterology, 25 Suppl 1, 2-7. doi:10.1016/S1521-6918(11)70003-8 Peer Reviewed verified by ORBi |
 | Momozawa, Y., Mni, M., Nakamura, K., Coppieters, W., Almer, S., Amininejad, L., Cleynen, I., Colombel, J.-F., de Rijk, P., Dewit, O., Finkel, Y., Gassull, M. A., Goossens, D., Laukens, D., Lemann, M., LIBIOULLE, C., O'Morain, C., Reenaers, C., Rutgeerts, P., ... Georges, M. (2011). Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nature Genetics, 43 (1), 43-7. doi:10.1038/ng.733 Peer Reviewed verified by ORBi |
 | Louis, E. (2011). Thiopurine metabolites and TPMT activity measurement in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 34 (9), 1138-9. doi:10.1111/j.1365-2036.2011.04804.x Peer Reviewed verified by ORBi |
 | Bello, C., Belaiche, J., Louis, E., & Reenaers, C. (2011). Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids. Journal of Crohn's and Colitis, 5 (3), 196-202. doi:10.1016/j.crohns.2010.12.011 Peer Reviewed verified by ORBi |
 | Binion, D. G., Louis, E., Oldenburg, B., Mulani, P., Bensimon, A. G., Yang, M., & Chao, J. (2011). Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysis. Canadian Journal of Gastroenterology, 25 (9), 492-6. doi:10.1155/2011/938194 Peer Reviewed verified by ORBi |
| VALDES SOCIN, H. G., Tome, M., LUTTERI, L., Louis, E., & Beckers, A. (2011). Prevalence and prediction of gastric mucosal abnormalities in a prospective series of 50 patients with graves-Basedow disease [Poster presentation]. Belgian Internal Medicine Society, Bruxelles, Belgium. |
 | Momozawa, Y., Deffontaine Deurbroeck, V., Louis, E., & Medrano, J. F. (2011). Characterization of bacteria in biopsies of colon and stools by high throughput sequencing of the V2 region of bacterial 16S rRNA gene in human. PLoS ONE, 6 (2), 16952. doi:10.1371/journal.pone.0016952 Peer Reviewed verified by ORBi |
| De Greef, E., Hoffman, I., Smets, F., Van Biervliet, S., Scaillon, M., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., Peeters, H., Baert, F., D'Haens, G., Rahier, J., Etienne, I., Bauraind, O., Van Gossum, A., Vermeire, S., Fontaine, F., ... Veereman, G. (2011). Profile of Belgian Pediatric Crohn's Disease Patients: Associations between variables at diagnosis. Gastroenterology, 140 (5), 787. Peer Reviewed verified by ORBi |
| De Greef, E., Hoffman, I., Smets, F., Van Biervliet, S., Scaillon, M., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., Peeters, H., Baert, F., D'Haens, G., Rahier, J., Etienne, I., Bauraind, O., Van Gossum, A., Vermeire, S., Fontaine, F., ... Veereman, G. (2011). Profile of Belgian Pediatric Crohn's Disease Patients: Associations between variables at diagnosis. Acta Gastro-Enterologica Belgica, 74, 07. Peer Reviewed verified by ORBi |
| De Greef, E., Hoffman, I., Smets, F., Van Biervliet, S., Scaillon, M., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., Peeters, H., Baert, F., D'Haens, G., Rahier, J., Etienne, I., Bauraind, O., Van Gossum, A., Vermeire, S., Fontaine, F., ... Veereman, G. (2011). Profile of Belgian Pediatric Crohn's Disease Patients: Associations between variables at diagnosis. Journal of Crohn's and Colitis, 5 (1), 156. Peer Reviewed verified by ORBi |
 | Adler, M., Piessevaux, H., Louis, E., Lamy, V., Michielsen, P., & Geubel, A. (2011). Abdominal ultrasonography by the hepato-gastroenterologist: problems, demands, solutions. Acta Gastro-Enterologica Belgica, 74 (1), 67-9. Peer Reviewed verified by ORBi |
 | DE SENY, D., Sharif, M., Fillet, M., COBRAIVILLE, G., Meuwis, M.-A., Marée, R., HAUZEUR, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., Kirwan, J., Ribbens, C., & Malaise, M. (2011). Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Annals of the Rheumatic Diseases, 70 (6), 1144-52. doi:10.1136/ard.2010.135541 Peer Reviewed verified by ORBi |
| De Greef, E., Hoffman, I., Smets, F., Van Biervliet, S., Scaillon, M., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., Peeters, H., Baert, F., D'Haens, G., Rahier, J., Etienne, I., Bauraind, O., Van Gossum, A., Vermeire, S., Fontaine, F., ... Veereman, G. (2011). Profile of Belgian Pediatric Crohn's Disease Patients: Presentation and diagnostic features. Gastroenterology, 140 (5), 786. Peer Reviewed verified by ORBi |
 | Rahier, J.-F., Moutschen, M., Van Gompel, A., Van Ranst, M., Louis, E., Segaert, S., Masson, P., & De Keyser, F. (2010). Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology, 49 (10), 1815-27. doi:10.1093/rheumatology/keq183 Peer Reviewed verified by ORBi |
Georges, M., LIBIOULLE, C., & Louis, E. (2010). Dissection moléculaire de la prédisposition innée aux maladies inflamatoires chroniques de l'intestin: liason génétique, gènes candidats et études d'association du génome entier. In Maladies inflamatoires chroniques de l'instestin. Progrès en hépatho-Gastroentérologie. |
 | Allez, M., Karmiris, K., Louis, E., Van Assche, G., Ben-Horin, S., Klein, A., Van der Woude, J., Baert, F., Eliakim, R., Katsanos, K., Brynskov, J., Steinwurz, F., Danese, S., Vermeire, S., Teillaud, J.-L., Lemann, M., & Chowers, Y. (2010). Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects. Journal of Crohn's and Colitis, 4 (4), 355-66. doi:10.1016/j.crohns.2010.04.004 Peer Reviewed verified by ORBi |
 | Reenaers, C., Belaiche, J., & Louis, E. (2010). Should patients under long-term anti-TNF therapies be followed for tuberculosis contamination? Inflammatory Bowel Diseases, 16 (8), 1271-2. doi:10.1002/ibd.21162 Peer Reviewed verified by ORBi |
 | Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., Anderson, C. A., Bis, J. C., Bumpstead, S., Ellinghaus, D., Festen, E. M., Georges, M., Green, T., Haritunians, T., Jostins, L., ... Parkes, M. (2010). Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nature Genetics, 42 (12), 1118-25. doi:10.1038/ng.717 Peer Reviewed verified by ORBi |
 | Louis, E., Belaiche, J., & Reenaers, C. (2010). Do clinical factors help to predict disease course in inflammatory bowel disease? World Journal of Gastroenterology, 16 (21), 2600-3. doi:10.3748/wjg.v16.i21.2600 Peer Reviewed verified by ORBi |
 | Van Assche, G., Dignass, A., Panes, J., Beaugerie, L., Karagiannis, J., Allez, M., Ochsenkuhn, T., Orchard, T., Rogler, G., Louis, E., Kupcinskas, L., Mantzaris, G., Travis, S., & Stange, E. (2010). The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. Journal of Crohn's and Colitis, 4 (1), 7-27. doi:10.1016/j.crohns.2009.12.003 Peer Reviewed verified by ORBi |
 | Rahier, J.-F., Buche, S., Peyrin-Biroulet, L., Bouhnik, Y., Duclos, B., Louis, E., Papay, P., Allez, M., Cosnes, J., Cortot, A., Laharie, D., Reimund, J.-M., Lemann, M., Delaporte, E., & Colombel, J.-F. (2010). Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Clinical Gastroenterology and Hepatology, 8 (12), 1048-55. doi:10.1016/j.cgh.2010.07.022 Peer Reviewed verified by ORBi |
 | De Bock, M., De Seny, D., Meuwis, M.-A., Servais, A.-C., Minh, T. Q., Closset, J., Chapelle, J.-P., Louis, E., Malaise, M., Merville, M.-P., & Fillet, M. (2010). Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis. Talanta, 82, 245-254. doi:10.1016/j.talanta.2010.04.029 Peer Reviewed verified by ORBi |
 | Grimaud, J.-C., Munoz-Bongrand, N., Siproudhis, L., Abramowitz, L., Senejoux, A., Vitton, V., Gambiez, L., Flourie, B., Hebuterne, X., Louis, E., Coffin, B., De Parades, V., Savoye, G., Soule, J.-C., Bouhnik, Y., Colombel, J.-F., Contou, J.-F., Francois, Y., Mary, J.-Y., & Lemann, M. (2010). Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology, 138 (7), 2275-81, 2281.e1. doi:10.1053/j.gastro.2010.02.013 Peer Reviewed verified by ORBi |
 | Louis, E. (2010). Immunosuppressant combined with infliximab in Crohn's Disease: For 6 months, for 2 years, or forever? Inflammatory Bowel Diseases. doi:10.1002/ibd.21407 Peer Reviewed verified by ORBi |
 | Louis, E., Libioulle, C., Reenaers, C., Belaiche, J., & Georges, M. (October 2009). Génomique des maladies inflammatoires intestinales. Revue Médicale de Liège, 64, 24-28. Peer reviewed |
 | Hustinx, R., & Louis, E. (2009). The Role of PET/CT in the Monitoring and Diagnosis of Pediatric Inflammatory Bowel Disease. PET Clinics, 3, 597-603. doi:10.1016/j.cpet.2009.04.003 Peer Reviewed verified by ORBi |
 | Reenaers, C., Louis, E., & Belaiche, J. (2009). Thérapies biologiques et maladies inflammatoires chroniques intestinales. Revue Médicale de Liège, 64 (5-6), 301-304. Peer reviewed |
 | Louis, E., Tack, J., Vandenhoven, G., & Taeter, C. (2009). Evaluation of the GERD Impact Scale, an international, validated patient questionnaire, in daily practice. Results of the ALEGRIA study. Acta Gastro-Enterologica Belgica, 72 (1), 3-8. Peer Reviewed verified by ORBi |
 | Allez, M., Vermeire, S., Mozziconacci, N., Michetti, P., Laharie, D., Louis, E., Bigard, M.-A., Hebuterne, X., Treton, X., Kohn, A., Marteau, P., Cortot, A., Nichita, C., Vanassche, G., Rutgeerts, P., Lemann, M., & Colombel, J.-F. (2009). Efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF. Alimentary Pharmacology and Therapeutics. doi:10.1111/j.1365-2036.2009.04130.x Peer Reviewed verified by ORBi |
 | Louis, E., Belaiche, J., & Reenaers, C. (2009). Anti-tumor Necrosis Factor Nonresponders in Crohn's Disease : Therapeutic Strategies. Digestive Diseases, 27, 351-357. doi:10.1159/000228573 Peer Reviewed verified by ORBi |
 | Villani, A.-C., Lemire, M., Louis, E., Silverberg, M. S., Collette, C., Fortin, G., Nimmo, E. R., Renaud, Y., Brunet, S., Libioulle, C., Belaiche, J., Bitton, A., Gaudet, D., Cohen, A., Langelier, D., Rioux, J. D., Arnott, I. D. R., Wild, G. E., Rutgeerts, P., ... Franchimont, D. (2009). Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis. PLoS ONE, 4 (9), 7154. doi:10.1371/journal.pone.0007154 Peer Reviewed verified by ORBi |
 | Hustinx, R., & Louis, E. (2009). Outils isotopiques pour les MICI : PET et PET/CT. Côlon et Rectum, 3, 1-7. doi:10.1007/s11725-009-0147-7 Peer reviewed |
 | Louis, E., Libioulle, C., Reenaers, C., Belaiche, J., & Georges, M. (2009). Genetics of ulcerative colitis: the come-back of interleukin 10. Gut, 58 (9), 1173-6. doi:10.1136/gut.2008.169235 Peer Reviewed verified by ORBi |
 | De Seny, D., Ribbens, C., Cobraiville, G., Meuwis, M.-A., Marée, R., Geurts, P., Wehenkel, L., Louis, E., Merville, M.-P., Fillet, M., & Malaise, M. (2009). Protéomique par SELDI-TOF-MS des maladies inflammatoires articulaires: identification des protéines S100 comme protéines d'intérêt. Revue Médicale de Liège, 64 (Spec No), 29-35. Peer reviewed |
 | Louis, E., Belaiche, J., & Reenaers, C. (2009). Tailoring the treatment to the individual in Crohn's disease. Therapeutic Advances in Gastroenterology, 2, 239-244. doi:10.1177/1756283X09337180 Peer Reviewed verified by ORBi |
 | Piessevaux, H., De Winter, B., Louis, E., Muls, V., De Looze, D., Pelckmans, P., Deltenre, M., Urbain, D., & Tack, J. (2009). Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterology and Motility, 21 (4), 378-88. doi:10.1111/j.1365-2982.2009.01262.x Peer Reviewed verified by ORBi |
 | Polus, M., Montrieux, C., Giet, D., Louis, E., Belaiche, J., & Coche, E. (2009). Le depistage generalise du cancer colorectal: une absolue necessite et une realite imminente en Communaute francaise. Revue Médicale de Liège, 64 (2), 96-102. Peer reviewed |
 | Imielinski, M., Baldassano, R. N., Griffiths, A., Russell, R. K., Annese, V., Dubinsky, M., Kugathasan, S., Bradfield, J. P., Walters, T. D., Sleiman, P., Kim, C. E., Muise, A., Wang, K., Glessner, J. T., Saeed, S., Zhang, H., Frackelton, E. C., Hou, C., Flory, J. H., ... Georges, M. (Other coll.). (2009). Common variants at five new loci associated with early-onset inflammatory bowel disease. Nature Genetics, 41 (12), 1335-40. doi:10.1038/ng.489 Peer Reviewed verified by ORBi |
 | Louis, E., Belaiche, J., & Reenaers, C. (2009). Anti-TNF and Crohn's Disease: When Should We Stop? Current Drug Targets, 11 (2), 148-51. doi:10.2174/138945010790309957 Peer Reviewed verified by ORBi |
 | Villani, A.-C., Lemire, M., Fortin, G., Louis, E., Silverberg, M. S., Collette, C., Baba, N., Libioulle, C., Belaiche, J., Bitton, A., Gaudet, D., Cohen, A., Langelier, D., Fortin, P. R., Wither, J. E., Sarfati, M., Rutgeerts, P., Rioux, J. D., Vermeire, S., ... Franchimont, D. (2009). Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nature Genetics, 41 (1), 71-6. doi:10.1038/ng.285 Peer Reviewed verified by ORBi |
 | De Bock, M., De Seny, D., Meuwis, M.-A., Chapelle, J.-P., Louis, E., Malaise, M., Merville, M.-P., & Fillet, M. (2009). Challenges for Biomarker Discovery in Body Fluids Using SELDI-TOF-MS. Journal of Biomedicine and Biotechnology. doi:10.1155/2010/906082 Peer Reviewed verified by ORBi |
 | Loly, C., Belaiche, J., & Louis, E. (August 2008). Predictors of severe Crohn's disease. Scandinavian Journal of Gastroenterology, 43 (8), 948-54. doi:10.1080/00365520801957149 Peer Reviewed verified by ORBi |
 | Peeters, H., Cruyssen, B. V., Mielants, H., de Vlam, K., Vermeire, S., Louis, E., Rutgeerts, P., Belaiche, J., & De Vos, M. (January 2008). Gastroenterology - Clinical and genetic factors associated with sacroiliitis in Crohn's disease. Journal of Gastroenterology and Hepatology, 23 (1), 132-137. doi:10.1111/j.1440-1746.2007.05108.x Peer Reviewed verified by ORBi |
| Reenaers, C., Franchimont, N., Oury, C., Belaiche, J., Malaise, M., Bours, V., Theatre, E., Delvenne, P., & Louis, E. (2008). Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease. Scandinavian Journal of Gastroenterology, 43, 1334-1345. doi:10.1080/00365520802200010 Peer Reviewed verified by ORBi |
 | De Seny, D., Fillet, M., Ribbens, C., Marée, R., Meuwis, M.-A., Lutteri, L., Chapelle, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., & Malaise, M. (2008). Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clinical Chemistry, 54, 1066-1075. doi:10.1373/clinchem.2007.099549 Peer Reviewed verified by ORBi |
 | Louis, E., Reenaers, C., & Belaiche, J. (2008). Are we giving biologics too much time? When should we stop treatment? World Journal of Gastroenterology, 14, 5528-5531. doi:10.3748/wjg.14.5528 Peer Reviewed verified by ORBi |
| Louis, E., Reenaers, C., & Belaiche, J. (2008). Does the behavior of Crohn's disease change over time? Inflammatory Bowel Diseases, 14, 54-55. doi:10.1002/ibd.20561 Peer Reviewed verified by ORBi |
 | Guiot, J., Louis, E., Belaiche, J., & Louis, R. (2008). Manifestations respiratoires de la rectocolite ulcérohémorragique et de la maladie de Crohn. In EMC Pneumologie. Paris, France: Elsevier Masson SAS. |
 | Meuwis, M.-A.* , Fillet, M.* , Lutteri, L., Marée, R., Geurts, P., De Seny, D., Malaise, M., Chapelle, J.-P., Wehenkel, L., Belaiche, J., Merville, M.-P., & Louis, E. (2008). Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clinical Biochemistry, 41 (12), 960-7. doi:10.1016/j.clinbiochem.2008.04.021 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Barrett, J. C., Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., Silverberg, M. S., Taylor, K. D., Barmada, M. M., Bitton, A., Dassopoulos, T., Wu Datta, L., Green, T., Griffiths, A. M., Kistner, E. O., Murtha, M. T., Regueiro, M. D., Rotter, J. I., ... Daly, M. J. (2008). Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nature Genetics, 40 (8), 955-62. doi:10.1038/ng.175 Peer Reviewed verified by ORBi |
| Louis, E., Reenaers, C., & Belaiche, J. (2008). Does the phenotype at diagnosis (e.g., fibrostenosing, inflammatory, perforating) predict the course of Crohn's disease? Inflammatory Bowel Diseases, 14, 59-60. doi:10.1002/ibd.20559 Peer Reviewed verified by ORBi |
 | Meuwis, M.-A., Fillet, M., Chapelle, J.-P., Malaise, M., Louis, E., & Merville, M.-P. (2008). New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools. Expert Review of Molecular Diagnostics, 8, 327-37. doi:10.1586/14737159.8.3.327 Peer Reviewed verified by ORBi |
 | Dideberg, V., Kristjansdottir, G., Milani, L., Libioulle, C., Sigurdsson, S., Louis, E., Wiman, A. C., Vermeire, S., Rutgeerts, P., Belaiche, J., Franchimont, D., Van Gossum, A., Bours, V., & Syvanen, A. C. (15 December 2007). An insertion-deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Human Molecular Genetics, 16 (24), 3008-3016. doi:10.1093/hmg/ddm259 Peer Reviewed verified by ORBi |
 | Denis, M.-A., Reenaers, C., Fontaine, F., Belaiche, J., & Louis, E. (September 2007). Assessment of endoscopic activity lndex and biological lnflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level. Inflammatory Bowel Diseases, 13 (9), 1100-1105. doi:10.1002/ibd.20178 Peer Reviewed verified by ORBi |
 | Louis, E., Ancion, G., Colard, A., Spote, V., Belaiche, J., & Hustinx, R. (July 2007). Noninvasive assessment of Crohn's disease intestinal lesions with F-18-FDG PET/CT. Journal of Nuclear Medicine, 48 (7), 1053-1059. doi:10.2967/jnumed.107.040436 Peer Reviewed verified by ORBi |
 | De Jager, P. L., Franchimont, D., Waliszewska, A., Bitton, A., Cohen, A., Langelier, D., Belaiche, J., Vermeire, S., Farwell, L., Goris, A., Libioulle, C., Jani, N., Dassopoulos, T., Bromfield, G. P., Dubois, B., Cho, J. H., Brant, S. R., Duerr, R. H., Yang, H., ... Rioux, J. D. (July 2007). The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes and Immunity, 8 (5), 387-397. doi:10.1038/sj.gene.6364398 Peer Reviewed verified by ORBi |
Dideberg, V., Theatre, E., Farnir, F., Vermeire, S., Rutgeerts, P., De Vos, M., Belaiche, J., Franchimont, D., Van Gossum, A., Louis, E., & Bours, V. (May 2007). The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease. European Journal of Clinical Investigation, 37 (Suppl. 1), 79. Peer Reviewed verified by ORBi |
 | Van Gossum, A., Dewit, O., Louis, E., de Hertogh, G., Baert, F., Fontaine, F., Devos, M., Enslen, M., Paintin, M., & Franchimont, D. (February 2007). Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection. Inflammatory Bowel Diseases, 13 (2), 135-142. doi:10.1002/ibd.20063 Peer Reviewed verified by ORBi |
 | Dideberg, V., Louis, E., & Bours, V. (2007). Pharmacogenetics of infliximab in Crohn's disease. Acta Endoscopica, 37 (4), 521-530. doi:10.1007/BF02961799 Peer reviewed |
 | Belaiche, J., Delwaide, J., Polus, M., & Louis, E. (2007). Actualites therapeutiques en hepato-gastroenterologie. Revue Médicale de Liège, 62 (5-6, May-Jun), 303-9. Peer reviewed |
 | Belaiche, J., Chapelier, N., Wertz, S., & Louis, E. (2007). Les thérapies innovantes au CHU dans les maladies inflammatoires chroniques de l'intestin (MICI). Revue Médicale de Liège, 62 Spec No, 63-7. Peer reviewed |
 | Piront, P., Louis, E., Belaiche, J., & Polus, M. (January 2007). Le depistage du cancer colorectal. Revue Médicale de Liège, 62 (1), 15-20. Peer reviewed |
| Louis, E., Bours, V., Dideberg, V., & Belaiche, J. (2007). Les maladies inflammatoires chroniques intestinales : de la génétique au traitement. Revue Médicale de Liège, 62, 47-51. Peer reviewed |
 | Piront, P., Louis, E., Belaiche, J., & Polus, M. (2007). Screening for colorectal cancer in 2006. Acta Endoscopica, 37 (3), 305-313. doi:10.1007/BF02961920 Peer reviewed |
 | Louis, E., Boverie, J., Dewit, O., Baert, F., De Vos, M., & D'Haens, G. (2007). Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study. Acta Gastro-Enterologica Belgica, 70 (1, Jan-Mar), 15-19. Peer Reviewed verified by ORBi |
| Urbain, D., Tresinie, M., De Looze, D., Demedts, I., Hauser, B., Mana, F., Macken, E., Hoffmann, I., Scaillon, M., Van Callie-Bertrand, M., Van Gossum, A., Louis, E., & Vandenplas, Y. (2007). Capsule Endoscopy in paediatrics: multicentric Belgian study. Acta Gastro-Enterologica Belgica, 70 (1, JAN-MAR), 11-14. Peer Reviewed verified by ORBi |
 | Libioulle, C., Louis, E., Hansoul, S., Sandor, C., Farnir, F., Franchimont, D., Vermeire, S., Dewit, O., de Vos, M., Dixon, A., Demarche, B., Gut, I., Heath, S., Foglio, M., Liang, L., Laukens, D., Mni, M., Zelenika, D., Van Gossum, A., ... Georges, M. (2007). Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genetics, 3 (4), 538-543. doi:10.1371/journal.pgen.0030058 Peer Reviewed verified by ORBi |
 | Meuwis, M.-A., Louis, E., & Merville, M.-P. (2007). Contribution of proteomics to colorectal cancer diagnosis. Acta Endoscopica, 295-303. doi:10.1007/BF02961919 Peer reviewed |
 | HUSTINX, R., SPOTE, V., ANCION, G., COLLARD, A., BELAICHE, J., & LOUIS, E. (2007). Assessment of Crohn’s disease intestinal lesions with FDG PET/CT : A prospective correlation with endoscopy. Journal of Nuclear Medicine, 48 (SUPPL), 66. Peer Reviewed verified by ORBi |
 | Daniel, F., Loriot, M. A., Seksik, P., Cosnes, J., Gornet, J. M., Lemann, M., Fein, F., Vernier-Massouille, G., De Vos, M., Boureille, A., Treton, X., Flourie, B., Roblin, X., Louis, E., Zerbib, F., Beaune, P., & Marteau, P. (January 2007). Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis. Inflammatory Bowel Diseases, 13 (1), 19-23. doi:10.1002/ibd.20046 Peer Reviewed verified by ORBi |
| Baert, F., De Vos, M., Louis, E., & Vermeire, S. (2007). Immunogenicity of infliximab: how to handle the problem? Acta Gastro-Enterologica Belgica, 70 (2), 163-70. Peer Reviewed verified by ORBi |
 | Meuwis, M.-A.* , Fillet, M.* , Geurts, P., De Seny, D., Lutteri, L., Chapelle, J.-P., Bours, V., Wehenkel, L., Belaiche, J., Malaise, M., Louis, E., & Merville, M.-P. (2007). Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochemical Pharmacology, 73 (9), 1422-1433. doi:10.1016/j.bcp.2006.12.019 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Dideberg, V., Theatre, E., Farnir, F., Vermeire, S., Rutgeerts, P., Vos, M. D., Belaiche, J., Franchimont, D., Gossum, A. V., Louis, E., & Bours, V. (October 2006). The Tnf/Adam 17 System: Implication of an Adam 17 Haplotype in the Clinical Response to Infliximab in Crohn's Disease. Pharmacogenetics and Genomics, 16 (10), 727-734. doi:10.1097/01.fpc.0000230117.26581.a4 Peer Reviewed verified by ORBi |
 | Dideberg, V., Louis, E., Farnir, F., Bertoli, S., Vermeire, S., Rutgeerts, P., De Vos, M., Van Gossum, A., Belaiche, J., & Bours, V. (May 2006). Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study. Pharmacogenetics and Genomics, 16 (5), 369-373. doi:10.1097/01.fpc.0000204993.91806.b1 Peer Reviewed verified by ORBi |
 | Urbain, D., De Looze, D., Demedts, I., Louis, E., Dewit, O., Macken, E., & Van Gossum, A. (April 2006). Video capsule endoscopy in small-bowel malignancy: A multicenter Belgian study. Endoscopy, 38 (4), 408-411. doi:10.1055/s-2005-921203 Peer Reviewed verified by ORBi |
 | Willot, S., Vermeire, S., Ohresser, M., Rutgeerts, P., Paintaud, G., Belaiche, J., De Vos, M., Van Gossum, A., Franchimont, D., Colombel, J. F., Watier, H., & Louis, E. (January 2006). No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease. Pharmacogenetics and Genomics, 16 (1), 37-42. doi:10.1097/01.fpc.0000182776.57437.d8 Peer Reviewed verified by ORBi |
| Louis, E., Jorissen, P., Bastens, B., D'Haens, G., Schoofs, N., Burette, A., Christiaens, P., & Tack, J. (2006). Atypical symptoms of GORD in Belgium: Epidemiological features, current management and open label treatment with 40 mg esomeprazole for one month. Acta Gastro-Enterologica Belgica, 69 (2, Apr-Jun), 203-208. Peer Reviewed verified by ORBi |
| Vijverman, A., Piront, P., Belaiche, J., & Louis, E. (2006). Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003. Acta Gastro-Enterologica Belgica, 69 (1, Jan-Mar), 1-4. |
 | Vanmeerbeek, M., & Louis, E. (2006). Les IPP au très long cours: le problème est-il uniquement économique? Revue Médicale de Liège, 61 (5-6), 483-7. Peer reviewed |
| Belaiche, J., & Louis, E. (2006). Diagnosis of small bowel malabsorption syndromes in adults. Acta Gastro-Enterologica Belgica, 69 (1, Jan-Mar), 31-37. |
 | Louis, E., Watier, H. E., Schreiber, S., Hampe, J., Taillard, F., Olson, A., Thorne, N., Zhang, H., & Colombel, J.-F. (2006). Polymorphism in IgG Fc receptor gene FCGR3A and response to infliximab in Crohn's disease: a subanalysis of the ACCENT I study. Pharmacogenetics and Genomics, 16 (12), 911-4. doi:10.1097/01.fpc.0000230421.12844.fd Peer Reviewed verified by ORBi |
| Vijverman, A., Belaiche, J., & Louis, E. (November 2005). L'anemie chronique dans les maladies inflammatoires de l'intestin: revue de litterature. Revue Médicale de Liège, 60 (11), 888-92. Peer reviewed |
| Ausloos, F., Belaiche, J., & Louis, E. (September 2005). Implication des intolérances et allergies alimentaires dans le syndrome du côlon irritable: quelles sont les evidences? Revue Médicale de Liège, 60 (9), 744-9. Peer reviewed |
 | Franchimont, N., Reenaers, C., & Louis, E. (01 April 2005). Infliximab and the bone in Crohn's disease. Alimentary Pharmacology and Therapeutics, 21 (7), 918-919. doi:10.1111/j.1365-2036.2005.02434.x Peer Reviewed verified by ORBi |
| Gustot, T., Lemmers, A., Louis, E., Nicaise, C., Quertinmont, E., Belaiche, J., Roland, S., Van Gossum, A., Deviere, J., & Franchimont, D. (April 2005). Profile of soluble cytokine receptors in Crohn's disease. Gut, 54 (4), 488-495. doi:10.1136/gut.2004.043554 Peer Reviewed verified by ORBi |
 | El Yafi, F., Winkler, R., Delvenne, P., Boussif, N., Belaiche, J., & Louis, E. (March 2005). Altered expression of type I insulin-like growth factor receptor in Crohn's disease. Clinical and Experimental Immunology, 139 (3), 526-533. doi:10.1111/j.1365-2249.2004.02724.x Peer Reviewed verified by ORBi |
 | Laurent, S., Barbeaux, A., Detroz, B., Detry, O., Louis, E., Belaiche, J., & Meurisse, M. (2005). Development of adenocarcinoma in chronic fistula in Crohn's disease. Acta Gastro-Enterologica Belgica, 68 (1, Jan-Mar), 98-100. Peer Reviewed verified by ORBi |
 | Franchimont, N., Reenaers, C., Lambert, C., Belaiche, J., Bours, V., Malaise, M., Delvenne, P., & Louis, E. (December 2004). Increased expression of receptor activator of NF-kappa B ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clinical and Experimental Immunology, 138 (3), 491-498. doi:10.1111/j.1365-2249.2004.02643.x Peer Reviewed verified by ORBi |
 | Franchimont, N., Putzeys, V., Collette, J., Vermeire, S., Rutgeerts, P., De Vos, M., Van Gossum, A., Franchimont, D., Fiasse, R., Pelckmans, P., Malaise, M., Belaiche, J., & Louis, E. (15 September 2004). Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Alimentary Pharmacology and Therapeutics, 20 (6), 607-614. doi:10.1111/j.1365-2036.2004.02152.x Peer Reviewed verified by ORBi |
 | Louis, E., El Ghoul, Z., Vermeire, S., Dall'Ozzo, S., Rutgeerts, P., Paintaud, G., Belaiche, J., De Vos, M., Van Gossum, A., Colombel, J. F., & Watier, H. (01 March 2004). Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Alimentary Pharmacology and Therapeutics, 19 (5), 511-519. doi:10.1111/j.1365-2036.2004.01871.x Peer Reviewed verified by ORBi |
 | Louis, E., & Belaiche, J. (2004). Natural history and risk factors for colorectal cancer in inflammatory bowel disease. Acta Endoscopica, 34, 231-236. doi:10.1007/bf03009009 |
 | Dupont, P., Louis, E., & Belaiche, J. (2004). La video-capsule endoscopique: une nouvelle methode d'exploration du grele. Revue Médicale de Liège, 59 (7-8, Jul-Aug), 445-50. Peer reviewed |
 | Louis, E., Michel, V., Hugot, J. P., Reenaers, C., Fontaine, F., Delforge, M., El Yafi, F., Colombel, J. F., & Belaiche, J. (April 2003). Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut, 52 (4), 552-557. doi:10.1136/gut.52.4.552 Peer Reviewed verified by ORBi |
 | Polus, M., Piront, P., Jerusalem, G., Sautois, B., Louis, E., Detroz, B., Laurent, S., Belaiche, J., & Fillet, G. (April 2003). Prevention primaire et secondaire du cancer colorectal. Revue Médicale de Liège, 58 (4), 247-53. Peer reviewed |
 | Belaiche, J., & Louis, E. (2003). Subocclusion colique precoce apres traitement d'une maladie de Crohn refractaire active par infliximab. Gastroentérologie Clinique et Biologique, 27 (11), 1045-7. Peer Reviewed verified by ORBi |
 | Van Kemseke, C., Belaiche, J., Steeman, C., & Louis, E. (2003). Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease. Acta Gastro-Enterologica Belgica, 66 (1, Jan-Mar), 1-6. Peer Reviewed verified by ORBi |
 | Louis, E. (2003). Epidemiology, clinical presentation and diagnostic strategy of gastro-esophageal reflux. Acta Endoscopica, 33, 679-684. doi:10.1007/BF03002605 |
 | Piront, P., Belaiche, J., & Louis, E. (2003). Revue de l'épidémiologie de la maladie de Crohn en Europe. Acta Endoscopica, 33, 199-205. doi:10.1007/bf03028412 |
 | Kaskas, B. A., Louis, E., Hindorf, U., Schaeffeler, E., Deflandre, J.-L., Graepler, F., Schmiegelow, K., Gregor, M., Zanger, U. M., Eichelbaum, M., & Schwab, M. (January 2003). Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine. Gut, 52 (1), 140-142. doi:10.1136/gut.52.1.140 Peer Reviewed verified by ORBi |
 | Louis, E., & Belaiche, J. (2003). Optimizing treatment with thioguanine derivatives in inflammatory bowel disease. Best Practice and Research. Clinical Gastroenterology, 17 (1), 37-46. doi:10.1053/bega.2002.0346 Peer Reviewed verified by ORBi |
 | Louis, E., & Belaiche, J. (2003). Classification of Crohn's disease - Vienna and Beyond. Inflammatory Bowel Disease Monitor, 5, 49-54. Peer Reviewed verified by ORBi |
 | Berlaiche, J., & Louis, E. (December 2002). Severe lower gastrointestinal bleeding in Crohn's disease: Successful control with infliximab. American Journal of Gastroenterology, 97 (12), 3210-3211. Peer Reviewed verified by ORBi |
Bettiol, J., Sele, J., Henket, M., Louis, E., Malaise, M., Bartsch, P., & Louis, R. (December 2002). Cytokine production from sputum cells after allergenic challenge in IgE-mediated asthma. Allergy, 57 (12), 1145-1150. doi:10.1034/j.1398-9995.2002.23586.x Peer Reviewed verified by ORBi |
 | Louis, E., & Belaiche, J. (October 2002). Behaviour of Crohn's disease according to the Vienna classification - Reply. Gut, 51 (4), 614-615. Peer Reviewed verified by ORBi |
 | Vermeire, S., Louis, E., Carbonez, A., Van Assche, G., Noman, M., Belaiche, J., De Vos, M., Van Gossum, A., Pescatore, P., Fiasse, R., Pelckmans, P., Reynaert, H., D'Haens, G., & Rutgeerts, P. (September 2002). Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease. American Journal of Gastroenterology, 97 (9), 2357-2363. doi:10.1111/j.1572-0241.2002.05991.x Peer Reviewed verified by ORBi |
 | Louis, E. (September 2002). Pharma clinics le medicament du mois. L'esomeprazole. Revue Médicale de Liège, 57 (9), 610-2. Peer reviewed |
 | Piette, C., Polus, M., & Louis, E. (August 2002). Implications pathologiques du systeme neuroendocrinien digestif. Revue Médicale de Liège, 57 (8), 509-18. Peer reviewed |
 | Laurent, S., Detry, O., Detroz, B., De Roover, A., Joris, J., Honore, P., Louis, E., Belaiche, J., & Jacquet, N. (August 2002). Strictureplasty in Crohn's disease : Short- and long-term follow-up. Acta Chirurgica Belgica, 102 (4, JUL-AUG), 253-255. doi:10.1080/00015458.2002.11679307 Peer Reviewed verified by ORBi |
 | Delforge, M., Plomteux, O., Delfosse, V., Fontaine, F., & Louis, E. (August 2002). Oesophage de Barrett: mise au point. Revue Médicale de Liège, 57 (8), 535-45. |
 | Vermeire, S., Louis, E., Rutgeerts, P., De Vos, M., Van Gossum, A., Belaiche, J., Pescatore, P., Fiasse, R., Pelckmans, P., Vlietinck, R., Merlin, F., Zouali, H., Thomas, G., Colombel, J. F., & Hugot, J. P. (July 2002). NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology, 123 (1), 106-111. doi:10.1053/gast.2002.34172 Peer Reviewed verified by ORBi |
 | Louis, E., Vermeire, S., Rutgeerts, P., De Vos, M., Van Gossum, A., Pescatore, P., Fiasse, R., Pelckmans, P., Reynaert, H., D'Haens, G., Malaise, M., & Belaiche, J. (July 2002). A positive response to infliximab in Crohn disease: Association with a higher systemic inflammation before treatment but not with-308 TNF gene polymorphism. Scandinavian Journal of Gastroenterology, 37 (7), 818-824. doi:10.1080/713786515 Peer Reviewed verified by ORBi |
 | Esters, N., Vermeire, S., Joossens, S., Noman, M., Louis, E., Belaiche, J., De Vos, M., Van Gossum, A., Pescatore, P., Fiasse, R., Pelckmans, P., Reynaert, H., Poulain, D., Bossuyt, X., & Rutgeerts, P. (June 2002). Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. American Journal of Gastroenterology, 97 (6), 1458-1462. doi:10.1111/j.1572-0241.2002.05689.x Peer Reviewed verified by ORBi |
 | Louis, E., DeLooze, D., Deprez, P., Hiele, M., Urbain, D., Pelckmans, P., Deviere, J., & Deltenre, M. (March 2002). Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. European Journal of Gastroenterology and Hepatology, 14 (3), 279-284. doi:10.1097/00042737-200203000-00012 Peer Reviewed verified by ORBi |
 | Piront, P., Louis, E., Latour, P., Plomteux, O., & Belaiche, J. (February 2002). Epidemiology of inflammatory bowel diseases in the elderly in the province of Liege - A three-year prospective study. Gastroentérologie Clinique et Biologique, 26 (2), 157-161. Peer Reviewed verified by ORBi |
 | Louis, E. (January 2002). Pharma-clinics le medicament du mois. Le rabeprazole (Pariet). Revue Médicale de Liège, 57 (1), 53-6. Peer reviewed |
 | Baert, F., Schmit, A., D'Haens, G., Dedeurwaerdere, F., Louis, E., Cabooter, M., de Vos, M., Fontaine, F., Naegels, S., Schurmans, P., Stals, H., Geboes, K., & Rutgeerts, P. (2002). Budesonide in Collagenous colitis: A Double-Blind Placebo-Controlled Trial With Histologic Follow-Up. Gastroenterology, 122, 20-25. doi:10.1053/gast.2002.30295 Peer Reviewed verified by ORBi |
 | Van Assche, G., Baert, F., De Reuck, M., Devos, M., De Wit, O., Hoang, P., Louis, E., Mana, F., Pelckmans, P., Rutgeerts, P., Van Gossum, A., & D'Haens, G. (2002). The role of aminosalicylates in the treatment of ulcerative colitis. Acta Gastro-Enterologica Belgica, 65 (4), 196-9. Peer Reviewed verified by ORBi |
 | Belaiche, J., Burette, A., De Vos, M., Louis, E., Huybrechts, M., & Deltenre, M. (2002). Observational survey of NSAID-related upper gastro-intestinal adverse events in Belgium. Acta Gastro-Enterologica Belgica, 65 (2, Apr-Jun), 65-73. Peer Reviewed verified by ORBi |
| Louis, E., & Belaiche, J. (2002). Pregnancy and inflammatory bowel disease. Acta Gastro-Enterologica Belgica, 65 (4, Oct-Dec), 230-232. |
 | Louis, E., Mathieu, A., Oger, A. F., Degroote, E., Aboul Nasr El Yafi, F. A., & Belaiche, J. (December 2001). Behaviour of Crohn's Disease According to the Vienna Classification: Changing Pattern over the Course of the Disease. Gut, 49 (6), 777-82. doi:10.1136/gut.49.6.777 Peer Reviewed verified by ORBi |
 | Denis, M. A., Louis, R., Malaise, M., Belaiche, J., & Louis, E. (February 2001). Increased Response of Blood Eosinophils to Various Chemotactic Agents in Quiescent Crohn Disease. Scandinavian Journal of Gastroenterology, 36 (2), 190-5. doi:10.1080/003655201750065951 Peer Reviewed verified by ORBi |
 | Postal, A., Detry, O., Louis, E., Hardy, N., Belaiche, J., & Jacquet, N. (2001). Ileo-caecal actinomycosis: Report of a case simulating complicated inflammatory bowel disease. Acta Gastro-Enterologica Belgica, 64 (4, Oct-Dec), 318-320. Peer Reviewed verified by ORBi |
 | Louis, E. (2001). The Immuno-Inflammatory Reaction in Crohn's Disease and Ulcerative Colitis: Characterisation, Genetics and Clinical Application. Focus on Tnf Alpha. Acta Gastro-Enterologica Belgica, 64 (1), 1-5. |
 | Belaiche, J., Desager, J. P., Horsmans, Y., & Louis, E. (January 2001). Therapeutic Drug Monitoring of Azathioprine and 6-Mercaptopurine Metabolites in Crohn Disease. Scandinavian Journal of Gastroenterology, 36 (1), 71-6. doi:10.1080/00365520150218084 Peer Reviewed verified by ORBi |
 | Belaiche, J., & Louis, E. (2001). L'azathioprine dans la maladie de Crohn : un traitement toujours d'actualité. Hépato-Gastro, 8, 207-213. |
 | Bettiol, J., Bartsch, P., Louis, R., De Groote, D., Gevaerts, Y., Louis, E., & Malaise, M. (December 2000). Cytokine Production from Peripheral Whole Blood in Atopic and Nonatopic Asthmatics: Relationship with Blood and Sputum Eosinophilia and Serum Ige Levels. Allergy, 55 (12), 1134-41. doi:10.1034/j.1398-9995.2000.00711.x Peer Reviewed verified by ORBi |
 | Louis, R., Leyder, E., Malaise, M., Bartsch, P., & Louis, E. (October 2000). Lack of Association between Adult Asthma and the Tumour Necrosis Factor Alpha-308 Polymorphism Gene. European Respiratory Journal, 16 (4), 604-8. doi:10.1034/j.1399-3003.2000.16d06.x Peer Reviewed verified by ORBi |
 | Belaiche, J., & Louis, E. (September 2000). Traitement de la maladie de Crohn de l'adulte par anticorps anti-tumor necrosis factor-alpha (TNF alpha). Revue Médicale de Liège, 55 (9), 827-32. Peer reviewed |
 | Van Kemseke, C., Belaiche, J., & Louis, E. (August 2000). Frequently Relapsing Crohn's Disease Is Characterized by Persistent Elevation in Interleukin-6 and Soluble Interleukin-2 Receptor Serum Levels During Remission. International Journal of Colorectal Disease, 15 (4), 206-10. doi:10.1007/s003840000226 Peer Reviewed verified by ORBi |
 | Louis, E., Ribbens, C., Barreto Dos Santos, A., Franchimont, D., De Groote, D., Hardy, N., Boniver, J., Belaiche, J., & Malaise, M. (May 2000). Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clinical and Experimental Immunology, 120 (2), 241-246. doi:10.1046/j.1365-2249.2000.01227.x Peer Reviewed verified by ORBi |
 | Louis, E., & Belaiche, J. (May 2000). Reflux gastro-oesophagien de l'adulte: diagnostic et traitement. Revue Médicale de Liège, 55 (5), 341-4. Peer reviewed |
 | Louis, E., Peeters, M., Franchimont, D., Seidel, L., Fontaine, F., Demolin, G., Croes, F., Dupont, P., Davin, L., Omri, S., Rutgeerts, P., & Belaiche, J. (January 2000). Tumour Necrosis Factor (Tnf) Gene Polymorphism in Crohn's Disease (Cd): Influence on Disease Behaviour? Clinical and Experimental Immunology, 119 (1), 64-8. doi:10.1046/j.1365-2249.2000.01106.x Peer Reviewed verified by ORBi |
Melange, M., D'Haens, G., Devos, M., Kartheuser, A., Louis, E., Pattyn, P., Pelckmans, P., Penninckx, F., Potvin, P., Schapira, M., Van de Stadt, J., & Van Gossum, A. V. (2000). The medical management of severe acute and chronic ulcerative colitis--current recommendations from the Belgian Working Group. Acta Gastro-Enterologica Belgica, 63 (3), 273-4. Peer Reviewed verified by ORBi |
 | Belaiche, J., & Louis, E. (2000). Initial Medical Management of Severe Acute Ulcerative Colitis. Acta Gastro-Enterologica Belgica, 63 (3, Jul-Sep), 275-8. |
 | Louis, E., & Belaiche, J. (2000). Genetics of Crohn's Disease Behaviour. Acta Gastro-Enterologica Belgica, 63 (4, Oct-Dec), 377-9. |
 | Belaiche, J., & Louis, E. (2000). Traitement médical des colites aiguës inflammatoires sévères. Hépato-Gastro, 7, 39-45. |
Lamproye, A., Louis, E., Louis, R., & Belaiche, J. (October 1999). Reflux gastro-oesophagien et asthme. Revue Médicale de Liège, 54 (10), 805-8. Peer reviewed |
 | Franchimont, D., Martens, H., Hagelstein, M.-T., Louis, E., Dewé, W., Chrousos, G. P., Belaiche, J., & Geenen, V. (August 1999). Tumor Necrosis Factor Alpha Decreases, and Interleukin-10 Increases, the Sensitivity of Human Monocytes to Dexamethasone: Potential Regulation of the Glucocorticoid Receptor. Journal of Clinical Endocrinology and Metabolism, 84 (8), 2834-9. doi:10.1210/jcem.84.8.5931 Peer Reviewed verified by ORBi |
 | Belaiche, J., Louis, E., D'Haens, G., Cabooter, M., Naegels, S., De Vos, M., Fontaine, F., Schurmans, P., Baert, F., De Reuck, M., Fiasse, R., Holvoet, J., Schmit, A., & Van Outryve, M. (August 1999). Acute Lower Gastrointestinal Bleeding in Crohn's Disease: Characteristics of a Unique Series of 34 Patients. Belgian Ibd Research Group. American Journal of Gastroenterology, 94 (8), 2177-81. doi:10.1111/j.1572-0241.1999.01291.x Peer Reviewed verified by ORBi |
 | Belaiche, J., Van Kemseke, C., & Louis, E. (May 1999). Use of the Enteroscope for Colo-Ileoscopy: Low Yield in Unexplained Lower Gastrointestinal Bleeding. Endoscopy, 31 (4), 298-301. doi:10.1055/s-1999-17 Peer Reviewed verified by ORBi |
 | Louis, E., Louis, R., Shute, J., Lau, L., Franchimont, D., Lamproye, A., Radermecker, M., Djukanovic, R., & Belaiche, J. (May 1999). Bronchial Eosinophilic Infiltration in Crohn's Disease in the Absence of Pulmonary Disease. Clinical and Experimental Allergy, 29 (5), 660-6. doi:10.1046/j.1365-2222.1999.00508.x Peer Reviewed verified by ORBi |
Louis, E., Marquis, P., & Nalet, B. (April 1999). Comment évaluer la sévérité d'un RGO et quels sont les objectifs thérapeutiques? Revue Médicale de Bruxelles, 20 (2), 114-5. |
 | Belaiche, J., & Louis, E. (1999). Maladie de Crohn. Récidives post-opératoires. Conduite à tenir. Acta Endoscopica, 29, 253-262. doi:10.1007/BF03019415 |
 | Louis, E., & Belaiche, J. (1999). Treatment of Inflammatory Bowel Disease with Azathioprine: How to Use It in 1999. Acta Gastro-Enterologica Belgica, 62 (4, Oct-Dec), 437-9. |
 | Franchimont, D., Louis, E., Dupont, P., Vrindts-Gevaert, Y., Dewé, W., Chrousos, G., Geenen, V., & Belaiche, J. (1999). Decreased Corticosensitivity in Quiescent Crohn's Disease: An Ex Vivo Study Using Whole Blood Cell Cultures. Digestive Diseases and Sciences, 44 (6), 1208-15. doi:10.1023/A:1026644711530 Peer Reviewed verified by ORBi |
 | Baert, F., Wouters, K., D'Haens, G., Hoang, P., Naegels, S., D'Heygere, F., Holvoet, J., Louis, E., Devos, M., & Geboes, K. (1999). Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut, 45 (3), 375-81. doi:10.1136/gut.45.3.375 Peer Reviewed verified by ORBi |
 | Belaiche, J., & Louis, E. (1999). Surveillance d'une maladie de Crohn en rémission de l'adulte. Hépato-Gastro, 6, 17-24. |
Franchimont, D. P., Louis, E., Croes, F., & Belaiche, J. (October 1998). Clinical Pattern of Corticosteroid Dependent Crohn's Disease. European Journal of Gastroenterology and Hepatology, 10 (10), 821-5. doi:10.1097/00042737-199810000-00001 Peer Reviewed verified by ORBi |
 | Franchimont, D., Louis, E., Dewé, W., Martens, H., Vrindts-Gevaert, Y., De Groote, D., Belaiche, J., & Geenen, V. (02 January 1998). Effects of Dexamethasone on the Profile of Cytokine Secretion in Human Whole Blood Cell Cultures. Regulatory Peptides, 73 (1), 59-65. doi:10.1016/S0167-0115(97)01063-X Peer Reviewed verified by ORBi |
 | Latour, P., Louis, E., & Belaiche, J. (1998). Incidence of Inflammatory Bowel Disease in the Area of Liege: A 3 Years Prospective Study (1993-1996). Acta Gastro-Enterologica Belgica, 61 (4, Oct-Dec), 410-3. Peer Reviewed verified by ORBi |
 | Belaiche, J., & Louis, E. (1998). Corticosteroid Treatment in Active Crohn's Disease. Acta Gastro-Enterologica Belgica, 61 (2, Apr-Jun), 153-7. |
 | Louis, E., & Belaiche, J. (1998). Nouveaux traitements immunomodulateurs dans la maladie de Crohn. Médecine et Hygiène, 56, 1543-1547. |
 | Louis, E., Franchimont, D., Piron, A., Gevaert, Y., Schaaf-Lafontaine, N., Roland, S., Mahieu, P., Malaise, M., De Groote, D., Louis, R., & Belaiche, J. (1998). Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clinical and Experimental Immunology, 113 (3), 401-406. doi:10.1046/j.1365-2249.1998.00662.x Peer Reviewed verified by ORBi |
 | Belaiche, J., & Louis, E. (1998). Les récidives post-opératoires de la maladie de Crohn. In M. Lemann & R. Modigliani, Les maladies inflammatoires intestinales (pp. 119-132). Paris, France: Doin. |
Franchimont, D., Louis, E., Belaiche, J., & Geenen, V. (1998). Corticosensibilité, corticodépendance et corticorésistance dans les affections inflammatoires et dysimmunitaires. Revue physiopathologique. Revue Médicale de Liège, 53, 33-37. Peer reviewed |
 | Louis, E., Belaiche, J., Van Kemseke, C., Franchimont, D., de Groote, D., Geenen, V., & Mary, J. Y. (October 1997). A High Serum Concentration of Interleukin-6 Is Predictive of Relapse in Quiescent Crohn's Disease. European Journal of Gastroenterology and Hepatology, 9 (10), 939-44. doi:10.1097/00042737-199710000-00004 Peer Reviewed verified by ORBi |
 | Louis, E., Moutschen, M., de Marneffe, P., Malherbe, R., Closon, T., T'Jean, M., Demonty, J., & Belaiche, J. (1997). Extensive Ulcerative Colitis and Extraintestinal Manifestations in a Patient with Hiv Infection and Significant Cd4 T-Cell Lymphopenia. Gastroentérologie Clinique et Biologique, 21 (11), 884-7. Peer Reviewed verified by ORBi |
 | Franchimont, D., Belaiche, J., Louis, E., Simon, S., GrandBastien, B., Gower-Rousseau, C., Fontaine, F., & Delforge, M. (1997). Familial Crohn's Disease: A Study of 18 Families. Acta Gastro-Enterologica Belgica, 60 (2, Apr-Jun), 134-7. Peer Reviewed verified by ORBi |
 | Roussomoustakaki, M., Satsangi, J., Welsh, K., Louis, E., Fanning, G., Targan, S., Landers, C., & Jewell, D. P. (1997). Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology, 112 (6), 1845-53. doi:10.1053/gast.1997.v112.pm9178675 Peer Reviewed verified by ORBi |
Tettelin, H., Carbone, M., Albermann, K., Albers, M., Arroyo, J., Backes, U., Barreiros, T., Bertani, I., Bjourson, A., Bruckner, M., Bruschi, C., Verhasselt, P., Voet, M., Volckaert, G., Wambutt, R., Watson, M., Weber, N., Wedler, E., Wedler, H., ... Vanoni, M. (1997). The Nucleotide Sequence Of Saccharomyces Cerevisiae Chromosome Vii. Nature, 387 (6632), 81-84. doi:10.1038/387s081 Peer Reviewed verified by ORBi |
Dujon, B., Albermann, K., Aldea, M., Alexandraki, D., Ansorge, W., Arino, J., Benes, V., Bohn, C., Bolotinfukuhara, M., Bordonne, R., Boyer, J., Camasses, A., Casamayor, A., Casas, C., Cheret, G., Cziepluch, C., Daignanfornier, B., Dang, D., Dehaan, M., ... Kleine, K. (1997). The Nucleotide Sequence Of Saccharomyces Cerevisiae Chromosome Xv. Nature, 387 (6632), 98-102. doi:10.1038/387s098 Peer Reviewed verified by ORBi |
 | Belaiche, J., & Louis, E. (1997). Le traitement corticoïde dans les poussées de la maladie de Crohn de l'adulte. Médecine et Hygiène, 55, 1485-1491. |
 | Louis, E., & Belaiche, J. (1997). Genetics and Inflammatory Bowel Disease: From Association Studies to Wide Genome Screen. Acta Gastro-Enterologica Belgica, 60 (3, Jul-Sep), 201-3. |
Johnston, M., Hillier, L., Riles, L., Albermann, K., André, B., Ansorge, W., Benes, V., Bruckner, M., Delius, H., Dubois, E., Dusterhoft, A., Entian, K., Floeth, M., Goffeau, A., Hebling, U., Heumann, K., Heussneitzel, D., Hilbert, H., Hilger, F., ... Hoheisel, J. (1997). The Nucleotide Sequence Of Saccharomyces Cerevisiae Chromosome XII. Nature, 387 (6632), 87-90. doi:10.1038/387s087 Peer Reviewed verified by ORBi |
Louis, E., Drion, V., & Belaiche, J. (1996). Utilisation des antibiotiques dans la maladie de Crohn : de la théorie à la pratique. Médecine et Hygiène, 54, 1464-1468. |
 | Louis, E., Satsangi, J., Roussomoustakaki, M., Parkes, M., Fanning, G., Welsh, K., & Jewell, D. (1996). Cytokine gene polymorphisms in inflammatory bowel disease. Gut, 39 (5), 705-10. doi:10.1136/gut.39.5.705 Peer Reviewed verified by ORBi |
Franchimont, D., Louis, E., Simon, S., & Belaiche, J. (1996). Intestinal Permeability in Crohn's Disease. Acta Gastro-Enterologica Belgica, 59 (1, Jan-Mar), 15-9. Peer Reviewed verified by ORBi |
 | Satsangi, J., Parkes, M., Louis, E., Hashimoto, L., Kato, N., Welsh, K., Terwilliger, J. D., Lathrop, G. M., Bellings, J., & Jewell, D. P. (1996). Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genetics, 14 (2), 199-202. doi:10.1038/ng1096-199 Peer Reviewed verified by ORBi |
Latour, P., Belaiche, J., Louis, E., Fontaine, F., Deflandre, J.-L., Loly, J., Oger, A., Defrance, P., Di Valentin, A., Delforge, M., Daenen, G., Lebas, M., Mohr, E., Wain, E., Gillard, C., & Thys, C. (1996). Incidence of Inflammatory Bowel Disease in the Province of Liege (Belgium). La Societe De Gastroenterologie Liegeoise. Acta Gastro-Enterologica Belgica, 59 (1, Jan-Mar), 3-6. Peer Reviewed verified by ORBi |
 | Louis, E., Franchimont, D., Deprez, M., Lamproye, A., Schaaf-Lafontaine, N., Mahieu, P., & Belaiche, J. (1996). Decrease in systemic tolerance to fed ovalbumin in indomethacin-treated mice. International Archives of Allergy and Immunology, 109 (1), 21-6. doi:10.1159/000237227 Peer Reviewed verified by ORBi |
Galibert, F., Alexandraki, D., Baur, A., Boles, E., Chalwatzis, N., Chuat, J., Coster, F., Cziepluch, C., Dehaan, M., Domdey, H., Durand, P., Entian, K., Gatius, M., Goffeau, A., Grivell, L., Hennemann, A., Herbert, C., Heumann, K., Hilger, F., ... Karpfingerhartl, L. (1996). Complete Nucleotide Sequence Of Saccharomyces Cerevisiae Chromosome X. EMBO Journal, 15 (9), 2031-2049. doi:10.1002/j.1460-2075.1996.tb00557.x Peer Reviewed verified by ORBi |
 | Louis, E., Franchimont, D., Lamproye, A., Van Kemseke, C., Schaaf-Lafontaine, N., Mahieu, P., & Belaiche, J. (September 1995). Systemic Immune Response after Rectocolonic Administration of Ovalbumin in Mice. International Archives of Allergy and Immunology, 108 (1), 19-23. doi:10.1159/000237112 Peer Reviewed verified by ORBi |
 | Louis, E., Belaiche, J., Van Kemseke, C., Schaaf-Lafontaine, N., Mahieu, P., & Mary, J. Y. (August 1995). Soluble Interleukin-2 Receptor in Crohn's Disease. Assessment of Disease Activity and Prediction of Relapse. Digestive Diseases and Sciences, 40 (8), 1750-6. doi:10.1007/BF02212697 Peer Reviewed verified by ORBi |
 | Louis, E., Louis, R., Drion, V., Bonnet, V., Lamproye, A., Radermecker, M., & Belaiche, J. (1995). Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy, 50 (9), 729-33. doi:10.1111/j.1398-9995.1995.tb01214.x Peer Reviewed verified by ORBi |
 | Louis, E., & Belaiche, J. (1995). Hydroxychloroquine (Plaquenil) for recurrence prevention of Crohn's disease after curative surgery. Gastroentérologie Clinique et Biologique, 19 (2), 233-4. Peer Reviewed verified by ORBi |
 | Louis, E., Lamproye, A., FRANCHIMONT, D., Van Kemseke, C., Schaaf-Lafontaine, N., MAHIEU, P., & Belaiche, J. (1995). Induction of cellular, but not humoral, tolerance to ovalbumin by direct injection into digestive tract segments or mesenteric lymph nodes in mice. Regional Immunology, 6, 251-256. Peer Reviewed verified by ORBi |
 | Belaiche, J., & Louis, E. (1995). Récidive post-opératoire de la maladie de Crohn après chirurgie curatrice : pathogénie et prévention. Hépato-Gastro, 2, 123-128. |
 | Belaiche, J., Houbiers, G., & Louis, E. (1995). Foie et maladies inflammatoires du tube digestif. Médecine et Hygiène, 53, 1618-1621. |
 | Belaiche, J., & Louis, E. (1994). Récidive post-opératoire de la maladie de Crohn après chirurgie curatrice. Médecine et Hygiène, 52, 1645-1651. |
 | Belaiche, J., Delwaide, J., & Louis, E. (1994). Gastroentéropathies avec pertes de protéines. In Encyclopédie médico-chirurgicale. |
Lamproye, A., Belaiche, J., Louis, E., Salmon, J., & Mahieu, P. (1994). Anticorps anticytoplasme des polynucléaires neutrophiles (ANCA) dans les maladies inflammatoires du tube digestif. Acta Gastro-Enterologica Belgica, 57 (2, Mar-Apr), 171-6. Peer Reviewed verified by ORBi |
Dujon, B., Esteban, P., Fernandes, L., Fobo, G., Fritz, C., Fukuhara, H., Gabel, C., Gaillon, L., Carciacantalejo, J., Garciaramirez, J., Gent, M., Ghazvini, M., Goffeau, A., Gonzalez, A., Grothues, D., Guerreiro, P., Hegemann, J., Hewitt, N., Hilger, F., ... Mewes, H. (1994). Complete Dna-Sequence Of Yeast Chromosome-Xi. Nature, 369 (6479), 371-378. doi:10.1038/369371a0 Peer Reviewed verified by ORBi |
 | Louis, E., & Belaiche, J. (1994). Experimental Models of Inflammatory Bowel Disease. Acta Gastro-Enterologica Belgica, 57 (5-6, Sep-Dec), 306-9. |
Belaiche, J., Delwaide, J., Vivario, M., Gast, P., Louis, E., & Boniver, J. (1993). Fundic Argyrophil Cell Hyperplasia in Atrophic Gastritis: A Search for a Sensitive Diagnostic Method. Acta Gastro-Enterologica Belgica, 56 (1, Jan-Feb), 11-7. Peer Reviewed verified by ORBi |
Delwaide, J., Latour, P., Gast, P., Louis, E., & Belaiche, J. (1993). Effects of Proglumide and Enprostil on Omeprazole-Induced Fundic Endocrine Cell Hyperplasia in Rats. Gastroentérologie Clinique et Biologique, 17 (11), 792-6. Peer Reviewed verified by ORBi |
 | Louis, E., Belaiche, J., Franchimont, D., Delwaide, J., & Gast, P. (1993). Apports récents de la génétique dans les maladies inflammatoires intestinales. Acta Clinica Belgica, 48 (6), 383-91. Peer Reviewed verified by ORBi |
Belaiche, J., Delwaide, J., Louis, E., & Gast, P. (1993). Les cellules ECL et leurs récepteurs: rôle physiologique et intérêt physiopathologique. Acta Gastro-Enterologica Belgica, 56 (3-4, May-Aug), 235-44. Peer Reviewed verified by ORBi |
Louis, E., Belaiche, J., Delwaide, J., & Gast, P. (November 1992). Alternatives thérapeutiques dans la maladie de Crohn et la rectocolite ulcero-hémorragique: données actuelles. Revue Médicale de Liège, 47 (11), 573-8. Peer reviewed |
Gueenen, V., Franchimont, N., Louis, E., Robert, F., de Groote, D., & Franchimont, P. (1992). Nouvelles approches pharmacologiques basées sur les interactions neuro-endocrino-immunitaires. Médecine et Hygiène, 50, 2076-2077. |
Geenen, V., Franchimont, N., Louis, E., Robert, F., De Groote, D., & Franchimont, P. (1992). Nouvelles approches pharmacologiques basées sur les interactions neuroendocrino-immunitaires. Médecine et Hygiène, 50, 2076-2077. Peer Reviewed verified by ORBi |
Belaiche, J., Delwaide, J., Louis, E., & Gast, P. (1992). Les cellules enterochromaffin-like (ECL) : de la physiologie à la pathologie. Médecine et Hygiène, 50, 2070-2074. |
Delwaide, J., Louis, E., Gast, P., & Belaiche, J. (January 1991). Traitement immunosuppresseur et maladie de Crohn. Revue Médicale de Liège, 46 (1), 22-8. Peer reviewed |
Louis, E., & Belaiche, J. (1991). Maladie de Crohn : de l'immunopathologie aux perspectives thérapeutiques. Médecine et Hygiène, 49, 3402-3406. |
Belaiche, J., Delwaide, J., Louis, E., & Gast, P. (January 1991). Les nouveaux dérivés de la salazosulfapyridine dans le traitement de la maladie de Crohn. Revue Médicale de Liège, 46 (1), 16-22. Peer reviewed |
Louis, E., Belaiche, J., Gast, P., & Delwaide, J. (January 1991). Aspects immunologiques actuels de la maladie de Crohn. Revue Médicale de Liège, 46 (1), 2-11. Peer reviewed |
Belaiche, J., Louis, E., Delwaide, J., & Gast, P. (January 1991). Les indices d'activité dans la maladie de Crohn. Revue Médicale de Liège, 46 (1), 11-5. Peer reviewed |
 | Delwaide, J., Vivario, M., Belaiche, J., Louis, E., Courtoy, R., Gast, P., & Boniver, J. (1991). Ultrastructural demonstration of histamine in human enterochromaffin like cell granules. Gut, 32 (7), 834. doi:10.1136/gut.32.7.834 Peer Reviewed verified by ORBi |
 | Louis, E., Servais, B., & Belaiche, J. (June 1990). L'état inflammatoire physiologique de la muqueuse digestive. Revue Médicale de Liège, 45 (6), 303-10. Peer reviewed |
Servais, B., Colombel, J. F., Louis, E., & Belaiche, J. (1990). Système immunitaire digestif et peptides neuroendocrines. Revue Médicale de Liège, XLV 7, 335-342. Peer reviewed |
 | Louis, E. (1989). Les intégrines leucocytaires : de la biologie moléculaire à l'immunopathologie et l'immunorégulation. Revue Médicale de Liège, XLIV 20, 615-625. Peer reviewed |
 | Louis, E., Philippet, B., Cardos, B., Heinen, E., Cormann, N., Kinet-Denoel, C., Braum, M., & Simar, L. J. (1989). Intercellular Contacts between Germinal Center Cells. Mechanisms of Adhesion between Lymphoid Cells and Follicular Dendritic Cells. Acta Oto-Rhino-Laryngologica Belgica, 43 (4), 297-320. Peer reviewed |
Heinen, E., Braun, M., Louis, E., Cormann, N., Tsunoda, R., Kinet-Denoel, C., Lesage, F., & Simar, L. J. (1988). Interactions between follicular dendritic cells and lymphoid cells. Advances in Experimental Medicine and Biology, 237, 181-4. doi:10.1007/978-1-4684-5535-9_26 Peer Reviewed verified by ORBi |
